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Abstract
Peripheral nerves are complex structures that have the ability to regenerate 
after injury in contrast to the central nervous system. Nonetheless, depending 
on the severity of the trauma, peripheral nerve injuries can cause life-long 
functional disabilities. It is widely believed that neurosurgical repair of injured 
peripheral nerves has reached its optimal refinement 1. Unfortunately, 
functional recovery following nerve repair is never complete. There is, 
therefore, a clinical need for novel strategies to promote axon regeneration 
following a nerve injury. Significant progress has been made to understand 
the role of different cell types and molecular processes that govern the 
regenerative response of an injured peripheral nerve. In this thesis we 
investigated the role of Wnt genes in peripheral nerve regeneration. Wnt 
genes encode highly conserved secreted glycoproteins that are involved 
in tissue regeneration, Schwann cell development and axon outgrowth. 
This suggests that Wnt signalling may play a role in PNS regeneration. 
Recently, we have shown that the expression of several Wnt-genes is 
regulated in the injured human peripheral nerve. Wnt signalling involves a 
number of intersecting molecular pathways, which include a range of Wnt 
ligands, receptors, extracellular modulators and downstream intracellular 
signalling molecules. Here we will first review the cellular and molecular 
changes that occur following a peripheral nerve after injury.  Secondly, 
we give an overview of what is currently known about the complex Wnt-
signalling pathways and finally we provide the scope and outline of this 
thesis. 
1. Peripheral nerves
Peripheral nerves are essential for the communication between the 
central nervous system (CNS; comprised of the brain and spinal cord) and 
the body. Peripheral nerves of the somatic nervous system relay sensory 
(afferent) information from muscles, skin and internal organs to the CNS 
and motor (efferent) impulses from the CNS towards muscles (Fig. 1). While 
most nerves contain both sensory and motor axons, some nerves contain 
exclusively motor or sensory axons. The dorsal root ganglia (DRG) contain 
the cell bodies of sensory neurons of the peripheral nervous system (PNS). 
On both sides, 31 DRG’s are located alongside the human spinal column. 
All sensory neurons have a pseudo-unipolar phenotype: they possess one 
axonal process with two branches. The peripheral branch runs through a 
peripheral nerve and innervates end organs in the skin (amongst which 
for instance the Pacini and Rufini bodies) or muscle spindles. The central 
branch ascends through a dorsal spinal root filament towards the dorsal 
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column in the spinal cord. Cell bodies of the motor neurons are located 
in the ventral horn of the spinal cord. The axons of motor neurons leave 
the spinal cord through a ventral spinal root filament and innervate the 
muscles (Fig 1). 
Peripheral nerves are composed of multiple cell types (Fig. 2) 2-4. Besides 
nerve fibres, nerves contain at least three types of fibroblasts, myelinating 
and non-myelinating Schwann cells, macrophages and blood vessels. 
The connective tissue of the peripheral nerve consists of three sheaths: 
the epineurium, perineurium and endoneurium. The epineurium is 
a strong layer of fibroblasts which ensheaths the whole nerve. In the 
nerve, axons are bundled in structures called fascicles. Another layer of 
fibroblasts, called the perineurium, covers the fascicles. Inside the fascicles, 
endoneurial fibroblasts are diffusely distributed between nerve fibres and 
Schwann cells. Endoneurial fibroblasts are often observed near blood 
vessels or situated in a parallel orientation under the fibroblasts sheet of 
the perineurium 2,3. 
Figure 1. Anatomy of the peripheral nervous system
Schematic representation of peripheral nerves of the somatic nervous system. Peripheral 
nerves relay sensory information from muscles, skin and internal organs to the CNS. The cell 
bodies of these sensory neurons are located in DRG located alongside the spinal cord (purple 
and green circles). Input from muscle spindles is directly synapsed on motor neurons, which 
reside in the ventral horn of the spinal cord (orange stars). The axons of motor neurons leave 
the spinal cord through a ventral spinal root filament and innervate the muscles.
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Schwann cells are the resident glia cells of the peripheral nerve. Schwann 
cells are intimately associated with axons and are essential for their 
maintenance 5. A basal lamina tube surrounds the Schwann cell and 
axon. There are two principal types of Schwann cells: myelinating and 
non-myelinating Schwann cells. Myelinating Schwann cells produce an 
insulating, lipid-rich, myelin sheath around axons. The myelin sheath is not 
continuous along the entire axon. Schwann cells line up along the axon 
with small intermitting ‘gaps’, named nodes of Ranvier. The axonal plasma 
membrane at nodes of Ranvier is greatly enriched in voltage gated ion 
channels. The organization of these channels is essential for the ‘saltatory’ 
action potential propagation 6-8. Non-myelinating Schwann cells envelop 
multiple axons. Since these types of axons (c-fibres) are not myelinated they 
propagate action potentials relatively slowly 9. Furthermore, delta fibres are 
thinly myelinated and display intermediate action propagation velocity. 
Next to the traditional categorization in non-myelinating and myelinating 
Schwann cells, Schwann cells of motor and sensory pathways display 
different molecular characteristics and therefore represent phenotypic 
Schwann cell variants 10.
Blood vessels can be found throughout the epineurium and smaller 
capillaries are found in the endoneurium. The intact peripheral nerve is 
Figure 2. Anatomy of the peripheral nerve
Nerves consist of various cell types. Next to nerve fibres, nerves contain at least three types 
of fibroblasts, myelinating and non-myelinating Schwann cells, macrophages and blood 
vessels. The epineurium is a strong layer of fibroblasts which ensheaths the whole nerve. In 
the nerve, axons are bundled in structures called fascicles. Another layer of fibroblasts, called 
the perineurium, covers the fascicles. Inside the fascicles, endoneurial fibroblasts are diffusely 
distributed between nerve fibres and Schwann cells. (adapted from openstax CNX, chapter 13.4)
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an immune-privileged organ. The blood-nerve-barrier consists of the 
endoneurial capillaries and perineurial sheath 11. Macrophages are the 
primary source of antigen presenting cells of the PNS. In the intact peripheral 
nerve, relatively low numbers (2-9% of the endoneurial cells) of resident 
macrophages are present 12. When the nerve is injured, macrophage 
numbers can increase ~10 fold, as macrophages in the circulation are 
actively recruited to the site of injury 13. 
2 Peripheral nerve injury
The leading cause of peripheral nerve injury is trauma to the extremities due 
to traffic, sports or domestic accidents 14. It is estimated that approximately 
67.000 individuals sustain a peripheral nerve injury in the United States 
annually 15,16. Peripheral nerve injury is a rather heterogeneous condition. 
Lesions range from brachial plexus injuries to injuries of distal nerves e.g. 
the digital nerves in the hand. Depending on the location and severity of 
the injury a certain degree of functional recovery may occur. Following 
a sharp injury of a digital nerve sensation usually returns several months 
after surgical repair. In contrast, recovery of function is usually very limited 
following repair of lesions of one or more nerves of the brachial plexus. 
Human peripheral nerve injuries are classified depending on the severity 
of the injury 17. Sunderland devised a five-tier classification system, based 
on the extent of damage to the basal lamina tubes, axons, and the 
epineurium. In first-degree injuries (also called neurapraxia) basal lamina 
tubes and the epineurium are intact and there is axonal continuity but there 
is a physiological block of nerve conduction. These patients do not require 
surgical intervention to regain functional recovery. Second-degree injuries 
(also called axonotmesis) comprise a disruption of axonal continuity and 
myelin, but the basal lamina tubes remain intact. Complete functional 
recovery often occurs after this type of injury. Third-degree injuries are 
characterized by severed axons and endoneurium, but the epineurum and 
perineurium remain continuous. Spontaneous recovery of this type of injury 
is possible, although surgery might be needed. Fourth-degree injuries are 
injuries where only the epineurium remains continuous, and fourth-degree 
injuries typically require surgical intervention. In fifth-degree injuries the 
continuity of the nerve is entirely lost due to rupture. Recovery without 
reconstructive nerve surgery will not take place. Later the classification 
‘neuroma-in-continuity’ (NIC) was added indicating a continuous nerve 
with excessive fibrosis that contains a mixture of the above mentioned 
injuries 18. The formation of a NIC interferes with functional recovery, 
although the exact mechanisms how this occurs remain elusive. Currently, 
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the best strategy for NIC treatment is resection, followed by autologous 
nerve grafting. 
2.1 Axonal regeneration
The ability of the PNS to mount a regenerative response has been the 
subject of extensive study. Upon axonal injury, the proximal axonal segment 
retracts approximately 2 mm from the site of injury. The axons in the distal 
nerve segment disintegrate and the debris is removed a process known as 
Wallerian degeneration 19. Injured peripheral axons in the proximal stump 
form a growth cone and have the ability to regrow and re-innervate muscle 
and skin. The growth cone functions both as the site of axonal extension, and 
detects axon guidance cues to navigate the growing axon in the correct 
direction 20. When the regenerating axon has found a basal lamina tube 
that it can enter, axon growth continues at a speed of 2 to 4 mm a day in 
rats. Following a transection injury the basal lamina tubes are interrupted. 
Following nerve repair, part of the injured axons will successfully cross the 
repair site which occurs in an at random fashion. As a result, an axon may 
end up in a basal lamina tube that was originally occupied by another 
axon. This can result in inappropriate innervation of target cells (also called 
misrouting) which interferes with functional recovery, when for instance 
antagonistic muscles are innervated 21. 
Following a lesion, the nucleus of a neuron translocates to the periphery of 
the cell body and the endoplasmatic reticulum (ER) disperses. This process 
is usually referred to as chromatolysis. An injured neuron switches from 
a state in which it conveys electrical signals to its target cells (a “synaptic 
transmission state”), to an axonal growth and repair state 22. Upon injury, 
multiple retrograde signals are transported from the periphery to the 
neuronal cell body. First there is an initial rapid ion flux, followed by importin-
mediated retrograde transport of neurotrophic factors and cytokines such 
as LIF, IL-6 and transcription factor STAT3 to the cell body 23,24. These signals 
are thought to govern changes in neuron-intrinsic gene expression which 
are usually referred to as the regeneration-associated gene (RAG)-program 
25-27 (reviewed in 28). Microarray studies on the gene expression changes in 
axotomized DRG neurons showed that the RAG-program consists of several 
hundred RAGs29-31, encompassing a large number of gene classes including 
receptors, neuropeptides, signal transduction molecules, ion channels, 
growth cone proteins such as Gap43 32 and transcriptional regulators, for 
instance ATF3, c-Jun, KLF7, NFIL-3 and Smad1 33-35. Next to changes in the 
transcriptional program, epigenetic modifications have been found, for 
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instance acetylation of Histone 3 Lys 9 by histone acetyltransferases as 
PCAF, which are essential for the initiation of axon regeneration 36,37.
2.2 Schwann cells are essential for PNS regeneration
Upon injury, Schwann cells distal from the injury site de-differentiate, 
re-enter the cell cycle and are transformed from a myelinating towards 
an axonal growth supportive phenotype 38. Myelin is phagocytized 
by both macrophages and de-differentiated Schwann cells 39,40. 
Proliferating Schwann cells form structures called ‘bands of Bunger’ 
which provide structural guidance for regenerating axons 41. In addition 
to structural support, de-differentiated Schwann cells produce and 
secrete a multitude of axonal growth factors that stimulate and guide 
regenerating axons towards their proper end organs, including (but not 
limited to) nerve growth factor (NGF) 42, brain-derived neurotrophic 
factor (BDNF) 43, and glial cell-line derived neurotrophic factor (GDNF) 44-
46. Regenerating axons grow at a pace of only 2 to 4 mm per day in the 
rat. It can therefore take a considerable time before regenerating axons 
reach their targets. This, together with the relatively short time during 
which denervated Schwann cells are able to provide a growth supportive 
environment 47,48, results in a ‘window of opportunity’ of around 3 months 
for successful PNS regeneration in the rat 24,49. Proximal peripheral nerve 
injuries typically result in dissatisfactory functional recovery because axons 
have to bridge long distances. Schwann cell regenerative support may 
have come to an end by the time the tip of the axon has bridged a long 
distance reducing further outgrowth. After Schwann cell - axon contact has 
been re-established, axonally expressed Neuregulin 1 type I and type III, 
initiates the re-myelination response of Schwann cells 50,51. At first, myelin 
sheaths are thin and inter-nodal distances are short, which results in slower 
conduction of action potentials 52. Conduction velocities remain decreased 
years after reconstructive nerve surgery, indicating that the process of re-
myelination is a slow process.
The process through which Schwann cells de-differentiate to adopt a pro-
regenerative phenotype after nerve injury is only partly understood. Upon 
nerve injury, Schwann cells in the distal nerve segment lose contact with 
their axons because of the Wallerian degeneration. Following the loss of 
axonal contact, multiple transcription factors, including c-Jun and Sox2, 
govern Schwann cell de-differentiation from a myelinating towards a pro-
regenerative cell 38,53,54. These transcription factors drive the de-myelination 
process and re-entry into the cell cycle, as well as the expression of 
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neurotrophic factors. The current notion is that there are distinct molecular 
drivers that activate the de-myelination and the myelination gene program 
55. These programs are thought to cross inhibit each other, and appropriate 
regulation of both pro- and de-myelination signals is essential for myelin 
formation and for remyelination of newly formed axons following an 
injury 55.
2.2.1 Drivers of demyelination
Mature, myelinating Schwann cells express very low levels of c-Jun, but its 
expression is quickly induced upon injury. C-Jun plays a major role in the 
de-differentiation of Schwann cells from a myelinating cell towards a repair 
cell 38,53. Myelination in PNS development is not affected in mice in which the 
c-Jun gene is conditionally mutated in their Schwann cells, but these mice do 
display a delayed clearance of myelin 53, and a notable loss of regenerative 
capacity and functional recovery upon nerve injury 38. Another transcription 
factor that acts as a negative regulator of myelination is sex-determining 
region Y-box 2 (Sox2). Sox2 is co-regulated with c-Jun in de-differentiating 
Schwann cells 53. Furthermore, viral vector-mediated overexpression of 
Sox2 in cultured Schwann cells blocked the expression of myelin-associated 
genes and these Schwann cells failed to myelinate in-vitro 54. Sox2 is not 
regulated by c-Jun, as c-Jun conditional mutant mice are still able to up-
regulate Sox2 after nerve injury 38. Upon nerve transection, Sox2 mediates 
important functions of Schwann cells, including their capacity to bridge a 
tissue gap, a process which is initiated by Eph-B of fibroblast origin 56. Other 
negative signalling pathways that have a role in myelination include notch 
57 , Pax3 58 and ERK signalling 59.
2.2.2 Drivers of myelination
Transcription factors that drive myelination are expressed in Schwann cells 
during both development and re-myelination. One of the essential drivers 
of myelination and myelin maintenance is the transcription factor Krox20 
(also known as Egr2) 60-62. Krox20 activates various myelin genes 63, and 
suppresses multiple genes with a role in immature Schwann cells including 
c-Jun and Sox2 54,64. Krox20 mutant mice demonstrate a specific myelination 
deficit in peripheral nerves. Radial sorting and the 1:1 relationship between 
axons and Schwann cells remain intact, but myelin sheaths are not 
formed 60. Another key transcription factor for myelination is Sox10. Sox10 is 
necessary for the expression of Oct6 65, a transcription factor that governs 
the progression from Schwann cell precursor cells to mature Schwann cells 
and is involved in the initiation of myelination 66,67. Other factors that have 
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been implied in myelination in-vitro are NFκB and cAMP 68,69, although 
this has not been reproduced in-vivo 70. From these findings, an ever 
more complete picture of the intricate molecular network that controls the 
differentiation state of Schwann cells is gradually emerging. 
2.3 Macrophages regulate nerve regeneration.
Macrophages are innate immune-cells that play a key role in the early stages 
of peripheral nerve regeneration (reviewed in 71). De-differentiated Schwann 
cells release multiple cytokines and chemokines that attract macrophages 
from the circulation 59,72,73. Macrophages are the most abundant immune 
cell that infiltrate in an injured nerve 72 and are essential for the process of 
Wallerian degeneration after nerve injury 74. The importance of Wallerian 
degeneration is illustrated by the finding that aged animals demonstrate a 
slowed clearance of myelin, this is reported to be the cause of decreased 
axonal regeneration in aged animals 75.
Following a nerve transection, macrophages are among the first cells to 
populate the gap between the nerve stumps. In the newly formed tissue 
‘bridge’, they respond to the hypoxic environment by producing vascular 
endothelial growth factor (VEGF), which stimulates blood vessel formation. 
These newly formed blood vessels guide Schwann cells in their migration 
over the bridge to connect the proximal and distal nerve stumps 76. Lastly, 
recent studies have demonstrated a role for macrophages in the axon 
regeneration process itself. Depletion of macrophages by either clodronate 
or ganciclovir results in a significant inhibition of PNS regeneration of both 
sensory and motor fibres 77,78. 
2.4 Fibroblasts in neuroregeneration and neural scarring
Connective tissue in peripheral nerves consists mostly of fibroblasts and the 
extracellular matrix they secrete. Fibroblasts play a key role in peripheral 
nerve regeneration. Following a nerve transection, they are among the first 
(together with macrophages) to populate the gap that is formed between 
the two nerve stumps. Furthermore, fibroblasts interact with Schwann 
cells and impede their proliferation and increase their motility after nerve 
injury 79. Fibroblasts can have a negative influence on nerve regeneration. 
Especially in human PNS injury, fibroblasts proliferate vigorously and 
contribute to the formation of a nerve scar also known as a Neuroma-in-
continuity (NIC). The formation of an NIC in the injured human nerve hampers 
recovery of function 80. The biological mechanism how a NIC interferes 
with functional recovery is not fully understood. Fibroblasts produce a 
17
1
non-permissive, inhibitory extracellular matrix consisting of Chondroitin 
sulphate proteoglycans (CSPGs) 81 and repulsive axon guidance proteins, 
such as Sema3A 82. It is believed that this non-permissive environment 
hampers and misdirects axonal growth through the NIC. However the non-
permissive environment of the NIC alone cannot explain why regenerated 
axons, which are regularly observed in high numbers distal from NIC tissue 
83, are not accompanied by a return of function. The presence of axons 
in the distal stump is corroborated by electromyographical studies. Three 
months after the initial injury, axonal continuity towards the biceps muscle 
was measured in more than 90% of NIC patients without any signs of clinical 
recovery 84. This indicates that the formation of a NIC influences the function 
of traversing axons in other ways. We recently demonstrated that in a large 
proportion of patients with a NIC multiple focal myelin deficits are present 
which may contribute to the conduction block often observed in patients 
with an NIC 85-87 and the observed poor functional recovery.
2.5 Strategies to improve PNS regeneration
Although the advances in surgical repair techniques have resulted in 
considerable improvements in recovery after PNS injury, many patients 
remain with substantial functional impairments for the rest of their lives. 
Multiple factors that are currently beyond the control of the nerve surgeon 
limit the functional recovery after nerve injury.
Various lines of investigation have tested experimental strategies to improve 
the regenerative capacity of an injured peripheral nerve: 1) Artificial nerve 
conduits in combination with cell transplantation have been developed 
to bridge gaps formed in larger nerve traumas, 2) Brief per-operative 
electrical stimulation (ES) has been used to promote axon regeneration and 
3) Molecular approaches have been used to stimulate the regenerative 
response of the injured nerve. 
In extensive nerve traumas, such as NIC, reconstruction of the nerve with an 
autologous nerve graft is often necessary 88-90. A large body of research has been 
performed to develop artificial nerve conduits that can serve as a nerve graft in 
reconstructive nerve surgery without the need for a donor nerve 91-93. Interesting 
developments in this field include the use of conduits that release neurotrophic 
factors 94,95. Furthermore, conduits that are populated with Schwann cells 96-98 
and Schwann cell transplantations have been used to bridge a nerve gap 99-101. 
Although artificial nerve conduits are continuously improving, the autologous 
nerve graft remains the best way to repair a nerve so far. 
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A noteworthy technique that is being investigated to speed up PNS 
regeneration is ES of the injured nerve 102. ES boosts the expression of the 
neurotrophic factor BDNF and its receptor TrkB in regenerating motorneurons 
103. Furthermore, ES stimulates re-myelination of focally demyelinated 
nerves 104. Two clinical studies have now demonstrated the beneficial effects 
of electrical stimulation in human PNS injury 106,107. In carpal tunnel patients 
axon growth was significantly accelerated by ES 106. In patients with digital 
nerve transection that underwent reconstructive epineurial nerve surgery, 
ES significantly increased sensory recovery 107. 
A central problem that hampers functional recovery of PNS injuries is 
that Schwann cells are unable to maintain their pro-regenerative state 
for prolonged periods of time 24,108. Although the transcription factors that 
control the Schwann cell phenotype are reasonably well described, it 
is currently unclear why denervated Schwann cells are unable to retain 
their pro-regenerative state for prolonged periods. Further research into 
factors that endogenously influence the repair phenotype of Schwann cells 
is therefore essential. Hopefully, newly identified factors can not only be 
modified to enable Schwann cells to maintain their pro-regenerative state, 
but also to efficiently switch Schwann cells towards a myelinating phenotype 
after re-innervation has taken place. Recently, it has been demonstrated in 
rats that ES also increased the regeneration of motor and sensory axons in 
chronically denervated nerves 105.
Many research groups have employed molecular strategies to enhance 
axonal growth either by boosting the intrinsic growth program of 
neurons 35, or by increasing the expression of neurotrophic factors in the 
injured nerve. The latter was originally attempted by application of the 
(recombinant) protein 109-113. Although some studies demonstrated modest 
favourable effects, various challenges hamper the efficacy of this strategy. 
For example the tendency of neurotrophic factors to degrade fast would 
require the repeated application of protein to accomplish a positive effect 
in a slow process as nerve regeneration 114, Application of lentiviral vectors 
in a nerve has been shown to induce long term overexpression of a desired 
transgene, for instance neurotrophic factor such as NGF and GDNF, in 
Schwann cells for prolonged periods 115,116. Prolonged local expression of 
high levels of neurotrophic factors produced encouraging effects; axons are 
attracted towards areas containing high levels of transgenically expressed 
neurotrophic factors and neuronal survival was increased. A disadvantage 
of this strategy appeared to be that the normal gradient of neurotrophic 
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factors is disrupted; therefore axons remain at the location of transduction 
and long-distance regeneration is impaired. This process has been labelled 
the ‘candy store effect’ and has been described for multiple neurotrophic 
factors 117,118. Future studies that tightly control the temporal expression of 
neurotrophic factors are currently being developed. Next to stimulating 
the expression of neurotrophic factors, lentiviral transduction of Schwann 
cells may also provide a method to influence the differentiation state of 
Schwann cells.
3 The Wnt gene family
In this thesis we have focused on the role of Wnt (wingless-type MMTV 
integration site family) genes in regeneration of the injured peripheral 
nerve. Wnt genes encode highly conserved secreted glycoproteins that are 
involved in tissue development and regeneration. Wnt ligands have hardly 
been studied in the context of peripheral nerve regeneration but several 
lines of evidence suggest that Wnt signalling may play an important role in 
PNS regeneration: 1) Wnt ligands have a role in Schwann cell development 
119-121, 2) Wnt ligands act as axon guidance factors 122-131, and 3) Following a 
PNS injury the Wnt receptor Ryk is up-regulated in sensory neurons 132 and 
Tannemaat et al. found that several Wnt ligands, receptors and downstream 
pathway members were significantly regulated in human neonatal NIC 
tissue 133. 
In general, the Wnt signalling pathways (described in detail below) are 
involved in the development and regeneration of multiple tissues, including 
the CNS and PNS 134-136. In CNS development Wnt ligands, including Wnt5a, 
are involved in neurogenesis 137,138, proliferation of neuronal stem cells 139 
and act as axonal guidance cues 123,124,129,140. In PNS development Wnt ligands 
have been demonstrated to be involved in the differentiation from neural 
crest cells towards Schwann cells 119-121, in myelination 141 and axon growth 
and peripheral organ innervation of the sympathetic nervous system 130,142. 
After CNS injury Wnt signalling is re-induced in the neural scar and hampers 
axonal growth 125,126,143. Apart from the finding that the Wnt receptor Ryk is 
up-regulated in DRG neurons after peripheral nerve injury 132, nothing is 
known about the involvement of Wnt signalling in PNS regeneration. In the 
following sections we provide an overview of the Wnt-gene family, including 
the canonical and non-canonical signalling pathways.
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3.1 Wnt signalling: Wnt ligands and Wnt receptors.
Wnt signalling encompasses at least 4 complex and interacting signalling 
pathways. Research from the last three decades has shown that Wnt 
signalling is evolutionary conserved 144. Wnt signalling has been extensively 
studied in the context of development 145, health and disease 146,147, with a 
special focus on cancer 148,149 and tissue regeneration 150.
In most vertebrates, the family of Wnt ligands consists of 19 members, each 
of which share a conserved pattern of 23 or 24 cysteines and are subject to 
both palmitoylation and glycosylation 151,152. Multiple receptors for Wnt ligands 
have been reported in the literature. First, the Frizzled (Fzd) family of Wnt 
receptors, consists of 10 different members 153. The low density lipoprotein 
related receptors 5/6 (Lrp5/6) have been documented as Fzd co-receptors 
154,155. Secondly, the three (pseudo) tyrosine kinase receptors, receptor like 
tyrosine kinase (Ryk), and receptor tyrosine kinase related orphan receptor 1 
and 2 (Ror1 and Ror2) act as Wnt receptors 128,156-159. Recently, protein tyrosine 
kinase 7 (PTK7) and melanoma cell adhesion molecule (Mcam, also know 
as Cd146) have also been identified as Wnt receptors 160,161. This brings the 
number of currently known Wnt receptors to 17, culminating in a stunning 
number of potential ligand receptor interactions 162.
3.2 Wnt modulators
An array of trans-membrane and extracellular Wnt signalling modulators 
has been recently reviewed by Cruciat et al. 163. The Dickkopf (Dkk) family 
consists of 4 members of secreted antagonists of Wnt function. These 
antagonists function by inhibiting the Wnt co-receptor Lrp 164,165.  Kremen 
has been discovered to function as a Dkk receptor, which functionally co-
operates with Dkk by potentiating the endocytosis of Lrp6 and thereby 
regulating Wnt/β-catenin signalling 166. Another extra-cellular Wnt modulator 
of particular interest is Wnt inhibitory factor 1 (Wif-1), which acts as an 
extracellular Wnt sink, binding Wnt with its WIF domain 167. Finally, the family 
of secreted frizzled related proteins (Sfrp’s) contain a cysteine rich domain 
(CRD) Wnt binding domain, similar to Fzd. The Sfrp’s act as extracellular 
modulators of Wnt signalling 168. Sfrp’s display a bimodal effect. At low 
concentrations, they function as agonists of canonical Wnt signalling, while 
at higher concentrations they function as inhibitors 169.
E3 ligases, zink and ring finger 3 (ZNRF3) and ring finger protein 43 (RNF43) 
are identified as trans-membrane antagonists of Wnt signalling 170,171. They 
target cell membrane expressed Fzd receptors to lysosomes, thereby 
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impeding their availability for signalling. Interestingly, the excreted protein 
family R-Spondin (R-spon) antagonizes ZNRF3 and RNF43 their function 
via receptor Lgr4, -5, -6, making R-spon a Wnt agonist 172,173. Recently, the 
antagonistic effect of ZNRF3 and RNF43 has also been demonstrated for 
Wnt receptors Ror and Ryk 174. Depending on the combination of Wnt-ligand, 
receptor and modulator context, different downstream Wnt pathways can 
be initiated, making the Wnt signalling pathway extraordinarily diverse and 
complex 175. 
3.3 Wnt pathways
The Wnt β-catenin pathway (also known as the canonical pathway) is a well-
documented pathway that is involved in proliferation, differentiation and 
cell death. It signals through Fzd and Lrp 5/6 to activate Dishevelled (Dsh). 
Dsh can in turn in-activate the β-catenin destruction complex, consisting of 
Axin, Adenomatous polyposis coli (APC) and the kinases, glycogen synthase 
kinase-3 (GSK-3) and casein kinase 1 (CK-1) 176,177. As a result β-catenin 
accumulates in the cell and enters the nucleus 178. Without Wnt signals, TCF/
LEF is part of a complex with Groucho and acts as a transcriptional silencer 
179,180. Upon entry to the nucleus, β-catenin displaces Groucho to initiate TCF/
LEF transcription 181. TCF/LEF has numerous binding partners that influence 
its transcriptional activity, one of which is nemo-like kinase (NLK). NLK is 
a MAP kinase related protein that can phosphorylate TCF, resulting in a 
decreased DNA-binding affinity and inhibition of Wnt induced, β-catenin 
mediated, transcriptional activity 182. 
Next to the β-catenin pathway, there are multiple non-canonical Wnt 
signalling pathways. One of these is a pathway that inhibits the canonical 
pathway 183. Another has been coined the Planar Cell Polarity (PCP) pathway. 
This pathway signals through the small GTPases Rac and Rho via Daam1 to 
rearrange the cytoskeleton. This can cause the asymmetric distribution of 
Fzd, Ror, Van Gogh-like (Vangl-1 and -2) and flamingo (Celsr1-3) 184. The PCP 
pathway plays a role in inner ear and neural tube formation and neural 
crest migration 185-187. Finally, Wnt signalling can initiate a Ca2+ dependent 
pathway 188,189. This Wnt pathway has been called the Ca2+ pathway. Wnt 
stimulation can lead to increased Ca2+ fluxes, originating from internal Ca2+ 
stores. This can lead to activation of both CamKII and protein kinase C (PKC), 
finally activating transcription factors NFκB, NFAT and CREB 190. The various 
Wnt pathways interact with numerous other pathways, one of which is the 
Foxo pathway. In bone development Foxo signalling has shown to supress 
Wnt/β-catenin signalling 191.
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3.4 Wnt target genes
The target genes of Wnt signalling vary considerably depending on the 
extracellular Wnt ligand-, modulator-, transmembrane receptor- and 
downstream-context. Some well-defined targets include, c-Myc 192, 
PPARdelta 193, Pitx2 194 and Axin2. Axin2 is part of a negative feedback loop 
of the β-catenin pathway 195-198. As such, its expression has been employed 
as an indicator for active canonical Wnt signalling. 
4 Concluding remarks 
Multiple findings suggest that Wnt signalling probably plays a key role in 
the regenerative response of the PNS: 1) Wnt family members are regulated 
in human NIC 133, 2) Wnt ligands regulate Schwann cell differentiation 
and myelination during development 119-121,141, two processes that are also 
essential during PNS regeneration, and 3) Wnt ligands have been shown to 
either hamper or stimulate axon growth, depending on the experimental 
and cellular context 122-131. Taken together, these findings strongly suggest 
that Wnt signalling may play an important role in PNS regeneration. 
Deeper insight in all the molecular signalling pathways that govern PNS 
injury, will potentially allow for the future development of molecular tools 
that will either strengthen the endogenous regenerative response, or inhibit 
the molecular processes that are at the basis of dissatisfactory outcomes 
after PNS injury. 
5 Scope and outline of this thesis
As described above severe lesions of a peripheral nerve can result in 
the formation of a neuroma-in-continuity (NIC). In patients that do not 
display any recovery of function the NIC is resected and the nerve is 
reconstructed with a peripheral nerve graft. The work described in this 
thesis has two interconnected aims. First, we used NIC tissue obtained 
following reconstructive surgery for a histopathological analysis in order 
to provide insight in processes that interfere with functional recovery. The 
results of these studies are described in chapter 2. Second, we set out to 
study the role of Wnt ligands in the nerve regeneration process. We focused 
on Wnt ligands because 1) a microarray study on NIC performed in our 
laboratory revealed that the expression of Wnt5a and several other Wnt 
genes was changed in NIC; 2) Wnt5a is a known axon guidance factor that 
exerts context dependent axon growth inhibitory and/or stimulatory effects. 
In chapter 3 of this thesis we first analyse the endogenous regulation 
of Wnt signalling genes in both human NIC tissue and in two models of 
rodent peripheral nerve injury. We demonstrate that there is extensive, 
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coordinated regulation of Wnt pathway gene expression in the injured rat 
nerve, including the Wnt ligands Wnt5a, -5b and -4. In the NIC and in the 
rat nerve Wnt5a is expressed in Schwann cells and the receptor for Wnt5a 
is expressed by regenerating axons, which suggest that axons in the NIC 
and in an injured rat nerve may “sense” Schwann cell derived Wnt5a. In 
chapter 4 bio-assays were used to provide insight in the role Wnt signalling 
plays in the process of axon outgrowth of dorsal root ganglion neurons. This 
chapter demonstrates that Wnt ligands (Wnt5a, Wnt5b, Wnt4) influence the 
process of axon outgrowth in a context dependent way and also affect the 
differentiation state of Schwann cells. To assess the impact of Wnt signalling 
in the context of peripheral nerve regeneration, in chapter 5 we describe 
experiments that interfere with Wnt signalling in PNS injury in-vivo. Chapter 
6 provides a general discussion of the data described in this thesis and 
highlights future directions.
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Abstract 
Functional recovery does not occur in 10% of patients with Neonatal 
brachial plexus palsy (NBPP). In these patients resection of a neuroma-
in-continuity (NIC) and surgical nerve reconstruction is required. The 
formation of a NIC appears to prohibit functional recovery, however, the 
underlying biological mechanism(s) are poorly understood. In this article 
a large series of NIC-tissue (n = 17 neonatal and n = 3 adult patients), 
was systematically investigated using an array of (immuno)histochemical 
techniques. A key finding is that NIC in a large proportion (74%) of patients 
contain multiple focal, globular areas with strongly diminished myelination. 
These focal myelin deficits (FMD) contain Schwann cells that enwrap 
axons in an apparently normal configuration but do not form myelin. 
A bio-mathematical analysis predicts that in a 2 cm neuroma there is a 
>95% probability that an axon will encounter 10 FMD. Importantly, axon 
segments in these non-myelinated areas have disturbed nodes of Ranvier 
as FMD contained significantly less clustered Na(v)1.6 channels, Caspr and 
Ankyrin-G. Axons that course through multiple FMD may provide the cell 
biological basis for the conduction block that occurs in patients with NBPP. 
These findings may inspire novel strategies to promote functional recovery 
following NBPP by improving myelination in the NIC. 
Introduction
Neonatal brachial plexus palsy (NBPP) is a peripheral nerve traction injury. 
The resulting nerve damage varies depending on the angle, duration and 
magnitude of forces acting on the spinal nerves C5 to T1. Severe lesions 
result in life-long functional impairment of the shoulder, elbow and hand 
function. The prevalence of NBPP is 1.6 - 2.9 per 1000 births. Although 
complete spontaneous recovery occurs in the majority of NBPP patients, 
surgical treatment is indicated in approximately 10% of patients 1. The initial 
clinical presentation of NBPP correlates poorly with the severity of the injury. 
A major challenge in the treatment of NBPP lies in the distinction between 
axonotmetic lesions, which recover spontaneously and neurotmetic lesions 
and root avulsions that do not 2,3. Typically, a neuroma-in-continuity (NIC) 
of the superior trunk of the brachial plexus is found during exploration 4. 
The NIC is usually resected, followed by nerve grafting with the autologous 
sural nerve. In most patients this results in the recovery of function, which is 
however, never complete 5-7.
Resection of the NIC in NBPP does not significantly diminish clinical motor 
activity 4 and neurolysis does not show improvement in function 5,6. Apparently, 
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the formation of a NIC prohibits functional recovery, the reason of which is 
poorly understood. Neuroma tissue is characterized by excessive fibrosis, 
which is generally considered an impediment to axonal regeneration 8,9. We 
have previously shown that the inhibitory axon guidance molecule Semaphorin 
3A is up-regulated in the NIC and contributes to its growth-inhibitory 
properties 10. However, impaired axonal regeneration through the NIC cannot 
fully explain the absence of functional recovery. A histopathological study 
of neuroma tissue obtained during NBPP surgery showed that the nerves 
distal from the NIC contain thousands of axons 11, a number that should be 
sufficient for a significant degree of spontaneous recovery of function 12. These 
histological data correlate well with electromyographical studies. At the age 
of three months, axonal continuity towards the biceps muscle was present 
in more than 90% of patients without any signs of clinical recovery 13. These 
histological and electrophysiological data do not constitute preliminary signs 
of impending recovery: in a study of ten patients, the NIC was not resected in 
five patients because intra-operative electrophysiological recordings showed 
neural continuity across the neuroma, but these patients did not recover 
well 14. The lack of functional recovery in the presence of axonal continuity 
may be partially explained by ’axonal misrouting’. Random innervation of 
target muscles leads to co-contraction of antagonists (i.e., biceps and triceps 
muscle) resulting in an inability to flex the elbow voluntarily 15. Another possible 
explanation is that the formation of a NIC affects the function of the traversing 
axons. There is evidence from electrophysiological studies that a conduction 
block occurs in NBPP patients 16,17.
The aim of this study was to test the hypothesis that the absence of 
spontaneous recovery of arm function in patients with a NIC is at least in 
part due to impaired myelination of axons. A large series of NIC-tissue was 
resected during reconstructive surgery in NBPP patients, and a smaller 
number from adult patients with a traumatic brachial plexus lesion. The NIC’s 
were systematically investigated using an array of (immuno)histochemical 
techniques. We found that a majority of NIC samples show focal myelin 
deficits (FMD) that present as typical spherical areas virtually devoid of 
myelin. These areas are present throughout the neuroma. Many FMD are 
filled with motor axons that are enveloped by Schwann cells that do not 
myelinate. A biomathematical analysis indicates that >95% of axons that 
traverse a NIC of two centimeter length encounter ten or more demyelinated 
areas. The current observations provide the first cell biological evidence 
that impaired spontaneous functional recovery following NBPP may at 
least be in part caused by focal myelination deficits in the NIC.
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Materials and Methods
Material 
We investigated NIC material of 20 patients (17 NBPP and 3 adult traction 
brachial plexus lesion of the superior trunk). All patient material was obtained 
and anonymized as stated in the Code of conduct for responsible use of 
Human Tissue and Medical Research (2011). The NIC was identified during 
nerve reconstructive brachial plexus surgery. The severity of the lesion of 
each exposed spinal nerve was classified as avulsion, partial avulsion, 
neurotmesis, intraforaminal neurotmesis, axonotmesis, or normal, based on 
CT myelography results, intraoperative morphological characteristics, direct 
nerve stimulation, and frozen-section examination. A lesion was considered 
a NIC when the following features were present: a normal appearance of 
the spinal nerve at the intraforaminal level, a clear increase of the cross-
sectional diameter at the juxtaforaminal level, abundant epineurial fibrosis, 
loss of fascicular continuity, increased consistency, and increased length 
of the nerve elements with concomitant distal displacement of the trunk 
divisions. On direct electrical stimulation of the spinal nerve proximal to the 
neuroma, contractions of related muscles were not strong enough to move 
the limb 18. Resected neuroma tissue and proximal and distal stumps were 
snap-frozen within 15 min after resection and stored at -80°C. In addition, 
following grafting left over sural nerve segments that would otherwise have 
been discarded were used as controls. Sural nerves were kept in Ringer 
solution and subsequently snap-frozen and stored at -80°C. The average 
age of the 17 NBPP patients was approximately 5 months (141.5 +/- 6.8 days 
n = 17). Neuroma material originated from the superior trunk of the brachial 
plexus. The proximal nerve stump consisted of a portion of the spinal nerve 
C5 or C6 located directly adjacent to the neuroma tissue. The age and 
gender of all 20 patients is provided in Table 1.
Immunohistochemistry
Neuroma and proximal and distal stumps and sural nerve tissue were 
cut into transverse, 20 µm cryosections. Sections were immersion-
fixed in 4% paraformaldehyde in 0.1 M PBS, pH 7.4, for 15 min at RT. 
Immunohistochemistry was performed in Tris-buffered saline (TBS), pH 
7.4, containing 0.2% Triton X-100 and 5% fetal calf serum (FCS) with the 
following primary antibodies: mouse anti-neurofilament (1:1000; 2H3 
ascites; developmental studies hybridoma bank, University of Iowa, IA), 
rabbit anti-S100 (1:400; Dako, High Wycombe, UK), rat anti-myelin basic 
protein (MBP, 1:400; MAB386; Millipore, Temecula,CA), mouse anti-SMI32 
(1:1000; SMI32; Steinberger monoclonals Inc., Lutherville  MD), rabbit anti-
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Table 1. Patient table
The table displays all used m
aterial of neurom
a-in-continuity patients, patients have been anonym
ized by a letter (a – t). Their corresponding 
age at surgery, sex and days after the initial traum
a are provided. For all available tissue, w
e scored for the presence of FM
D
 in a cross section 
(0 = no, 1 = yes). Subsequently, the num
ber of FM
D
s w
ere counted. 
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Na(V) 1.6 (1:200; ASC-009; Alamone labs, Jeruzalem, IL), sheep anti-Caspr 
(1:100; AF7548; R&D systems, Minneapolis, MN),  mouse anti-K(v)1.2 (1:100; 
75-008; Neuromab; UC Davis, CA), mouse anti-Ankyrin-G (1:100; 75-146; 
Neuromab; UC Davis, CA), rabbit anti-Krox20 (1:200; PRB-236P; Covance, 
Princeton NJ) goat anti-Oct6 (1:100; sc-11661; Santa Cruz; Dallas, TX). 
Antigen-antibody binding was visualised by secondary antibodies from 
Jackson ImmunoReagents, (1:1000; West Grove, PA). 
In Situ Hybridisation
RNA probe generation and the in situ hybridization (ISH) procedure have 
been described previously 19. In short, digoxigenin-labeled sense and 
antisense probes were generated from linearized full-length human 
MBP cDNAs by in vitro transcription. Hybridisation specificity was verified 
by comparison with a sense probe hybridization control. We first tried to 
combine the protocols for ISH and immunohistochemistry (IHC) to examine 
MBP-protein and MBP-mRNA localization in the same tissue section. 
However, the ISH procedure has a negative impact on the MBP-protein 
staining. Therefore ISH and IHC for MBP were performed on adjacent 
sections.       
Epon embedding and Staining of myelinated axons
A freshly obtained centre portion of neuroma tissue was fixed in 2.5% 
Glutaraldehyde/4%Paraformaldehyde in 0.1 M Na-cacodylate buffer 
pH 7.4. Tissue was post fixed in 1% OsO4 (Osmium) solution in 0.1 M Na-
cacodylate buffer pH 7.4 and subsequently dehydrated stepwise by 
increasing concentrations of ethanol and acetone and embedded in Epon 
at increasing temperatures. Semi-thin sections of 1 µm were cut on an 
ultramicrotome with a diamond knife and stained by Tuloidine blue.
Imaging and quantification
Images were obtained using either a Zeiss Axioplan 2 microscope (Overkochen, 
Germany) fitted with an Evolution QEi digital camera (MediaCybernetics, 
Silver Spring, MD), or a Leica Microsystems camera (Wetzlar, DE). Confocal 
images were obtained with Leica TCS SP5 (Wetzlar, DE). FMD quantification 
was performed by manual outlining of the total nerve portion, fascicles and 
FMD of sections triple stained for MBP, S100 and NF of 20 patients for which 
nerve portions were available by using Photoshop CS4. Subsequently, the 
corresponding surface areas were measured, and respective percentage 
of the fascicles was calculated. Finally, the number of FMD per section was 
counted and average proportion of the fascicle surface area with FMD.
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Three NIC characteristics were quantified according to a semi-quantitative 
scoring system to obtain a correlation with FMD load. Transverse nerve 
sections were attributed points as follows: 1) the total sectional surface 
(1 = <5 mm2; 2 = 5 to 10 mm2; 3 = > 10 mm2); 2) the presence of intact 
fascicles (0 = no; 1 = yes); 3) the presence of thickened fibrotic epineurium 
(0 = no; 1 = partially surrounded; 2 = completely surrounded). A final 
score was calculated by applying the following formula: Scoreintactness fascicle 
x(Scoresize+Scorethickness epineurium). Scores were binned to form three groups; 
1: 0-1 points, 2: 2-3 points, and 3: 4-5 points. A high score indicates that a 
nerve section has a large surface area with at least one intact fascicle and 
thickened epineurium. A low score means a nerve section either has a small 
surface area without a thickened epineurium and/or no intact fascicles. 
Quantification of Na(v)1.6, Ankyrin-G, K(v)1.2, Caspr, Oct6 and Krox20 
expression was performed with Image pro Plus software. First, FMD 
were outlined manually. Subsequently, the Na(v)1.6 signal was quantified 
using fixed thresholds. Na(v)1.6, Oct6 and Krox20 signal inside the FMD 
was compared to the predicted amount of signal based on the directly 
surrounding myelinating tissue.
Probability calculation of whether axons encounter a FMD in a 50 μm 
section. For our binomial model we convert the measured volume fraction 
in a 20 μm section to the probability that an axon traverses a FMD in a 
50 μm section. Because FMD are approximately 50 μm in diameter, they 
can be fitted completely in a 50 μm section, this simplifies our binomial 
model. A FMD volume fraction of 2.8% was measured in 20 μm sections 
by dividing FMD outlines to fascicle outlines. The volume of a sphere of 50 
μm diameter is 2/3 of the volume of a cylinder of the same diameter and 
height. Therefore, 2.8% divided by this fraction provides a probability of 4.2% 
that an axon will traverse a FMD in a 50 μm section. 
Statistical analysis
Data from quantification of FMD were tested for normality using D’Agostino 
& Pearson normality test. When data were normally distributed, one-way 
ANOVA was applied, if data were not normally distributed a Kruskal-
Wallis test was performed together with Dunns post hoc testing. Na(v)1.6 
, Ankyrin-G, K(v)1.2 and Caspr signal data were tested for significance by 
a paired student t test. A p-value <0.05 (indicated by *) was considered 
significant. 
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Results
Focal myelin deficits are a characteristic feature of neuroma-in-
continuity
In general neuroma material is comprised of seemingly healthy nerve 
fascicles as well as areas of substantial inter-neural scarring and cellular 
disorganization. All neuromas are surrounded by an abnormal epineurium 
displaying variable degrees of thickening. In 74% of patients, IHC for myelin 
basic protein (MBP) revealed a striking pattern of circular or oval shaped 
areas with focal deficits in myelination randomly present in fascicles with 
intact continuity in their course through the NIC (Fig. 1A-C; Table 1). FMD are 
found in NIC of both 5 months old babies and adult patients (Table 1). The 
pattern of myelination in NIC tissue was also compared to that in leftover 
sural nerve segments. FMD were exclusively observed in NICs and not in 
the sural nerve (Fig. 1D-F). 
Focal myelin deficits contain axons and Schwann cells in a normal 
anatomical configuration
To investigate whether the FMD were due to the absence of myelinating 
Schwann cells, sections were stained with the Schwann cell marker S100 
and MBP (Fig. 1A-C, 1G-J). FMD do contain S100 positive Schwann cells that 
envelop axons as shown by neurofilament (NF) staining. The S100 positive 
Figure 1. Identification and histological characterization of FMD
A - C, Low magnification images of representative sections of a NIC and its corresponding 
proximal stump (insert) processed for immunohistochemistry for S100 (Schwann cells, A) 
and MBP (myelin, B). C is a merged image of A and B. MBP staining shows areas of FMD, 
indicated by arrows. FMD are hardly present in the proximal stump. D - F, S100 (D) and MBP 
(E) immunohistochemical staining of healthy sural nerve. F, is a merged image of D and E. 
Note that FMD are not observed in healthy sural nerve. G - J, Immunohistochemical staining 
for S100 (G), MBP (H) and NeuroFilament (I) demonstrate that FMD contain Schwann cells 
and axons but MBP expression is significantly reduced. J is a merge image of panels G, H, I. 
K - N, Hoechst nuclear staining (K) and Immunohistochemical staining of a section of a NIC 
for motor axons in FMD using SMI-32 (L) and MBP (M). SMI-32, a marker for motorneurons, 
detects numerous axons in FMD. N is an overlay of K, L, M. O - R, Schwann cells in FMD 
exhibit diminished expression of MBP mRNA (green) and protein (red). MBP (O) and NF (Q) 
IHC and MBP ISH (P) on adjacent sections show that FMD are associated with an overall 
decrease of MBP mRNA, however ISH signal is still detected in occasional Schwann cells in 
FMD indicated by arrows. R is an overlay of O, P, Q. S - T, An example of an epon embedded 
semi-thin section stained with osmium exhibits clusters of axons (encircled with white dotted 
lines) which lack proper myelination. Axons in FMD vary in diameter and FMD is surrounded 
by myelinated axons (Scalebar 50 µm for panels G - N, 100 µm for panels O - R and 30 µm 
for panels S - T).
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Schwann cells located in the FMD do display a normal 1:1 relationship with 
axons (Fig. 1G-J), but do not contain MBP. To exclude the possibility that 
clusters of axons in the FMD are entirely composed of c-fibers, which are 
unmyelinated by definition, sections were stained for the motorneuron 
marker SMI32 (Fig. 1K-N). This staining shows that FMD contain many 
SMI32-positive motor axons. Taken together, these observations indicate 
that FMD contain numerous axons of motorneurons that are enveloped by 
Schwann cells that do not form myelin. 
Focal myelin deficits can be visualized independent of MBP 
immunohistochemistry
To determine whether lower MBP protein levels are associated with 
decreased MBP transcript expression levels in Schwann cells in FMD, MBP 
IHC was combined with MBP ISH (Fig. 1O-R). Because of incompatibility of 
the two protocols we applied these two staining procedures on adjacent 
sections and subsequently identified FMD with deficits in MBP (Fig. 1O) and 
MBP mRNA (Fig. 1P). In most FMD a clear overall decrease of MBP mRNA 
expression occurred. Some FMD contained a small number of Schwann 
cells that display a clear ISH signal without apparent MBP expression (Fig. 
1P; white arrows). All FMD are filled with axons (Fig. 1Q).
To further confirm that axons in FMD are not myelinated, a classical osmium 
staining was employed on neuroma tissue from 4 patients (Fig. 1S,T). This 
immunohistochemistry-independent method showed that FMD are indeed 
deficient in myelin and contain axons of a wide variety of diameters ranging 
from smaller than 1 µm to 6 µm.  
A quantitative analysis of FMD indicates that most axons in a neuroma 
are subject to focal demyelination
In order to investigate the size and shape of individual FMD in NIC, 20 μm 
serial sections were stained for MBP, S100 and NF (Fig. 2). Individual FMD 
were often observed into the directly adjacent sections, but rarely extend 
into more than 2 to 3 sections. FMD have a spherical shape, which can be 
deduced from their increase and subsequent decrease in size in adjacent 
sections. FMD appear and disappear seemingly random across fascicles. 
The average diameter of FMD is 51 μm +/- 18 μm.
To quantify the presence of FMD in NICs of all patients, an 
immunohistochemical-based quantification with MBP, S100 and NF of FMD 
was performed. The corresponding proximal and distal nerve-stumps were 
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Figure 2. Analysis in serial sections reveals the typical spherical nature of FM
D
A-D
, Serial sections through a N
IC
 w
ere stained for M
BP, individual FM
D
s w
ere num
bered starting in the first section (section A) and their 
presence w
as tracked in the subsequent sections. FM
D
 I, II and III are present in sections A and B and have disappeared in sections C
 and D
. 
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D
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ber IV starts as a sm
all structure in section I, becom
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D
 in sections B and C
 and has disappeared in section D
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C
 three new
 FM
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D
s (not num
bered), one in section C
 and one in section D
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only present in a single section. This m
eans that FM
D
 are spherical areas devoid of m
yelin, opening up the possibility that a single axon can 
encounter m
ultiple FM
D
 (Scalebar 75 µm
).
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also quantified where available. FMD with varying degrees of severity were 
identified in 14 of 17 NBPP and in all adult patients (Table 1; Fig. 3D). The 
size of the total nerve, the number of fascicles and FMD were quantified 
(data not shown). The average proportion of the fascicle surface area with 
FMD was 2.8%. Proximal and distal nerve pieces had a significantly lower 
number of FMD (7,0 +/- 1,8 and 3,8 +/- 2,6 respectively) compared to NIC 
(20,3 +/- 5,5; p<0.05; Fig. 3A). Because FMD were present in some proximal 
and distal nerve portions, an unbiased classification of nerve sections, 
independent of their clinical classification as NIC, proximal or distal stump 
was made (described in Materials and Methods). The scoring system, based 
on the degree of epineurial fibrosis, provides an enhanced prediction of the 
amount of FMD per group compared to the clinical classification of the 
Figure 3. Quantitative analysis of FMD in neuroma-in-continuity
A, The number of FMD were counted in transverse sections of proximal stump (prox, green), 
NIC (neu, yellow) and distal nerve stump (dist, blue) tissue. FMD were visualized by triple 
staining for S100, MBP and neurofilament and considered an FMD when they were devoid 
of MBP but contained S100-positive Schwann cells and neurofilament stained axons. NIC 
exhibit significantly more FMD than the proximal and distal stumps (7.0 +/- 1.8; 20.3 +/- 5.5; 
3.8 +/- 2.6; *p<0.05). B, An unbiased grouping of specimens by their cross sectional surface 
(1 = <5 mm2; 2 = 5 to 10 mm2; 3 = > 10 mm2), thickened epineurium (0 = no; 1 = partially 
surrounded; 2 = completely surrounded) and the presence of at least one intact fascicle (0 = 
no; 1 = yes) produces 3 groups (0, 1 and 2). The colors green (proximal stump), yellow (NIC) 
and blue (distal stump) indicate the distribution of proximal stumps, NIC and distal stumps 
in groups 0, 1 and 2. Group 2 has a significantly higher number of FMD compared to group 
0 (2.2 +/- 1.0; 10.4 +/- 2.9; 28.4 +/- 7.2; *** indicates p<0.001). This demonstrates that FMD 
are found predominantly in large nerve portions with a strongly fibrotic epineurium. C, A 
binomial model predicts the probability of the number of FMD that an axon will encounter in 
a 2 cm neuroma. Each line provides the probability that an axon traverses an FMD. Based 
on this model, an axon has a >95% probability to encounter at least ten FMD (dotted line 
indicates 95% probability and 2 cm distance). The 10 thick lines indicate a probability of >95% 
for axons over a 2 cm distance to encounter an equal amount of FMD, thinner lines indicate 
a <95% probability to encounter that amount of FMD over a 2 cm distance (the probability 
that an axon encounters 11 FMD, is 0.949). D, Table of all included material for this study; 
patients are indicated by a letter from a- t. For each available nerve portion the number of 
FMD are counted in a single section (prox is proximal stump, neu is neuroma-in-continuity 
and dist is distal stump). This table corresponds with Fig. 3A. E, Based on our binomial model 
a graphical representation of axons that traverse multiple FMD in a NIC. Axons are indicated 
by lines that traverse the neuroma (yellow) from the proximal stump (green) towards the 
distal stump (blue), along their lengths axons encounter different numbers of FMD, which 
are indicated by grey ovals. Proximal axons encounter an occasional FMD, in the NIC there 
are many FMD. When an axon reaches the distal stump, it has encountered multiple FMD.
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Figure 4. Axons in FMD display a decreased number of clustered components of nodes of 
Ranvier   
A – S, High magnification photomicrographs of typical FMDs in neuroma, 
immunohistochemically stained for MBP (B,G,L,Q) and neurofilament (C,H,M,R) in combination 
with Sodium channel Na(v)1.6 (A), Ankyrin-G (F), Potassium channel K(v)1.2 (K) or Caspr (P), 
with subsequent overlays of channels (D,I,N,S) and quantification of corresponding node of 
Ranvier component inside FMD compared to expected signal based on directly surrounding 
myelinating tissue (E,J,O,T). Dashed outlines are based on FMD outline in corresponding 
MBP channel. A, Shows Sodium channel 1.6 which is normally accumulated at Schwann 
cell internodes, marked decreased Sodium channel 1.6 staining is observed within FMD as 
compared to healthy myelinating surrounding tissue. C, FMD contains numerous axons; the 
amount of neurofilament staining in and outside FMD is indiscernible. E, Quantification of 
Sodium channel 1.6 channels staining in and around FMD shows a significant decrease in 
FMD (193 +/- 35; 548 +/- 116;** p<0.01; Scalebar 50 µm). F, Shows Ankyrin-G accumulated 
at Schwann cell internodes, a decrease of Ankyrin-G staining is seen in FMD compared to 
surrounding myelinating tissue. J, Quantification of Ankyrin-G accumulation in and around 
FMD demonstrate a significant decrease in FMD (288 +/- 135; 582 +/- 189; * p<0.05; Scalebar 
30 µm). K, Shows K(v)1.2 accumulated at Schwann cell juxtaparanodes, a decrease of K(v)1.2 
seems visible in FMD compared to surrounding myelinating tissue. N, Quantification of 
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2tissue: NIC, proximal or distal stump. Tissue with a larger cross-sectional area, an intact fascicle and a thicker epineurium had significantly more 
FMD (Group1: 2.2 +/- 1.0; Group 2: 10.4 +/- 2.8 and Group 3: 28.4 +/- 7.1; 
p<0,001; Fig. 3B).
 
In order to estimate the potential functional significance of FMD, a model 
was developed to calculate the average number of FMD an axon will 
encounter in a typical 2 cm long segment of a neuroma. In this model two 
assumptions were made, namely that FMD are randomly present across a 
fascicle, and axons progress through the neuroma in a straight line. Under 
these assumptions the number of FMD that are traversed by an axon is 
binomially distributed (n = number of sections, k≥ FMD encountered, p = 
% of axons that encounter a FMD per 50 μm section). Since FMD have an 
average diameter of 51 µm, we could calculate that for a 50 μm section p 
= 4,2% (as described in Material and methods). A typical 2 cm neuroma 
will be comprised of 400 sections with a thickness of 50 μm. In a binomial 
distribution with these parameters, the probability is >95% that an axon will 
traverse ≥10 FMD (Fig. 3C). It should be noted that the probability of an 
axon encountering FMD will increase if it traverses the nerve in a tortuous 
manner, so this calculation is likely an underestimation of the number of 
FMD encountered by axons in the NIC. Figure 3E provides a schematic 
illustration of the relationship between axons and FMDs in a NIC based on 
the outcome of this biomathematical analysis.  
Multiple components of nodes of Ranvier display diminished clustering in 
FMD.
Saltatory conduction in myelinated axons requires functional nodes of 
Ranvier. We hypothesized that nodes of Ranvier on axons in FMD are 
disturbed. Therefore we studied the distribution of the sodium channel 
Na(v)1.6 (a protein localized at internodes), the postassium channel K(v)1.2 
(localized at juxtaparanodes), Ankyrin-G (which serves as an intracellular 
anchor for sodium channels at nodes of Ranvier) and the contactin-
associated protein (Caspr; present at paranodes). The localization of 
these four proteins was studied in myelinated areas of the NIC and in 
K(v)1.2 accumulations in and around FMD demonstrate a non-significant decrease in FMD 
(2930 +/- 1439; 11080 +/- 5449; p = 0.06.; Scalebar 30 µm). P, Shows Caspr accumulated at 
Schwann cell paranodes, a decrease of Caspr accumualtions is visible in FMD compared 
to surrounding myelinating tissue. T, Quantification of Caspr accumulations in and around 
FMD demonstrate a significant decrease in FMD (774 +/- 331; 4545 +/- 1767; ** p<0.001; 
Scalebar 30 µm).
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Supplemental Figure 1. High magnification photomicrographs for components of nodes of 
Ranvier
A – T, Healthily myelinating tissue was (immuno)histochemically stained for DAPI (nuclei; 
A,F,K,P), MBP (C,H,M,R) and neurofilament (D,I,N,S) in combination with Sodium channel 
Na(v)1.6 (B), Ankyrin-G (G), Potassium channel K(v)1.2 (L) or Caspr (Q), with subsequent 
overlays of channels (E,J,O,T). B, Shows a Sodium channel accumulation indicating a node 
of Ranvier (indicated by arrow). C, MBP staining shows that present axons are myelinated. 
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FMDs by using a triple staining for NF, MBP and the respective node of 
Ranvier protein. Na(v)1.6 and Ankyrin-G were present in distinct clusters on 
myelinated axons in between the myelin sheaths, while K(v)1.2 and Caspr 
were localized in the (juxta)paranodal region of the nodes of Ranvier 
(Supplemental Fig. 1). In FMD the typical nodal and paranodal clustering 
of these protein components of nodes of Ranvier was visibly disturbed (Fig. 
4). A quantitative analysis revealed a 2.0 to 2.5 fold decline in the signal for 
Na(v)1.6 and its intracellular anchor protein Ankyrin-G, and a 6 fold decline 
in Caspr in FMD as compared to myelinated areas of the NIC (Fig. 4A-E, F-J, 
N-T). The localization of the potassium channel K(v)1.2 is disturbed in FMD 
(Fig. 4J-M), but quantitative analysis does not demonstrate a significant 
decline in signal in FMD p = 0.06 (Fig. 4O) It is possible that because of 
spreading of these markers of Ranvier along non-myelinated axons in 
FMD, expression declines below the limit of detection. We therefore limit 
our findings to accumulations.
Transcription factors are not differentially expressed in Schwann cells of 
FMD
The expression of two transcription factors (EGR2/Krox20 and POU3F1/
Oct6), which have a key role in the myelination program of Schwann cells, 
was compared for Schwann cells that populate FMD and their surrounding 
myelinating Schwann cells. We employed an immuno-histochemical 
analysis of EGR2/Krox20 and POU3F1/Oct6 in combination with MBP and 
DAPI. A quantitative analysis did not reveal significant differences between 
Schwann cells that populate FMD to those of surrounding myelinating tissue 
for both transcription factors (Supplemental Fig. 2; Oct6 A-D; Krox20 E-H).
Discussion
The degree of functional recovery after traumatic nerve injury depends on 
a range of factors. These include the age of the patient, the severity of the 
lesion, the distance of the lesion to the end organs, and the degree of mis-
E, Shows that Na(v)1.6 accumulation is present on an axon (indicated by arrow). G, 
Demonstrates that Ankyrin-G is accumulated at nodes of Ranvier as expected (indicated 
by arrow). H, Demonstrates that present axons are myelinated. J, Shows that Ankyrin-G is 
present on the node of Ranvier of a myelinated axon (indicated by arrow). L, Demonstrates 
that potassium channel K(v)1.2 is accumulated in juxtaparanodes (indicated by arrow). M, 
Indicated that present axons are myelinated. O, Shows that K(v)1.2 is present on a myelinated 
axon (indicated by arrow; Scalebar 10 µm). Q, Demonstrates Caspr staining on paranodes 
(indicated by arrow). R, Shows present axons are myelinated. T, Indicates that Caspr 
accumulations are present on myelinated axons (indicated by arrow; Scalebar 30 µm).
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routing 8,20-22. The results of the present study show for the first time that 
focal deficits in myelination are present in 74% of NIC of patients in which 
spontaneous recovery after a closed brachial plexus traction lesion did not 
occur. The observed FMD are typically spherical or ovoid in shape and 
are present in fascicles filled with axons that exhibit an otherwise normal 
pattern of myelination. FMD contain Schwann cells that do not form myelin 
but enwrap axons in a normal 1:1 relationship. FMD are found in NIC of 
both 5 months old babies and adult patients indicating that the presence 
of FMD is not related to age. As illustrated in Figure 3E, our mathematical 
model predicts that virtually all axons in a NIC have multiple focal deficits 
in myelination. The functional deficits found in patients with NIC may 
therefore at least in part be caused by a reduction in the propagation of 
axon potentials resulting from the focal defect in the myelination of axons.
Clinical implications
The key finding of this study is that multiple areas with FMD are present 
in NIC in a large proportion of patients. This pathological feature may 
contribute to the lack of spontaneous recovery following a brachial plexus 
traction injury in this group of patients. The focal nature of FMD is a novel 
feature not previously observed in other peripheral demyelinating diseases. 
Genetic demyelinating disorders like Charcot-Marie-Tooth type 1 (CMT1) 
disease can display a segmental demyelination 23-25. Immune-mediated 
demyelinating diseases like Guillain-Barré syndrome are characterised 
by a heavy infiltrate of mononuclear cells 26. Both genetic and immune-
mediated forms of peripheral nerve demyelination do display patterns of 
demyelination that are distinct from the FMD we find in NIC. 
The deficits in myelination in NIC may, however, have significant clinical 
implications. We find fewer accumulations of Na(v)1.6 channels, Caspr and 
Ankyrin-G on axons in FMD compared to myelinated axons. The clustering 
of sodium channels on the axon membrane at the nodes of Ranvier of 
myelinated axons is essential for saltatory action potential propagation 
27. Various demyelinating pathologies display disrupted sodium channel 
organisation 28,29. The distribution of sodium channels is also abnormal in 
multiple animal models of demyelination, including PLP/- 30 and Trembler-J 
mice (a CMT1 animal model) 31. The decreased density of clusters of Na(v)1.6 
channels in FMD suggests that saltatory conduction through the NIC is 
impaired which might have a negative impact on muscle function.
It is technically challenging to demonstrate a conduction block in OBPI 
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patients through nerve conduction studies because of the complex anatomy 
of the brachial plexus. Its small size in neonates, its highly fasciculated 
nature and the potential presence of misrouted axons make it difficult to 
record supramaximal stimulus intensities proximal and distal to the lesion 
and to consistently record compound muscle action potentials (CMAPs) of 
target muscles. Reliable measurements become virtually impossible when 
the examination is performed in a conscious three-month-old neonate. 
Conduction studies on sedated patients before or during surgery have 
been more successful. An electrophysiological study in 129 patients reports 
that 25% of NBPP are exclusively caused by a conduction block 16. In a more 
recent study, a drop in compound motor action potentials (CMAPs) of 
more than 50% was found during intra-operative measurements in 25% of 
OBPI patients undergoing reconstructive surgery 17. In a histological paper 
examining acoustic neuromas from patients with severe hearing deficits, a 
conduction block is implied, based on local, subtle deficits in myelination 32. 
Together, these studies suggest that action potential propagation could be 
impaired in NIC, in spite of axonal continuity.
The decision for surgical intervention in NBPP should always be based on 
recovery of function, as electrophysiological data can be misleading 14,33. A 
recent paper 17, reports that the authors developed a treatment algorithm, 
where they decide to resect a NIC with less than 50% conduction and, 
subsequently, to perform nerve grafting. Although the applied algorithm 
is under debate 34 these clinical observations point toward the existence of 
deficits in nerve conduction in NIC. There was no evidence in our data that 
the total number of FMD in the neuroma declines over time, as there was no 
correlation between age at the time of operation and FMD load. It should 
be noted, however, that all patients were treated within a relatively short 
time window (88 – 190 days; average: 139.2), so that a possible temporal 
correlation between the FMD load and age of the patient over a longer 
period cannot be excluded. Delaying surgical exploration in severe injuries 
should be avoided whenever possible as chronic denervation of the end 
organ and especially of the nerve can negatively influence the functional 
recovery 35. It is not clear whether FMD contain newly regenerating axons, or 
axons that did not rupture. Since FMD are mainly observed in anatomically 
intact fascicles, it is possible that FMD pathology impedes the function of 
axons that remained in continuity. The apparent failure of Schwann cells 
to myelinate axons in a NIC might be a target for the development of new 
treatment strategies. Brief electrical stimulation of a focally demyelinated rat 
nerve leads to a robust enhancement of the intrinsic myelination response 
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36. Whether this technique, which has also been used to promote axonal 
regeneration in the compressed nerve 37, might be useful in the treatment 
of traction lesions remains to be established. 
Mechanisms of formation of Focal myelin deficits 
In order to further understand the presence of FMD, we sought to 
explore different possible mechanisms of myelin deficiency, including an 
immune-mediated mechanism, deficits in (de)differentiation of SC, and a 
relation with the degree of fibrosis. Although a number of demyelinating 
neuropathies have been described, the spherical, focal nature of the 
unmyelinated areas we observed here is remarkable. Some cases have 
been reported with plaque-like demyelination in peripheral nerves 38. Both 
in this report and other cases of acquired demyelinating disease, immune 
cells mediate the process of demyelination 39. We did not observe CD68 
positive macrophages in our series of NIC (data not shown). Although we 
cannot exclude that at this relatively late time-point after injury (5 months) 
these immune cells have receded from the NIC, we have no evidence that 
the formation of FMD is the result of an immune system-mediated process. 
It is important to note that we do not observe morphological features 
as onion bulbs that are indicative of active re- and de-myelination. This 
suggests that demyelination plays no role in the pathogenesis of FMD but 
myelin defects probably represent a failure to myelinate axons after the 
initial nerve trauma.
The gross pathological features of NIC might provide some insight in 
the mechanism of FMD development. We observe that the size of the 
neuroma, combined with the presence of a continuous epineurial fibroblast 
sheet correlates with the load of FMD in NIC. This suggests that fibrosis 
is either a direct cause of FMD, or that fibrosis and FMD are caused by 
the same process. It is possible that extensive fibrosis and an increase in 
nerve diameter causes compression, which can result in focal deficits in 
myelination, as is commonly observed in compression neuropathies such as 
carpal tunnel syndrome 40,41. Demyelination has also been demonstrated in 
animal models of nerve constriction 42,43. Recently, it has been described that 
polymorphisms in the 3’ UTR of the collagen gene COL5A1 are associated 
with an increased risk of the development of carpal tunnel syndrome 44. It 
is therefore possible that the extensive fibrotic response observed in the 
NIC is directly or indirectly involved in the pathogenesis of FMD. It can not 
be excluded that other mechanisms related to nerve compression, like 
ischemia, are also involved 45,46. Animal models for inducible focal nerve 
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demyelination could provide further insight in the pathophysiology of 
FMD 47,48. Conversely, axonal signals initiate the myelination program of 
enveloping Schwann cells 49,50. It is therefore possible that focal areas of 
axonal dysfunction are causal to FMD formation.
Myelin formation by Schwann cells is tightly controlled by transcription 
factors that dictate their state of differentiation and myelination 51. POU3F1/
Oct6 has been identified as a key transcription factor for pro-myelinating 
Schwann cells 52. Conversely, EGR2/Krox20 is expressed by mature 
myelinating Schwann cells 53. To identify if these transcription factors are 
dysregulated in FMD, immunohistochemistry for Krox20 and Oct6 was 
performed. However, the expression levels of Oct6 and Krox20 in and 
outside FMD were not changed (Supplemental Figure 2). Interestingly, 
c-Jun, a negative regulator of myelination 54 is also widely expressed by 
Schwann cells in neuroma tissue. Similar to KROX20 and Oct6, c-Jun is not 
differentially expressed in FMD (data not shown). 
Conclusion
The discovery of FMD in NIC sheds a new light on the neuropathology that 
underlies the absence of functional recovery in a subset of patients with 
NBPP and adult traumatic brachial plexus injury. The presence of FMD 
indicates that either dysfunctional Schwann cells or focal areas of axonal 
dysfunction are a central element of the pathobiology of NIC. FMD are 
found in relatively intact fascicles, where they may impede action potential 
propagation of otherwise intact axons. More work is needed to elucidate 
the mechanism by which FMD are formed. The discovery of FMD may 
inspire novel strategies to treat traumatic brachial plexus injuries aimed at 
improving the myelinating properties of Schwann cells in the NIC.
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Abstract
A human neuroma-in continuity (NIC), formed following a peripheral 
nerve lesion, impedes functional recovery. The molecular mechanisms 
that underlie the formation of a NIC are poorly understood. Here we show 
that the expression of multiple genes of the Wnt family, including Wnt5a, is 
changed in NIC tissue from patients that underwent reconstructive surgery. 
The role of Wnt ligands in NIC pathology and nerve regeneration is of 
interest because Wnt ligands are implicated in tissue regeneration, fibrosis, 
axon repulsion and guidance. The observations in NIC prompted us to 
investigate the expression of Wnt ligands in the injured rat sciatic nerve and 
in the dorsal root ganglia (DRG). In the injured nerve, four gene clusters were 
identified with temporal expression profiles corresponding to particular 
phases of the regeneration process. In the DRG up- and down regulation 
of certain Wnt receptors suggests that nerve injury has an impact on the 
responsiveness of injured sensory neurons to Wnt ligands in the nerve. 
Immunohistochemistry showed that Schwann cells in the NIC and in the 
injured nerve are the source of Wnt5a, whereas the Wnt5a receptor Ryk is 
expressed by axons traversing the NIC. Taken together, these observations 
suggest a central role for Wnt signalling in peripheral nerve regeneration.  
Introduction
Peripheral nerve injuries can cause life-long functional disability in patients. 
The regenerative response of an injured peripheral nerve is dependent on 
a variety of parameters, including the age of the patient, the distance of 
the lesion to the end organs, and the severity of the injury 1. Following injury 
to a human peripheral nerve often a neural scar is formed at the site of 
the lesion, which hampers regeneration. Occasionally, the cellular response 
in an injured human nerve culminates in the formation of a neuroma-in-
continuity (NIC). The biological processes that underlie the formation of a NIC 
following injury and how the NIC inhibits functional recovery remain poorly 
understood. In an effort to determine the changes in gene expression that 
occur in an injured human peripheral nerve, Tannemaat et al. performed 
a microarray analysis on NIC tissue derived from eight patients with severe 
brachial plexus injury 2. 722 genes were differentially expressed in the NIC 
compared to the proximal nerve stump. 
Interestingly, the Wnt pathway was significantly overrepresented in the set of 
differentially expressed genes. The Wnt gene family is of particular interest 
in the process of PNS regeneration. Wnt signalling has been implicated 
in tissue regeneration 3-5, stem cell maintenance 6,7, cell proliferation 8,9, 
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differentiation 10,11, axon guidance during CNS development 12-14, and inhibition 
of CNS regeneration 15,16. Following spinal cord injury Wnt5a is expressed in 
the neural scar that forms at the injury site and axonal expression of the Wnt 
receptor Ryk mediates the repulsive effects of Wnt5a on axon regeneration. 
Wnt signalling has thus been implicated as a contributing factor in the 
inhibition of axon regeneration following spinal cord injury 15,16.
Several components of the Wnt gene family have been studied in PNS 
development. For instance, Wnt ligands have been shown to guide the 
differentiation from neural crest cells towards Schwann cells 17-19. Furthermore, 
Wnt3a together with R-spondin mediate Schwann cell lineage progression 
during PNS development and instigate the process of radial sorting 19. Also, 
Wnt5a stimulates organ innervation by the sympathetic nervous system. 
Wnt5a KO animals display deficits in the innervation pattern of intercostal 
nerves 20. The axonal effects of Wnt5a during PNS development are mediated 
through an autocrine loop with the Wnt receptor Ror2 21. Surprisingly little is 
known about Wnt signalling in PNS regeneration, except for the finding that 
the Wnt receptor Ryk is up-regulated in dorsal root ganglion (DRG) neurons 
after a peripheral nerve injury 22. 
In different cellular contexts, Wnt5a has been described either as a chemo-
repulsive 14-16,23-25 or a neurotrophic factor 13,21,26. It has been proposed that 
different Wnt receptor expression patterns are responsible for the activation 
of distinct intracellular signalling cascades 12,27,28 which mediate repulsive 
or neurotrophic effects. Therefore detailed insight in which Wnt ligands, 
receptors, and modulators are expressed under specific conditions is 
essential in order to understand the functional involvement of Wnt ligands 
in axon regeneration and tissue repair following peripheral nerve injury.
The aim of this chapter is to provide a comprehensive analysis of the 
regulation of Wnt pathway genes in the context of PNS injury and regeneration 
in the rat and human nerve. To this end we first verified changes in these 
genes in human NIC identified in the microarray study 2 and confirmed 
Wnt5a up-regulation by immunohistochemistry. We then quantified the 
expression of Wnt gene transcripts over a range of post-lesion time points 
in the proximal and distal portions of crushed or transected sciatic nerves 
and in the dorsal root ganglia, in rats. After sciatic nerve crush injury the 
endoneurial tubes remain intact and most axons readily regenerate towards 
the muscle and skin through their original endoneurial tube. Following a 
sciatic nerve transection injury and subsequent repair both the axons as 
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well as the endoneurial tubes are interrupted. The severed axons have to 
cross from the proximal to the distal stump and have to find a suitable 
endoneurial tube before they can regrow towards and re-innervate the 
target tissues. As a result, regeneration of a transected nerve is more 
challenging than recovery of crushed nerves, it was investigated whether 
these different injuries affects Wnt gene expression. In the nerve four clusters 
of Wnt-pathway genes with distinct temporal patterns of expression were 
observed. The F-Spondin1 and Wnt2 clusters are mainly composed of Wnt 
ligands, including Wnt5a, Wnt5b and Wnt4, which are up-regulated as 
early as 3 days post-injury. A third gene cluster consists of genes that are 
first down-regulated and subsequently return to baseline level. This pattern 
of expression strongly correlates with the expression pattern of myelin basic 
protein (MBP), a protein component of myelin. Finally, the Axin2 cluster is 
characterized by a set of transcripts up-regulated from 14 days onward. In 
human NIC, Wnt5a was the most significantly up-regulated Wnt ligand. In 
the rat several Wnt ligands, including Wnt5a/b, Wnt4 and the Wnt receptor 
Ryk responded to nerve injury. Wnt5a/b is expressed in Schwann cells in 
the injured rat peripheral nerve and in the NIC. These data form the basis 
for the functional studies on the role of Wnt ligands in peripheral nerve 
regeneration described in chapters 4 and 5.
 
Material and Methods
Human material
All human material was anonymized as stated in the code of conduct for 
responsible use of human tissue and medical research (2011) 29. During 
nerve reconstructive brachial plexus surgery the NIC was identified and 
classified by an array of tests, as described in the Material and Methods 
section of 30. Resected neuroma, and corresponding proximal and distal 
stumps were snap-frozen within 15 minutes and stored at -80˚C. Human 
material was sectioned on a cryostat in 20 or 40 µm sections. Sections were 
stored in -80˚C until further use.
RNA isolation and cDNA production from human tissue
Human NIC and corresponding proximal and distal stumps of six patients 
were sectioned on a cryostat 40 µm sections and immediately placed in 
1 mL Trizol Reagent (15596018; Thermo Fisher Scientific, Waltham, MA, 
USA) and stored at -80˚C. Tissue was homogenised with an ultra-turrax 
(IKA-Labortechnik, Staufen DE). Phase separation was performed by 
application of Trizol solution in combination with chloroform to a phase 
lock gel tube (5prime, Hilden DE). The aqueous phase was transferred 
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to an RNAse-free tube and mixed with an equal volume of 70% ethanol. 
Subsequently, Samples were loaded to an RNeasy Mini column (Qiagen, 
Valencia, CA, USA) and processed according to the RNeasy mini protocol 
(from step 3). The RNA concentration was determined by measuring the 
absorption at 260 nm on a nanodrop ND-1000 (Nanodrop Technologies, 
Wilmington, DE, USA). The RNA quality was determined on a Bioanalyzer 
(Agilent technologies, Santa Clara, CA, USA) and RNA was only included 
when the RNA integrity number (RIN) was ≥5.5. 150 ng of RNA was used 
for cDNA production using the Quantitect reverse transcription kit (Qiagen, 
Valencia, CA, USA).
Micro-array based human gene expression analysis
Micro-array analysis is performed as described earlier 2. Briefly, NIC and 
proximal stump tissue of eight patients was dissected and total RNA was 
isolated and analysed for concentration and quality, as described above. 
Micro-array analysis was performed with Agilent 44K Whole Human 
Genome arrays (Agilent technologies, Santa Clara, CA, USA). Sample 
labelling, hybridization and processing were performed according 
manufacturer instructions. Micro-arrays were scanned with an Agilent DNA 
Micro-array Scanner at 5 µm resolution. Scans were quantified using Agilent 
feature extraction software (version 8.5.1). Raw gene expression data were 
imported in R statistical processing environment and analysed by LIMMA 
package in Bioconductor (www.bioconductor.org). P-values for differential 
regulated gene expression in NIC and proximal stump were corrected for 
multiple testing by Bonferroni correction algorithm.
qPCR based human gene expression analysis
cDNA was 20x diluted in water, and used for qPCR analysis. A SyBR green 
kit was used as described and the PCR procedure was performed on ABI 
7900 HT (Applied Biosystems, Foster city, CA, USA). Data were analysed by 
7300 Sequence detection software 1.4 (Applied Biosystems). The reference 
genes were B2M, YWHAZ and UBC, identified in accordance with 31.  
Animals
All animal experiments were approved by the KNAW animal ethical 
committee and were in accordance with European directive 2010/63/EU. 
Adult female Wistar rat (weight rage 180-200 g) were purchased from 
Harlan (Indianapolis, IN, USA).
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Animal surgery
One-hundred-sixteen adult female Wistar rats received either a unilateral 
nerve crush or transection and co-aptation of their left sciatic nerve under 
hypnorm (Fentanyl; 0.08 mL / 100 g i.m.)/dormicum (Midozolam; 0.05 mL 
/ 100 g s.c.) anaesthesia, in accordance with 32,33. Directly after the surgery 
and 1 day after surgery all animals received Temgesic (0.03 mL / 100 g s.c.) 
as analgesic.  
Animal material for Immunohistochemistry
Fifty-eight rats were sacrificed by transcardial perfusion with 4% 
paraformaldehyde (PFA) in 0.1 M PBS, pH 7.4, at 3, 5, 14, 28, 42 and 90 days 
after injury. The sciatic nerves and corresponding L4 and L5 DRG’s were 
dissected and post-fixed in 4% PFA in 0.1 M PBS, pH 7.4, O/N at 4˚C, after 
which tissue was cryoprotected in 25% sucrose in 0.1 M PBS pH 7.4 O/N at 
4˚C. All tissue was snap-frozen on dry ice and embedded in Tissue-Tek 
(Sakura, Alphen aan den Rijn, NL) and kept at -20˚C until 20 µm sections 
were made on a cryostat. 
Immunohistochemistry
Sections were immersion-postfixed in 4% PFA in 0.1 M PBS, pH 7.4 for 15 
minutes at R.T. Immunohistochemistry (IHC) was performed in Tris-buffered 
saline (TBS), pH 7.4, containing 0.2% Triton X100 and 5% fetal calf serum. IHC 
was performed with the following antibodies: mouse anti-neurofilament 
(1:1000; 2H3 ascites; Developmental Studies Hybridoma Bank, University of 
Iowa, IA, USA), rabbit anti-S100, rabbit anti-Wnt5a (1:100; for human tissue; 
#2530; Cell signalling, Beverly, MA, USA) goat anti-Wnt5a (1:100; for human 
tissue; AF645; R&D systems, Minneapolis, MN, USA), rabbit anti-Wnt5a (1:100; 
for rat tissue; Abcam, Cambridge, UK), rabbit anti-Ryk (1:500; a gift from Dr. 
Yimin Zou), rabbit anti-calnexin (1:200; ab22595; Abcam, Cambridge, UK).
RNA isolation and cDNA production from rat tissue
Fifty-eight rats were sacrificed by decapitation after CO2/O2 sedation at 3, 5, 14, 
28, 42 and 90 days after injury. Three 6mm sciatic nerve segments (one proximal 
to, one around the injury site and one distal to the injury site) and corresponding 
L4 and L5 DRG’s were dissected and immediately placed in 1 mL Trizol Reagent 
(Ambion; 15596018) and stored at -80˚C. RNA isolation was performed by first 
applying Trizol to a phase lock gel (5prime, Hilden DE), followed by isolation on 
RNAeasy mini columns (Qiagen, Valencia, CA, USA). RNA concentration was 
determined by 260 nm absorption on a nanodrop 1000 spectrophotometer (Thermo 
scientific; Waltham, MA, USA) 150 ng of RNA was used for cDNA production using 
the Quantitect reverse transcription kit (Qiagen, Valencia, CA, USA).
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qPCR on rat cDNA
cDNA was 20x diluted in mQ, and employed for qPCR. SyBR green kit was 
used as described and PCR procedure was performed on ABI 7900 HT 
(Applied Biosystems, Foster city, CA, USA) data were analysed by 7300 
Sequence detection software 1.4 (Applied Biosystems, Foster city, CA, USA). 
The reference genes were GAPDH, NSE and β-actin in accordance with 
34. qPCR data is shown in heatmaps generated by hierarchical clustering. 
The data are plotted as log2 values compared to a healthy uninjured nerve 
or L5 DRG. Statistical analysis of qPCR data was performed with linear 
models with time as a factor in the R statistical processing environment. 
Multiple testing correction was applied using the Benjamini Hochberg 
method. Genes that exhibited significant regulation (p<0.05) over the entire 
timeline (by the F-test) were selected for post-hoc testing with Dunnett’s test 
using uninjured nerve or DRG as the control group, to identify significant 
timepoints. 
Primers
All primers were designed on the Primer3 NCBI website with melting 
temperature ~60˚C. A complete list of all primer sequences is provided in 
as a supplementary table (Primer list). 
Results
Specific WNT genes are differentially expressed in the human NIC
To gain insight in the gene expression changes that occur in human 
neuroma-in-continuity (NIC) a micro-array analysis was performed on NIC 
tissue of eight patients after neonatal brachial plexus injury (NBPI). A total 
of 722 genes were differentially expressed 2. The complete gene expression 
Table 1. Wnt pathway genes are differentially expressed in human NIC
Micro-array analysis of human NIC material shows that Wnt5a, Sfrp4, Wnt2b, Daam1 and 
Ror2 are up-regulated and Fzd8 and Nlk are down-regulated compared to proximal 
stump 2.
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data set will be published elsewhere. Here we focus on changes in gene 
expression of the Wnt pathway. The expression of seven members of the 
Wnt pathway was significantly changed, namely, Wnt5a, Wnt2b, Sfrp4, 
Fzd8, Ror1, Daam1, Nlk (Table 1). A Fisher exact test demonstrates that the 
Wnt pathway was significantly overrepresented in the set of significantly 
regulated genes (p<0.05). qPCR validation of the expression of these Wnt 
genes was performed on an extended patient group, which included the 
eight original patients used for the microarray study and six new patients 
(Fig. 1A, B). qPCR analysis of human NIC tissue corroborated that Wnt5a, 
Sfrp4, Ror1, Daam1 and NLK are differentially expressed. Using qPCR, 
no significant differences were observed for Wnt2b and Fzd8. Taken 
together, we show that a Wnt ligand (Wnt5a), a Wnt receptor (Ror1), and 
two intra-cellular downstream Wnt signalling factors (Daam1 and NLK) are 
differentially expressed in NIC.
Wnt5a is expressed by Schwann cells of the NIC
Wnt5a was selected as a promising gene for further study because of its role 
in axon outgrowth 12-14, neurogenesis 35,36, differentiation 37-39, proliferation 
40-42 and fibrosis 43. All these processes are of considerable interest in the 
context of the formation of a NIC. To our knowledge all commercially 
available Wnt5a antibodies recognize both Wnt5a and Wnt5b. We used 
Wnt5a/b antibodies to investigate the cellular localisation of Wnt5a/b in 
Figure 1. Specific Wnt pathway genes are differentially expressed in human NIC
A, qPCR analysis shows that 5 months after injury human NIC tissue has increased levels 
of Wnt5a mRNA compared to the proximal stump. B, in addition to Wnt5a (p<0.001), qPCR 
analysis shows that extracellular Wnt modulator Sfrp4, Wnt pathway member Daam1 and 
the Wnt receptor Ror1 are upregulated. Wnt pathway member Nlk is down regulated. Wnt 
receptor Fzd8 and Wnt ligand Wnt2 are not differently expressed between the NIC and the 
proximal stump (* p<0.05, ** p<0.01, *** p<0.001).
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Figure 2. Cellular localisation of Wnt5a/b and Ryk in NIC
A-D, Immunohistochemistry for Wnt5a/b on human NIC tissue sections. The nuclei of intra-
fascicular cells are identified by DAPI (A, blue). Many intra-fascicular cells express Wnt5a/b 
(B, green). Neurofilament positive axons (C, red) present in the NIC are often found in 
close vicinity to the Wnt5a/b expressing cells (D, overlay of panels A, B and C). E-H, Strong 
Wnt5a/b (F, green) expression is visible in intracellular perinuclear structures (blue in A). 
Co-staining with the ER-marker calnexin (G, red) reveals that Wnt5a/b is expressed in the 
ER (H, overlay of panels E, F, G). I-P, Cellular localisation of Ryk in NIC. Co-staining for DAPI, 
Ryk and Neurofilament reveals that Ryk expression (green in J) is observed on individual 
neurofilament positive axons (K, red) and in axon bundles (N, green) that traverse the human 
NIC (L, overlay of panels I, J, K). Panel M to P also show that Ryk is weakly expressed around 
the nuclei (blue in M) in the NIC (P, overlay of M, N, O). 
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NIC by a triple immuno-histochemical analysis for Wnt5a/b, Neurofilament 
(NF) and Calnexin (Fig. 2A-H). Nuclei were stained with DAPI (Fig. 2A, E, I, 
M). Wnt5a/b was localized to intra-fascicular cells (Fig. 2B, F) that were 
often present in close association with NF labelled neurites (Fig. 2C, K, O). 
Due to incompatibility of the Wnt5a/b and S100 (a Schwann cell marker) 
antibodies IHC co-staining to further identify the cell type that expresses 
Wnt5a/b was not possible. The intra-fascicular localisation of Wnt5a/b 
positive cells and the association of these cells with axons indicate that 
Wnt5a/b is expressed in Schwann cells. Interestingly, in many cells a distinct 
peri-nuclear staining pattern is visible for Wnt5a/b (Fig. 2B, D). Wnt5a/b 
co-localized with the ER marker calnexin (Fig. 2E-H). This indicates that 
intracellular Wnt5a/b is at least partly localised to the ER. Furthermore, a 
more diffuse extracellular staining for Wnt5a/b was visible, indicating that 
Schwann cells in a NIC produce and secrete Wnt5a/b and that Wnt5a/b is 
present in close proximity to axons that traverse the NIC.
Ryk is expressed by neurites that populate the human neuroma-in-
continuity
The Wnt5a receptor Ryk mediates the chemorepulsive effects of Wnt5a in 
the developing CNS and following injury to the spinal cord 14-16. To investigate 
whether the nerve fibres in the NIC express Ryk, an IHC double staining 
was performed for Ryk and NF (Fig. 2J-Q). Ryk and NF exhibit significant 
co-localisation (Fig. 2J-L, N-P), which indicates that this Wnt5a receptor is 
expressed in axons in a NIC. In addition to the distinct axonal Ryk expression, 
a relatively low Ryk signal is observed in many other cells in the NIC (Fig. 
2N-P; indicated by arrow). 
Expression analysis of Wnt signalling pathway genes following peripheral 
nerve injury in the rat
The observations on the expression and localization of Wnt5a mRNA, 
Wnt5a/b protein and Ryk in human neuroma tissue prompted us to study 
the expression of Wnt ligands and their receptors in the injured rat peripheral 
nerve. We employed two rat PNS injury models, sciatic nerve crush and 
sciatic nerve transection. In both injury paradigms we quantified transcript 
expression over a range of time points chosen to correspond to relatively 
well-defined aspects of the regeneration process, including the initiation of 
axonal regeneration, Schwann de-differentiation and proliferation (3 and 
5d post injury (p.i.)), axon extension and re-innervation (14, 28d p.i.) and re-
myelinisation, maturation and functional recovery (28, 42, 90d p.i.). In both 
injury paradigms we analysed a nerve portion proximal from the injury site 
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(prox), a nerve portion that includes the injury (inj) and a portion distal to 
the injury (dist).
An extensive analysis of the expression of the genes that constitute the Wnt 
signalling pathway, including Wnt ligands, Wnt receptors, Wnt modulators 
and downstream members of the Wnt pathway, revealed changes in gene 
expression at all levels of the Wnt pathway. The expression profiles of the 
Wnt genes were compared to expression of markers of immature and de-
differentiated (F-Spondin1 44-46) and myelinating (MBP 47) Schwann cells. 
Hierarchical gene clustering was performed in combination with heat map 
representation to show patterns of temporal co-regulation of genes. Gene 
clusters are named after each of the two marker genes or after a gene 
that represents the expression profile of the gene cluster. The expression 
profiles are compared to the gene expression levels of an uninjured control 
nerve. The fold changes and SEM are provided in the supplementary tables 
(sTable 1 - 3).  
The temporal expression patterns of the Wnt pathway genes appear to follow 
similar trends following nerve crush and transection, although it is apparent 
that the transected nerve demonstrates a more profound regulation of Wnt 
pathway genes (Fig. 3A-C). Two-way-ANOVA analysis demonstrates that 
there are significant differences in the degree of Wnt pathway regulation 
between the two injury paradigms (crush and transection). In the proximal 
stump 11 of 72 tested genes are significantly differentially regulated between 
injury paradigms, but this does not include any of the Wnt ligands. The injury 
site demonstrates a higher level of differential regulation between injury 
paradigms, with 40 of 72 significant genes, these include 9 of the 16 Wnt 
ligands. Finally the distal nerve has 41 of 72 genes significantly differentially 
regulated between injury paradigms, with 2 of the 16 Wnt ligands. All 
significantly differentially regulated genes are indicated with asterisks next 
to the gene name (Fig. 3A-C). 
Wnt family genes expression clusters in four distinct temporal profiles 
after peripheral nerve injury
All three nerve portions exhibit a gene cluster of up-regulated genes which 
includes Wnt4, Wnt5b, Wnt1 and F-Spon1. We refer to this cluster as the 
‘F-Spon1 cluster’. This cluster consists of genes that are up-regulated as 
early as 3 days after the lesion and up-regulation persists during late post-
lesion time points (42-90d p.i.). This cluster is especially pronounced in the 
injury containing and distal nerve portions (Fig. 3A-C, Fig. 4A).
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Figure 3A. Proximal stump
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Figure 3B. Injury site
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Figure 3C. Distal stump
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In the proximal nerve portion a second cluster of up-regulated Wnt ligands 
named the ‘Wnt2 cluster’ was identified. This cluster consists of genes up-
regulated after 5d p.i. that remain up-regulated untill 90d p.i. and consists 
of the Wnt ligands Wnt2, -5a, -9a, -10a, -10b and Wnt11 (Fig. 3A). 
The injury site and distal nerve portion both exhibit a large cluster of genes 
that are not regulated at early time points but are up-regulated from 
14d in crush and 28d in transection injury. This cluster is referred to as the 
‘Axin2 cluster’. Finally, a fourth cluster of genes was called the ‘MBP cluster’ 
because the temporal expression profiles of genes in this cluster followed 
that of MBP, exhibiting early down regulation of genes and normalisation 
of expression between 14 and 28 days after injury (Fig. 3B,C; Fig. 4B,C). The 
“Axin2 cluster” consists of 40 genes, including Fzd2, Vangl1, Axin1, Axin2, Ror2, 
Ryk, Vangl2, Lrp10, Wnt11, Fzd8, Wnt2, Sfrp2, Sfrp4, Ptk7, Fzd6, Mcam, Sfrp1, 
Lrp12, Lgr4, DKK3, DKK4, Dvl1, Foxo3, Foxo1, Mdb3, Ror1, Fzd4, Fzd1, Lrp6, 
Fzd3, Lrp5, Fzd7, Wnt6, Wnt9b, Wnt3a, Wnt9a and B-catenin (Fig. 3B,C; Fig. 
4B). The “MBP-cluster” contains 25 Wnt-genes (including Wnt16, Fzd5, Fzd9, 
Sfrp5 Spon2, Rspon1, Rspon3, Wif1, Lgr5, Lgr6, Lgr7, Foxo4, Foxo6; Fig. 3B,C; 
Fig. 4C). 
Taken together, in the rat Wnt signalling pathway genes display coordinated 
changes in expression after PNS injury (summarized in Fig. 4D). Genes in 
the F-Spon1 cluster (including Wnt4 and Wnt5b) and Wnt2 cluster (including 
Wnt5a) are significantly up-regulated during the early and intermediate 
stages of the regeneration process, suggesting that these Wnt-ligands may 
have a role in axon regeneration and/or Schwann cell de-differentiation (Fig. 
4A,D). Genes in the “Axin2 cluster” display changes in expression during later 
Figure 3. Changes in the expression of Wnt pathway genes after peripheral nerve injury 
in the rat
The expression of 72 Wnt pathway genes in crushed (left half of the figure) and transected 
(right half of the figure) rat nerve (3 to 90 days post injury) was analysed using qPCR. Data 
is presented as clustered heat maps for the proximal stump (A), injury site (B) and distal 
stump (C). Red indicates up- and blue down-regulation of mRNA expression of the analysed 
genes compared to uninjured control nerve. A, The proximal stump displays two clusters of 
co-regulated genes, the Wnt2 and F-Spondin cluster. B, C, the injury site (B) and distal nerve 
stump (C) exhibit three clusters of genes, the F-Spondin cluster, the axin-1 cluster and the 
MBP cluster. All corresponding fold changes and SEM are provided in supplemental table 1 
- 3. Asterisks indicate significant timepoints, asterisks behind gene names indicate significant 
effects of injury on the gene expression profile (* p<0.05, ** p<0.01, *** p<0.001). 
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stages of the regeneration process (Fig. 4B,D). These genes may therefore 
have roles in Schwann cell differentiation, remyelination of regenerated axons 
or other processes in the nerve that are important for the recovery of function 
of the injured nerve, e.g. target cell re-innervation. Finally the genes in the 
“MBP-cluster” are down-regulated in the early stages of regeneration and 
return to normal levels during the later stages of regeneration (Fig. 4C, D). 
Therefore these genes may have roles in the formation and/or maintenance 
of myelin and the post lesion maturation of Schwann cells.
Figure 4. Wnt pathway gene clusters in the distal stump of the transected sciatic nerve
The temporal expression profiles of individual genes in the F-Spondin1, Axin2 and MBP 
clusters in the distal stump were plotted to visualize the coordinated nature of the expression 
of Wnt-pathway genes after nerve transection. Black lines represent individual genes, blue 
lines indicate average regulation and red lines indicate regulation of the marker gene 
(F-spon1, MBP) or the Wnt2b or Axin2 gene. A, The F-Spondin cluster contains genes which 
are up-regulated from early time points onward (3d p.i.) and remains up-regulated up to 
late (90d p.i.) timepoints. B, The genes in the Axin2 cluster exhibit an up-regulation at later 
time points (14 - 28d p.i.) and remain up-regulated up to 42 to 90d p.i. C, The MBP cluster 
consist of genes that are down-regulated at early timepoints (3 – 14d p.i.) and return to 
baseline around 28d p.i. D, Schematic representation of the F-Spondin1 (green), Axin2 (red) 
and MBP (blue) clusters with an indication of their correspondence to post-injury repair 
events in the peripheral nerve as indicated at the X-axis of the graph suggesting that these 
genes may have a role in these processes. 
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IHC analysis of Wnt5a/b in experimental peripheral nerve injury
The Wnt5b transcript is up-regulated at the injury site and in the distal nerve 
stump of the injured rat peripheral nerve. Wnt5a is significantly up-regulated 
at 28d p.i. at the injury site in the transected nerve. The cellular location of 
Wnt5a and Wnt5b (Wnt5a/b) was investigated by IHC. This analysis was 
performed on rat 28d post crush sciatic nerve (Fig. 5 A-D). The antibody 
employed for human tissue was not functional on rat tissue, therefore 
another antibody (Abcam; ab72583) was used. Based on the peptide 
sequence it was raised to, this antibody recognizes both Wnt5a and Wnt5b. 
It is therefore not possible to discriminate between the expression of Wnt5b 
and Wnt5a protein in the nerve. Nerve sections were stained for DAPI (A), 
Wnt5a/b (B), the Schwann cell marker S100 (C) and NF (D). Schwann cells 
express Wnt5a/b, as indicated by co-expression of Wnt5a/b and S100. This 
is in line with the observation in NIC where Wnt5a/b is also predominantly 
expressed in Schwann cells. The distinct peri-nuclear staining for Wnt5a/b 
observed in Schwann cells in NIC tissue is not observed in rat Schwann cells.
To quantify Wnt5a/b protein expression levels we employed the same 
timeline as for our mRNA expression analysis in sciatic nerve tissue. 
Both crushed (Fig. 6A) and transected (Fig. 6B) nerves were analysed 
immunohistochemically. In the proximal portion of an injured nerve, 
relatively low levels of Wnt5a/b are detected in Schwann cells (Fig. 6A, 
6B). In the injury site and distal to the injury Wnt5a/b is up-regulated in 
Schwann cells and the up-regulation persists for at least 42 days. After 90 
days, the expression of Wnt5a/b had returned to baseline. At early time-
points (3-5d p.i.; Fig. 6A, A-F; Fig. 6B, A-C), a small population of cells with 
intense staining of Wnt5a/b are noticeable. Considering their distribution 
and round shape these cells are possibly macrophages. Macrophages are 
known to express Wnt5a 48 and are recruited to an injured peripheral nerve 
at these post-lesion timepoints 49. 
Figure 5. Wnt5a/b is expressed by Schwann cells in the injured rat nerve
A-E, Triple label Immunohistochemistry for Wnt5a/b, S100 and NF on transversal sections 
of rat peripheral nerve 28d after sciatic nerve crush. Wnt5a/b (B, green) is predominantly 
expressed in S100 positive Schwann cells (C, red) that enwrap neurofilament positive axons 
(D, white) in the injured rat nerve (E, overlay of panels A, B, C and D). Scale bar is 10 µm.
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Figure 6A. Wnt5a/b protein expression is up-regulated in the crushed rat nerve
A-O, Immunohistochemical staining of Wnt5a/b (green) and nuclear staining with DAPI (blue) on 
transversal sections through the proximal stump (left column), injury site (middle column) and distal 
stump (right column) of the rat peripheral nerve at 3 to 90 days after nerve crush. Wnt5a/b expression 
is low in the proximal stump at all time points (A,D,G,J,M). The injury site shows very high Wnt5a/b 
staining at 3 days (B) and this gradually diminishes in staining intensity over time from 5 (E), 14 (H), to 
28d p.i. (K) and returns to baseline at 90d p.i. (N). In the distal stump Wnt5a/b expression is increased 
at 3 (C), 5 (F), 14 (I) and 28d p.i. (L) and has returned to baseline at 90d p.i. (O). Quantification of 
Wnt5a/b signal in the proximal nerve stump, injury site and distal nerve stump is shown in the graphs 
in panels P to T. (* p<0.05, ** p<0.01, error bars represent SEM). Scale bar is 25 µm.
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Figure 6B. Wnt5a/b protein expression is up-regulated in the transected rat nerve
A-O, Immunohistochemical staining of Wnt5a/b (green) and nuclear staining with DAPI (blue) on 
transversal sections through the proximal stump (left column), injury site (middle column) and distal 
stump (right column) of the rat peripheral nerve at 3 to 90 days after nerve transection. Wnt5a/b 
expression is low in the proximal stump at all time points (A,D,G,J,M). The transection-coaptation site 
shows high Wnt5a/b staining at 3 days (B) gradually diminishing in staining intensity over time from 5 
(E), 14 (H), to 28d p.i. (K) and returns to baseline at 90d p.i. (N). In the distal stump Wnt5a/b expression is 
increased at 3 (C), 5 (F), 14 (I) and 28d p.i. (L) and has returned to baseline at 90d p.i. (O). Quantification 
of Wnt5a/b signal in the proximal stump, injury site and distal nerve stump is shown in the graphs in 
panels P to T. (* p<0.05, ** p<0.01, *** p<0.001, error bars represent SEM). Scale bar is 25 µm.
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3Wnt receptors are regulated in DRGs after PNS injuryThe injury-induced expression of several Wnt ligands in the sciatic nerve 
may have a role in functioning of the various cells present in the injured 
nerve (Schwann cells, fibroblasts, blood vessel cells, immune cells) and/or 
may have an impact on the regenerating axons themselves. To investigate 
the latter possibility the expression of Wnt receptors was analysed by 
qPCR in the L5 DRG. These DRGs contain the cell bodies of the sensory 
neurons of the sciatic nerve. Hierarchical gene clustering was performed 
in combination with heat map representation. All gene clusters are named 
after a gene that represents the expression profile of that gene cluster. 
The expression profiles are compared to the gene expression levels of 
an uninjured L5 DRG. The fold changes and SEM are provided in the 
supplementary tables (sTable. 4A-B). Two-way-ANOVA analysis identified 
four significantly regulated genes between the crush and transection injury 
paradigms, namely: Fzd8, Dvl1, Lrp10 and Sfrp2 (indicated by asterisks next 
to the gene name (Fig. 7)).
Figure 7. Differential expression of Wnt pathway genes in L5 DRG following sciatic nerve 
crush or sciatic nerve transection
Wnt-pathway gene expression was analysed in L5 DRG following sciatic nerve crush (left 
half) or transection (right half). In the heatmap red indicates up-regulation and blue down-
regulation compared to control DRG. Five gene clusters, named the R-spondin1, Ryk, Fzd8, 
Mcam and Dvl1 cluster, were observed. The Ryk cluster contains 7 Wnt receptors, which mostly 
peak in expression at 14d p.i. All fold changes and SEM are provided in supplemental table 
4. Significant timepoints are indicated by asterisks. Asterisks behind gene names indicate 
significant effects of injury on the gene expression profile (* p<0.05, ** p<0.01, *** p<0.001).
Figure 8. Ryk protein expression is increased in axotomized DRG neurons
A-H, Immunohistochemical staining of Ryk (green) in L5 DRG following sciatic nerve crush 
(top row) or transection (bottom row) ranging from control (0 day) to 28 days p.i. (right 
column). Ryk staining intensity is low in control DRG neurons (A, E). Ryk staining intensity 
increased over time, and peaks at 14d p.i. (C, G) and returns towards baseline at 28d p.i. 
(D,H). I, Quantitative analysis of Ryk expression in DRG following sciatic nerve lesion (* 
p<0.05, ** p<0.01, *** p<0.001, error bars represent SEM). 
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Five clusters could be distinguished. A cluster of highly up-regulated 
transcripts called the ‘Rspon1 cluster’ exhibits a peak of regulation at 14 to 
28d p.i. and consists of 5 genes, namely: Rspon1, Sfrp4, Lrp5, Ror1 and Lgr7. 
A second cluster of up-regulated genes called the ‘Ryk cluster’ displays a 
peak in regulation at 14d post-injury. The Ryk cluster consists of 12 genes, 
predominantly Wnt receptors, including Fzd1, Fzd2, Fzd5, Fzd7, Ryk, Lrp6, 
Vangl1, Dvl2, Rspon3, Spon2 and Rspon4. 
The next two clusters demonstrate a modest degree of down-regulation 
after injury. The Fzd8 cluster consists of 7 genes, specifically: Dkk2, Vangl2, 
Lgr6, Fzd6, Fzd4, Fzd8 and Fzd9. The Mcam cluster is comprised of 12 genes: 
Lrp12, Lgr5, Spon1, Mdb3, Axin2, Lgr4, Dkk4, Axin1, Mcam and Rspon2. 
Finally, a cluster named the ‘Dvl1 cluster’, contains genes that primarily 
exhibit down-regulation which is strongest at 5 days for the crush injury 
and 5 to 14 days after nerve transection. The Dvl1 cluster is comprised of the 
following 12 genes: Fzd3, Ror2, Sfrp5, Lrp10, Ptk7, Dkk3, Celsr2, Dvl1, Daam1, 
PKC, β-catenin and Sfpr1.
Figure 9. Comparative summary of Wnt5a, 5b and Wnt4 expression in human NIC and the 
injured rat nerve 
Summary of the observations on Wnt5a, Wnt5b and Wnt4 expression in human NIC and in 
the injured rat sciatic nerve. In NIC tissue Wnt5a mRNA levels are increased (indicated by + 
and red colour) compared to the proximal stump while Wnt5b and Wnt4 mRNA expression 
are detectable in the proximal stump and NIC but the levels are not increased (indicate by 
~ and no colour). Following injury of the rat nerve Wnt5a mRNA expression is induced in the 
proximal stump and at the injury site. Wnt5b and Wnt4 mRNA levels are increased at the 
injury site and the distal stump in comparison to the proximal stump. The Wnt5a receptor Ryk 
is clearly detectable on axons in the NIC and is induced in rat DRG neurons following nerve 
injury. Human distal nerve stumps were not analysed (N.A.).
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IHC analysis of the Ryk receptor 
The expression of Wnt receptor, Ryk, was investigated by IHC because of 
its known involvement in neurite outgrowth during development 14 and 
neuroregeneration in the spinal cord 15,16. Immunohistochemical analysis 
for Ryk was performed on the DRG following both crush (Fig. 8A-D) and 
transection/coaptation injury (Fig. 8E-H). Ryk protein expression shows 
a clear up-regulation, over time in both injury paradigms (Fig. 8), which 
corroborates earlier findings 22. A quantitative analysis demonstrates a 
similar pattern for both injury paradigms. Ryk staining intensity increases 
both after crush and transection injury and peaks at 14 days for both injury 
paradigms (crush: p<0.01, transection: p<0.001), while at 28 days p.i. Ryk 
staining intensity returns to baseline for both injury paradigms (Fig. 8I). 
Discussion
In this chapter the expression of a large proportion of Wnt pathway genes 
was investigated in the context of human and rat peripheral nerve injury. 
In human NIC, Wnt5a is the most prominently up-regulated Wnt gene. 
Schwann cells in the NIC express Wnt5a and regenerating axons express 
the Wnt5a receptor Ryk. Injury to the sciatic nerve of the rat induced 
coordinated changes in the expression of the Wnt gene family both in the 
injured nerve and in the DRG. In the injured rat nerve, four gene clusters 
could be identified (designated the F-Spon1, Wnt2, Axin2 and MBP clusters) 
with distinct temporal expression profiles that correspond to particular 
phases of axon regeneration and post-lesion functional recovery. The 
DRG exhibits dynamic up- and down regulation of a number of Wnt 
receptors, which suggests that nerve injury has a significant impact on the 
responsiveness of injured sensory neurons to Wnt ligands. In the injured rat 
nerve Wnt5a is up-regulated in the proximal nerve portion and at the injury 
site, while Wnt5b and Wnt4 are the most prominently up-regulated Wnt 
ligands at the injury site and in the distal nerve portion. Wnt5a/b protein 
is expressed in Schwann cells and Ryk is up-regulated in the DRG neurons 
after nerve injury. Thus, Wnt5a is up-regulated in the human NIC and in the 
proximal nerve portion and transection injury site of the rat nerve. Wnt5b 
and Wnt4 are up-regulated at the injury site and in the distal portion of the 
rat nerve, however these Wnt ligands are expressed but not increased in 
the NIC (Fig. 9). The changes in expression of the Wnt pathway genes both 
in human NIC and rat PNS injury indicate a central role for Wnt signalling in 
PNS regeneration.
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Similarities and differences in Wnt5a, Wnt5b and Wnt4 expression in 
human NIC and in the injured rat nerve
The cellular response to injury in a human and rat peripheral nerve is 
quite different. The formation of a NIC in an injured human nerve is the 
result of an extensive fibrotic response. It has been challenging to induce 
a NIC in rats that resembles the human NIC. Nerve traction combined with 
a crush injury resulted in subtle fusiform enlargement in rat nerves and 
a chaotic pattern of axon growth 50,51. However, this lesioning procedure 
did not induce the extensive fibrotic response observed following traction 
injuries to human nerves. We therefore choose to use the widely used and 
well-characterized nerve crush and transection as our injury models in 
the rat. Although the formation of a NIC is not observed in rats after a 
nerve crush or nerve transection 1,52, these models do induce Wallerian 
degeneration and following a transection injury endoneurial tubes are 
severed, Schwann cells and fibroblasts proliferate and migrate into the 
lesion site and regenerating axons display a relatively chaotic pattern of 
growth before they enter an endoneurial tube in the distal nerve stump. 
Figure 9 summarizes the similarities and differences in Wnt ligand gene 
expression between the human NIC and injured rat nerve. In the human 
NIC, Wnt5a is the only significantly up-regulated Wnt ligand, whereas 
Wnt5b and Wnt4 are expressed in the NIC but expression of these two Wnt 
ligands is not increased. In the injured rat nerve, Wnt5a is up-regulated 
in the proximal stump and injury site, whereas Wnt4 and Wnt5b are up-
regulated in the injury site and distal nerve stump (Fig. 9).
In the human NIC differential expression of several other Wnt genes that 
act at different levels of the Wnt signalling pathway was observed, in 
addition to Wnt5a. A Wnt-receptor (Ror1), a Wnt-modulator (Sfrp4) and two 
downstream Wnt pathway members (Daam1 and Nlk) were regulated. All 
these genes are also significantly regulated in the injured rat nerve, but the 
injured rat nerve exhibits regulation of many more Wnt genes (discussed 
below).   
A role for Wnt5-Ryk signalling in the injured human and rat nerve?
In both the human NIC and in the injured rat nerve Schwann cells appear 
to be the predominant source of Wnt5a/b. A diffuse extracellular staining 
was also observed, indicating Wnt5a/b is secreted into the extracellular 
space. Regenerating axons in the NIC and injured rat neurons express the 
Wnt receptor Ryk (Fig. 9), which indicates that regenerating axons in the 
human NIC and in the injured rat nerve could potentially be responsive 
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to Wnt5a/b secreted by Schwann cells. Wnt5a/Ryk signalling has been 
implicated in axon outgrowth both during development as well as after 
spinal cord injury. The involvement of Derailed (Drl), a Ryk homologue, 
in axon guidance was originally discovered in Drosophila 23,53-56. During 
mammalian development Wnt signalling mediates axon guidance of 
several neuronal populations including ventral midbrain monoaminergic 
neurons 13,35 and striatal projections 57. Wnt5a guides axons over the corpus 
callosum via the Ryk receptor 24 and corticospinal tract (CST) axons grow 
through the developing spinal cord driven by an anterior to posterior 
gradient of Wnt1 and Wnt5a. The development of the CST was impaired 
by infusion of antibodies that interfered with the function of Ryk 14. In the 
spinal cord a re-induction of Wnt gene expression occurred upon injury 
15,16,25,58. Wnt5a is expressed in the glial scar that forms after a spinal cord 
lesion, while the Wnt receptor Ryk is expressed by injured spinal cord 
axons and function blocking antibodies to Ryk promoted local sprouting 
of CST axons 16. Thus, Wnt/Ryk signalling is implicated in the inhibition of 
axon regeneration following CNS injury 15,16,25. In the human NIC, Wnt5a/Ryk 
signalling may therefore also contribute to the aberrant patterns of axon 
growth and/or the impaired regeneration of axons into the distal nerve 
stump. Conversely, Ryk-mediated stimulation of neurite outgrowth of 
embryonal mouse DRG neurons by Wnt3a has also been reported 26. This 
implies that, in some situations, Ryk can also be involved in the stimulation 
of axon outgrowth. 
In the distal portion of the injured rat nerve Wnt5b is up-regulated while 
Wnt5a expression is not increased in the distal nerve portion. The core 
promoter of Wnt5a is very similar in human and rat (72.5% homology), 
whereas the Wnt5b promoter region is not conserved between the two 
species 59. This may underlie the differential regulation of Wnt5b in the 
human NIC and at the injury site and in the distal portion of the rat nerve. 
Wnt5a has a high amino acid homology to Wnt5b (75.8%) 59. Although 
Wnt5b signalling has not been extensively studied, Wnt5b also signals 
through the Ryk receptor in Zebrafish gastrulation 60. However, Wnt5a and 
Wnt5b display distinct effects in chondrocyte development 40. It is therefore 
difficult to predict if Wnt5a and Wnt5b have similar functions in the injured 
rat and human nerve. In chapter 4 and 5 we have investigated the role of 
Wnt5a/b and Ryk in axon regeneration by using bioassays and by in-vivo 
manipulation of Wnt signalling.
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Wnt gene expression in the injured rat nerve
Four distinct clusters of Wnt genes were identified in the injured rat nerve. 
The F-Spon1 cluster consists of three Wnt ligands (Wnt1, Wnt4 and Wnt5b). 
These genes exhibit early up-regulation and remain up-regulated until at 
least 90d p.i. This temporal expression profile suggests that the significantly 
regulated Wnt ligands in this cluster (Wnt4 and Wnt5b) could potentially 
be involved in the stimulation of axon regeneration, the activation and 
de-differentiation of Schwann cells and in regenerative processes that 
occur later, i.e. remyelination and target cell re-innervation. The potential 
involvement of the genes in the F-Spon1 cluster in these processes is 
supported by known functions of Wnt4. Wnt4 (like Wnt5a) has been implied 
in CST development, Wnt4 attracts sensory neurites through Wnt receptor 
Fzd3 14,61. Following spinal cord injury Wnt4 is re-expressed around the 
injury site 16. Surprisingly, implantation of Wnt4 over-expressing bone 
marrow stromal cells in the injured spinal cord resulted in long range axon 
Figure 10. Overview of Wnt gene expression during regeneration in the injured rat nerve
A working model on how Wnt gene expression coincides with regenerative processes in the 
distal injured rat nerve. Red illustrates up-regulation. A, shows (early) denervated Schwann 
cells (bottom) as found in the injured distal peripheral nerve from 3-5d p.i.. Schwann cells 
de-differentiate and produce Wnt4 and Wnt5b for autocrine and paracrine signalling, and 
possibly signal to arriving growth cones (top). B, shows recently regrown axons (top) at 14-
28d p.i. together with Schwann cells (bottom) of the injured nerve. Schwann cells produce 
Wnt4 and Wnt5b to signal towards regenerating axons that have up-regulated multiple Wnt 
receptors including Ryk. Wnt5b and Wnt5 also mediate Schwann cell autocrine signalling, at 
14d p.i. through altered Wnt receptor availability initiates differentiation and re-myelination 
due to activation of the β-catenin pathway as demonstrated by Axin2 up-regulation. C, 
exhibits the late regenerative response at 28 – 90d p.i., with regrown axons (top) and a 
re-myelinating Schwann cell (bottom). Re-myelinating Schwann cells still produce Wnt4 
and Wnt5b but axons have returned their Wnt receptor expression to baseline. Schwann 
cells signal with Wnt ligands in an autocrine fashion to stimulate the β-catenin pathway as 
indicated by Axin2 up-regulation.
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retraction 15. This demonstrates that during spinal cord development and 
regeneration Wnt4 has very different effects on neurite growth. Wnt4 also 
plays a role in regulating the innervation of the neuromuscular junction. 
Wnt4 null-mutant mice demonstrate profound deficits in muscle innervation 
62. Taken together, this demonstrates that Wnt4 guides sensory neurite 
growth during CNS development, impedes neurite growth during CNS 
injury and guides the growth of motor neurites during PNS development. 
As mentioned before, Wnt5a has also been demonstrated to be involved in 
these processes 12-16,20,21. The high degree of amino acid homology between 
Wnt5b and Wnt5a suggest that Wnt5a and Wnt5b may have very similar 
roles in PNS regeneration. Therefore the role of Wnt5a, -5b and Wnt4 in PNS 
regeneration warrants further investigation.
Schwann cells of the injured nerve dramatically alter their function during 
the regenerative process. They first de-differentiate and stimulate axonal 
growth at the early stages of regeneration, and subsequently re-myelinate 
regenerated axons. The potential involvement of Wnt signalling from a 
growth promoting cell to a myelinating cells is indicated by the differential 
patterns of expression of genes in the MBP and Axin2 cluster which is 
especially clear in the transected distal nerve (Fig. 3C). The MBP cluster 
consists of genes that are down-regulated at early time points and return 
to baseline between 14 and 28d p.i. MBP is a principle component of myelin 
and therefore a marker for mature myelinating Schwann cells. Therefore, 
genes in the MBP cluster may have roles in the post-lesion maturation of 
Schwann cells and in Schwann cell myelinisation (Fig. 10A). At 14-28d p.i. 
the Axin2 cluster is up-regulated. This pattern of expression suggests that 
the genes in this cluster are involved in Schwann cell differentiation and/or 
re-myelination. Axin2 gene expression is stimulated by the β-catenin Wnt 
pathway 63,64, and has therefore been employed as an indicator for active 
β-catenin Wnt signalling 65 also in Schwann cells 19. Furthermore, the Axin2 
cluster contains numerous genes that are involved in the β-catenin pathway, 
including Lrp5/6, Fzd1/2/3/4/6/7 and Wnt3a. This all suggests that the Axin2 
cluster reflects active β-catenin signalling, a pathway essential for lineage 
progression of neural crest cells 66, the process of axonal sorting 19 and for 
myelination in Schwann cells 67. 
Altered Wnt receptor presence at the plasma membrane determines the 
outcome of Wnt ligand signalling 12,28. The Axin2 cluster includes 15 of the 17 
Wnt receptors, indicating that cells of the injured nerve undergo alterations 
in their responsiveness to Wnt-signalling during later stages of regeneration. 
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Possibly, Schwann cells alter their Wnt receptor expression to shift their 
interpretation of the Wnt5b and Wnt4 signal from de-differentiation to 
initialize re-myelination. This changing receptor expression pattern 
could underlie the activation of different Wnt pathways, in this case from 
β-catenin independent towards β-catenin dependent pathways on later 
post-lesion timepoints. This is consistent with earlier findings that show that 
the β-catenin pathway is an essential driver for myelination in Schwann 
cells 67 (Fig. 10B). In later stages (28-90d p.i.) of the regenerative response 
Schwann cells continue to re-myelinate and their altered Wnt receptor 
expression persists, and indeed Axin2 remains up-regulated indicating 
active β-catenin signalling (Fig. 10C).
Changes in Wnt receptor expression in the DRG
Axotomized DRGs exhibit five Wnt gene clusters. The R-Spondin1 and Ryk 
clusters contain a number of Wnt receptors which are up-regulated following 
injury, including Ror1 68,69, Lrp5 70, Fzd1 71, Fzd2 72, Fzd5 73 and Ryk 26. All of these 
receptors have been implicated in the process of neurite outgrowth. Of these 
six receptors it is known that Ryk is a known receptor for Wnt5a, -5b and -4 
14,15,60, Ror1 is a Wnt5a receptor 74 and Fzd5 is a receptor for Wnt5a and -4 
75. This suggests that injured sensory neurons undergo significant changes 
in their responsiveness to Wnt ligands that are expressed and increased in 
the injured nerve. The expression of these Wnt receptors peaks at 14d p.i. 
Therefore, DRG neurons are possibly more responsive to Wnt stimulation at 
14d p.i. compared to uninjured DRG neurons (Fig. 10B).
In addition to potential alterations in ligand receptor interaction at the level of 
the regenerating axons, injured DRG neurons may secrete Wnt modulators 
that affect Schwann cells in the injured nerve. R-spon1 is a ligand for the 
Lgr4/5 receptor and Lgr4 is up-regulated in the distal stump. Signalling 
through this receptor results in an increased Wnt receptor presence at the 
plasma membrane, therefore R-spon1 can function as a Wnt signalling 
agonist 76-78. Regenerating sensory neurons could transport R-spon1 and 
secrete it from their regenerating axons to facilitate Wnt signalling in de-
differentiated Schwann cells upon contact with a regenerated axon. 
Conclusion 
These findings demonstrate that genes of the Wnt signalling pathway are 
significantly regulated upon both human and rodent peripheral nerve injury. 
The regulation of the Wnt pathway suggests that it plays a key role in PNS 
regeneration. Therefore, further research into the role of Wnt-signalling in 
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PNS regeneration is warranted. As a first step to uncover the various roles of 
Wnt signalling in PNS regeneration we employed an array of functional in-
vitro bioassays in chapter 4. Furthermore, we study the Wnt pathway in-vivo 
in transgenic animals and lentiviral vector-based strategies in chapter 5.
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Primer list
Gene Primer_Forward (Sense) Primer_Reverse (AntiSense)
Fzd1 CACCTGGATAGGCATCTGGT ACAGGAAAATAATGGGCCGC
Fzd2 AAGCACGACGGCACCAAGAC AAGTAGCAGGCGATGACGATGG
Fzd3 CCAGCAGACAGCAGCTTTAG TGCACAAAGAAATGGCCGAA
Fzd4 AAGGACCAGGTGACGAAGAG GAACACAGTTCAGGCTCCTTT
Fzd5 CCAGTGTGCCAGGAAATCAC TGCTTCGTCCTGAGTGTCAT
Fzd6 CAGCTCTCCAGAACCAAACA CTGAGCGAACAAGCAGAGAT
Fzd7 CATCGGTACGTCCTTCCTGT CCATGAGCTTCTCCAGCTTC
Fzd8 CTTGTGGTCGGTGCTCTGCTT AGGTAGAGACAGTGGCGAAGGT
Fzd9 AAGACAGACCCCTCTCTGGA CCATAACTCAGCCCAGCCTA
Fzd10 AGCACCAGAGGGCTTATTGA TCTTCCCAAGTGCTCCAACA
Lgr4 ACGCTTAGATGCCAACCATATT ACAGATGGCGTAACTGGACA
Lgr5 TGAAGCACACTGCTCTGTTG CGGGACTGATAAACGTGAGG
Lgr6 TACTCTGTAACGGGCTGGTG ACAAGCTTGACCGGAGACAA
Lgr7 AGTACTGTGGCTATGCACCA ACACGACCCAGACAAAGACT
Lrp5 CTGGAGCTGCTGCACAGAACAT CGATGCGGTTGGTCTCTGAGTC
Lrp6 CGTGTTTCACTGGGGACATT TGAGCTCATCACTGTGGTCT
Lrp10 TGGAACTCACACAGCAGTCC TCAGGCAAGCAGTGGTTCAT
Lrp12 ATTGCCCAAACGGAAGGGAT AGTTGCAGCGATCAGAACGA
Ror1 ATCCCACCACAGGGTCAAAT CTGCGTATCCGGGAGGTATT
Ror2 CAGGACGTGGTGGAGATGAT TCGATCATGAGGGCGTAGAC
Ryk CACGCAGCTCCAACTACTTC ACTATGAAGGTGCAAAACTGCT
Vangl1 TTCGTCCTTAAATGCTTGGA CGGACTGTAAGCGAAGAACA
Vangl2 CACACGCATCGCCAAGGACAT ACAGCAGTGGAGGCAGCAACA
DKK1 TTCCAACGCGATCAAGAACC CTTGTTCCCGCCCTCATAGA
DKK2 TGCAAAGTGTGGAAGGATGC TTCTGGCACACATGGAGTCT
DKK2 TGCTGATGGTGGAGAGTTCAC CACCTAGAGAGGACTTGATGGA
DKK3 CTCTGAGGTGACCCTGTCAA TGCACATGGGCTGTGTTATT
DKK4 AGGTGACTGGTAACCGACAA TATTCTTTGGCATACTCTTAGCCTT
Lin28a TTAAGAAGTCTGCCAAGGGTCT CTCACTCCCAATACAGAACACG
Mcam AGGAGAGGCAGATACCCATTT CTGAGGCGGTGTTCATATTCC
Nlk ATGAAGGGCGGCTGAGATAC TGGTGACAGGCTCAAAGTCA
PTK7 AGAGCACCCACACAGTCAG AGAGGCCGCTATGTTCGG
Rnf43 TGGAGTCGGAAAGATCAGCAG ACCTTCCAAGGTGAGGTTCA
Wnt1 ACAGCGTTTATCTTCGCAATCA TAGTCGCAGGTGCAGGATT
Wnt2 AATTCGCCCGTGCATTTGTA CAGAGTACAGGAACCGCTCA
Wnt2b CACCCAGTGTGAGTGCAAAT AGTGTTTCTGCACTCCTTGC
Wnt3 CGCAATTACATCGAGATCA CATCTATGGTGGTACAGTTC
Wnt3a TCTGCCATGAACCGTCACAACA AGCAGGTCTTCACTTCGCAACT
Wnt4 AAGGCCATCCTGACACACAT CGCCGTCAAACTTCTCCTTT
Wnt5a CCACGCAGGACCTGGTCTACAT TAGCCACGCCCACAGCACAT
Wnt5b TCGACAGAGGCGGTGGAACT AGGCTCGGCTGATGGCATTC
Wnt6 TCCTCTACGCAGCCGATTCAC CAACAGGTCGCAGCCGCTAA
Wnt7a ACACTGCCACAATTCCGAGA ATGGACGGCCTCGTTGTATT
Wnt7b AACACGCACCAGTACACCAAGG TGACGAAGCAACACCAGTGGAA
Wnt9a CTGTGGGGACAACCTCAAGT CCCAGGAACTCCTTGACAAAC
Wnt9b CAGCTCTCCCCATTTCGTGA TTTGACAGCCGTGTCATAGC
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Gene Primer_Forward (Sense) Primer_Reverse (AntiSense)
Wnt10a CGCACGCATGAGACTCCACAA TTCGCCGCATGTTCTCCATCAC
Wnt10b ACAAGACCAGCCGCCTATT CGTTGACCCACTCTGTGACT
Wnt11 TTTCCGATGCTCCTATGAAGGT CCCCACTTCACTGTTGTGTAGA
Wnt16 AGAGAGTGCAACCGTACGTC TGTGGACATCGGTCATGCT
FoxO1 TACTCGGCCCAAGGAAAGTT TTAGCAGAGCACAGGCAGTA
FoxO3 AGAACAGACCAGCCACCTTT CATCATTGGGTCGTTGCGAA
FoxO4 TAACAGGTCCTCGGAAGGGA ATATCTGGGCGAGTGTCAGC
FoxO6 CATGCCAGCGACGACTAC CTTGGGTACATGAGTGGCGA
Axin1 CAAACCAAGCCAGCCACTAA TCTGTCTGTGCCTGGTCAAA
Axin2 AAACATGACCACTCTGGGCTA TCCTGTTCGGGCAAGCTAT
Celsr2 ACAGCTGTCGTCTTCCTGTC ACGTAGCGCTTCTCGCTAAA
Ctnnb1 CCTCTGTGAACTTGCTCAGGA TTCATTCCTGGAGTGGAGCAA
Daam1 ACTTGGATGGCCTGTCATGTA AGCCAATGAGGGAGGTATGT
Dvl1 TGGTGGTGCAGCTCAAGTAT CTGTGCAGTTCTGGGAGACT
Dvl2 ACCCATCTTGAGGCCACATT TGAGCCCAGGCACTAAGAAG
Mbd3 ACACCTGGCTATGCCTACCT TATGGGCAGGAGCAGTTCAG
Rspo1 TTGGACCGATGGAGAACCTG AGGCCAGATCCACCATAACC
Rspo2 TCCCATTTGCAAGGGTTGTTT ATACTGGCGCATCCCTTCTC
Rspo3 TACTATGCACTTGCGACTGATTT TTGGCTGCCGATGTATTCCATA
Rspo4 ACATGCGAGAGCTGTTTCAG AGACACTTCCCTTTGTAGAGGT
Spon1 AAGTCTCCAGGGTCATGGGT ACGGAAATCACGGCTCACAA
Spon2 ACCGCTGGACTGTGAAGTTT TAGCGAGTTCTGCTCTTGGC
Sfrp1 CTGCTCAACAAGAACTGCCA TAGATAGGCCGGTCCAGACA
Sfrp2 CAGAAGGGCCAGAGAGAGTT TGGGAAACCGGAAATGAGGT
Sfrp4 AAGGTCACCTGCTTCCAAAC TCCTGTAAGGGTGGCTTCAA
Sfrp5 TAGACAACCTGACAGGGAGC TTCTTCTTGTCCCAGCGGTA
Prkzc CATCGGGCGTGGAAGCTAT TCACCACCTTCATGGCGTA
Wif1 TCACACTTGTGTTAGTGGCATTTA TCCAAGGCAAAGACTCCATACA
Znrf3 TACACACTCACCGAGGAACC AGCCCAAGTCACAGTCTACA
Changes in expression of Wnt pathway genes following PNS injury
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Abstract
In this chapter bioassays were used to examine the responses of neurites 
from DRG neurons and cultured Schwann cells to Wnt5a, Wnt5b and Wnt4. 
These three Wnt ligands were chosen because, as shown in chapter 3, 
they are induced following injury to a human (Wnt5a) or rat peripheral 
nerve (Wnt5a, Wnt5b and Wnt4). In a classical repulsion assay Wnt5a 
does not exert repulsive activity, whereas Wnt5a, -5b and -4 promote 
neurite outgrowth of embryonic DRGs. Cultured naïve (unconditioned) 
adult DRGs neurons did not significantly respond to Wnt5a, but displayed 
a trend towards enhanced neurite growth. Upon a conditioning lesion 
the outgrowth of cultured, conditioned, adult DRG neurons is inhibited by 
Wnt5a. This switch in responsiveness may depend on their Wnt-receptor 
composition. Indeed, DRGs without Ryk (obtained from Ryk-/- mice), exhibit 
dramatically enhanced outgrowth in response to Wnt5a compared to 
wildtype DRGs, whereas overexpression of specific Wnt receptors (or 
combinations) stimulates or impedes neurite growth in a DRG-like cellular 
screen. Collectively, these data indicate that the receptor composition 
affects the neurite outgrowth response of sensory neurites to Wnt ligands. 
We also demonstrate that cultured primary Schwann cells respond to 
Wnt5a with up-regulation of Sox2, a transcription factor with a key role in 
Schwann cell differentiation. Functional perturbation studies of Wnt ligands 
in vivo in the injured peripheral nerve are required to study their role in the 
nerve regeneration process.
Introduction
Wnt ligand genes encode highly conserved, secreted glycoproteins that play 
important roles during normal development and in disease 1,2. Throughout 
the animal kingdom Wnt ligands are described in processes such as 
morphogenetic signalling, stem cell differentiation and oncogenesis. In the 
developing nervous system, a number of Wnt ligands, including Wnt5a, are 
required for axon guidance 3-10. The role of Wnt5 (a Wnt5a homologue) in 
axon guidance was originally discovered in Drosophila 4,11. Interestingly, in 
different cellular contexts opposing effects of Wnt5a on axon outgrowth 
and guidance have been described. Wnt5a can act as a repulsive axon 
guidance cue 4,5,7, or as a stimulant for axon growth 3,6,9,12. In cultured cortical 
neurons, increased axon growth was observed away form a source of Wnt5a. 
This indicates that repulsive turning of axons induced by Wnt5a translates 
into enhanced axon growth away from the Wnt5a source or gradient 7,13. 
Expression of only the Wnt receptor Ryk directs intra-cellular signalling 
towards axon growth, while combined expression of Wnt receptors Frizzled 
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and Ryk cause the axon to be repelled away from a source of Wnt and 
this also resulted in an increased axon growth rate 13. Wnt5a/Ryk signalling 
inhibits regenerative axonal growth in the damaged rodent spinal cord 
14-16. Wnt5a and Wnt4 are expressed by scar tissue that forms after spinal 
cord injury, and Ryk is expressed by injured spinal cord axons. Ryk specific 
antibodies and Wnt inhibitory factor-1 (Wif1) expressing bone marrow 
stromal cells were used to interfere with Wnt5a/Ryk signalling. This resulted 
in improved axonal growth of injured axons towards scar tissue formed at 
the lesion site. 
In work described in Chapter 3, we showed that the expression of certain 
Wnt ligand genes and members of the Wnt signalling pathway is changed 
significantly in human neuroma-in-continuity tissue (neural scar tissue 
formed after a human peripheral nerve lesion; NIC) derived from patients 
that did undergo nerve repair surgery and in the rat sciatic nerve following 
nerve injury. In the injured rat peripheral nerve multiple gene clusters were 
identified of which the temporal expression patterns suggest that Wnt 
signalling contributes to various aspects of PNS regeneration, including 
axonal regeneration, (de-) differentiation of Schwann cells and re-
myelination. In chapter 3 it was also shown that the expression of multiple 
Wnt receptors, including Ryk, Fzd1, Fzd2, Fzd5 and Lrp5, is up-regulated in 
dorsal root ganglia (DRGs) following a lesion of the sciatic nerve, in line with 
earlier findings 15,17. This suggests that axotomized DRGs alter their sensitivity 
to Wnt ligands.
In this chapter we employed a number of bioassays, as a first step to 
assess the potential roles of Wnt5a, Wnt5b and Wnt4 in PNS regeneration. 
We choose to focus on Wnt5a, -5b and -4 for the following reasons: 1) the 
expression of Wnt5a is enhanced four fold in the human NIC (chapter 3), 2) 
Wnt5a, -5b and -4 are up-regulation at the lesion site or in the distal portion 
of the injured rat nerve (chapter 3), 3) a number of potential Wnt5a/b and 
Wnt4 receptors, including Ryk, Fzd1, Fzd2 and Fzd5 are up-regulated in 
axotomized DRGs (chapter 3), 4) Wnt5a, and Wnt4 are known to be involved 
in both stimulating as well as repelling axon growth during development 
3-7,9,13 and 5) Wnt5a and Wnt4 inhibit neurite regeneration through Ryk in the 
injured spinal cord 15.
First, we performed an axon repulsion assay to assess if Wnt5a has 
chemorepulsive effects on embryonic DRG neurites. Second, axon outgrowth 
assays on cultured embryonic and adult rat DRG neurons derived from 
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naïve animals and from animals that received a sciatic nerve lesion were 
performed to investigate the effects of Wnt5a, Wnt5b and Wnt4. To examine 
the role of the Wnt receptor Ryk in Wnt5a-mediated outgrowth of sensory 
neurons we performed neurite outgrowth experiments with embryonic DRG 
neurons derived from Ryk receptor mutant mice (Ryk-/-). To investigate the 
role of additional Wnt receptors and combinations of Wnt receptors in Wnt-
mediated stimulation of neurite outgrowth and/or repulsion, a DRG neuron-
like cell line (F11 cell)-based medium-throughput neurite outgrowth screen was 
performed. Finally, we investigated whether cultured primary rat Schwann 
cells are responsive to Wnt stimulation.
Materials and Methods
Animal material
The Royal Dutch Academy of Sciences animal ethical committee approved 
all animal experimental procedures and experiments were in accordance 
with European directive 2010/63/EU. Adult and timed-pregnant Wistar rats 
were obtained from Harlan.  Ryk-/- animals were housed and sacrificed 
in the Leiden University Medical Centre (LUMC Leiden, NL), as approved 
by to the LUMC animal ethical committee. DRGs from RYK-/- mice were 
harvested in the LUMC and subsequently transported to the Netherlands 
institute for Neuroscience (Amsterdam, NL) for further experiments. 
Repulsion assay
The repulsion assay was performed with embryonic day 14 (E14) Wistar rat 
DRGs as described previously 18. In short, pregnant rats were sacrificed by 
decapitation after O2/CO2 sedation, the uterus was removed and placed 
in Leibovitz’s L15 medium (life technologies) at 0˚C. Subsequently, DRGs 
were harvested from E14 embryos, kept in Leibovitz’s L15 medium at 0˚C 
and embedded in matrigel as described below. Human embryonic kidney 
(HEK293T) cells were transfected with Wnt5a or Sema3a expression plasmid 
and cultured O/N in DMEM 10% FCS medium at 37˚C in an incubator in an 
inverted position (hanging droplet) to form cell aggregates. The following 
day the cell aggregates were placed on poly-L-lysine (PLL)/laminin coated 
coverslips, with two flanking DRGs. Aggregates and DRGs were covered by 
matrigel (Corning life sciences; New York, NY, USA) containing 20 ng / mL 
nerve growth factor (R&D systems, Minneapolis, MN, USA) and allowed to 
solidify in an incubator at 37˚C, after which they were placed in a 24 well 
plate in DMEM/F12 medium in incubator at 37˚C. DRGs were allowed to 
grow for 16 hours and then fixed by 4% PFA in 0.1 M PBS, pH 7.4. DRGs were 
subsequently immuno-histochemically (IHC) stained for neurofilament and 
109
4
a custom image-pro script quantified the directional growth of outgrowing 
axons. 
Axon outgrowth assay
Axon outgrowth assays were performed with E14 rat or mouse DRGs 
obtained as described for the repulsion assay. E14 DRGs were placed on a 
PLL/laminin coated coverslip, in DMEM/F12 medium containing increasing 
concentrations of Wnt5a, Wnt5b or Wnt4 and cultured O/N at 37˚C. DRGs 
were then fixed by 4% PFA in 0.1 M PBS, pH 7.4. DRGs were subsequently 
stained for neurofilament and a custom image-pro script based on masking 
the total outgrowth of neurites quantified axon outgrowth. Outgrowth was 
normalized to the mean of 0 ng Wnt, WT control condition. 
Adult dissociated sensory neuron culture
To serve as experimental control, the left and right L4 and L5 DRGs of four 
uninjured female Wistar rats (a total of 16 DRGs) were dissected, dissociated 
and cultured as described. Eight female Wistar rats received a unilateral 
sciatic nerve crush as described previously 19. 14 days later, ipsi-lateral L4 and 
L5 DRGs were dissected. Meninges and roots were removed in Leibovitz’s 
L15 medium with micro scissors. 0.25% Collagenase (Invitrogen; Waltham, 
MA) was added to cleaned DRGs for 30’ at 37˚C. DRGs were mechanically 
dissociated by glass pipette. After which, DRGs were again incubated in 
collagenase for 20’ at 37˚C and further dissociated with increasingly 
narrower glass pipettes, until a single cell suspension was obtained. The 
cell suspension was applied on top of 15% BSA in 0.1 M PBS pH 7.4 and 
centrifuged for 2800 rpm for 4 minutes at R.T. The cell pellet was resuspended 
and neurons cultured on PLL/laminin (Invitrogen; Waltham, MA) coated 
glass coverslips in Neurobasal/glutamax/PS/B27 with 5 ng / mL NGF (R&D 
systems, Minneapolis, MN), 2 ng / mL NT3 (R&D systems, Minneapolis, MN) 
and 2 ng / mL CNTF (R&D systems, Minneapolis, MN) at 37˚C, 5%CO2 in an 
incubator. Adult DRG cultures were performed in the presence of 0, 3 and 
30 ng / mL Wnt5a. After 12h cultures were fixed with 4% PFA in 0.1 M PBS pH 
7.4 and stained for neurofilament by immunohistochemistry. Cultures were 
immunohistochemically stained for neurofilament and subsequent images 
were obtained by a Sp8 confocal microscope (Leica; Wetzlar, DE). Images 
were analysed with Neuromath software 20.
Medium throughput neurite outgrowth screen
A mice neuroblastoma/rat embryonic DRG hybrid cell line, named the F11 
cell was used for this screen 21. F11 cells have previously been used to study 
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neurite outgrowth 21,22. F11 cells were plated in a 96 wells plate on day one 
with 70% confluence in DMEM with 10% FCS and PS and placed in incubator 
at 37˚C. At day two, medium was replaced for DMEM with 2% FCS without 
PS. After two hours cells were transfected by Lipofectamine 2000 (Life 
technologies, Waltham, MA) with a maximum of 160 ng of DNA per well. 
Co-transfections were performed with a fixed amount of 80 ng GFP vector 
and expression vectors for a Wnt receptor. At day three, cells were passaged 
into three 96 wells plates, one for 24, 48, and 72h. Cells were cultured in 
Neurobasal, B27, glutamax, PS with 6.25 μM cytosine arabinoside (Ara-C) 
and 5 µM forskolin. Experiments were performed in the presence of 0 or 30 
ng / mL Wnt5a. After incubation of 24, 48 or 72h cells were fixated in 4% PFA 
in 0.1 M PBS pH 7.4 and subsequently stained immuno-histochemically for 
GFP. A Cellomics arrayscan fluorescent microscope imager automatically 
imaged F11 cultures. Subsequently, neurite morphology was traced by 
Cellomics neuronal profiling BioAppliation v3.5 (Thermo Fisher Scientific; 
Waltham, MA, USA). All data were normalized to the mean of GFP transfected 
condition that was always present on the plate, (n = 10 per plate).        
Schwann cell culture assay
Primary rat Schwann cells were isolated from 6-week-old female rats. 
The epineurium of sciatic nerves was removed and nerves cut in 2 mm 
segments. Nerves were dissociated in DMEM with 1.25 units/ml dispase, 
0.05% collagenase and 10% FCS. Schwann cells were then cultured in 
DMEM, 3% FCS, glucose (1.5 mg / mL), PS, 1 μM Forskolin and 20 ng / mL 
β-Neuregulin medium, until a confluent culture was obtained. Medium was 
then replaced, removing the mitogens (forskolin and β-Neuregulin) from the 
medium. After 24h, 0, 3 or 30 ng / mL Wnt5a (Millipore; Billerica, MA, USA), 
Wnt5b or Wnt4 (R&D systems, Minneapolis, MN, USA) was added to the 
medium. Schwann cells were then incubated for 48h at 37˚C. Subsequently, 
Schwann cells were either fixed with 4% PFA in 0.1 M PBS, pH 7.4 for IHC, or 
medium was replaced with Trizol (Thermo Fisher Scientific; Waltham, MA, 
USA) and stored in -80˚C for RNA isolation. 
Immunohistochemistry
Immunohistochemistry was executed in Tris-buffered saline (TBS), pH 7.4, 
including 0.2% Triton X100 and 5% fetal calf serum with Rabbit anti-Sox2 
(1:800, Abcam, Cambridge, UK) in combination with a DAPI (to visualise 
nuclei). Images were obtained with confocal laser scanning microscope 
SP5 (Leica; Wetzlar, DE) and intra nuclear Sox2 intensity was measured with 
custom Image Pro script, based on DAPI outline. 
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RNA isolation and qPCR analysis
RNA isolation and qPCR were performed as described in chapter 3. 150 ng 
input RNA was used for reverse transcription reaction. GAPDH and β-actin 
were employed as housekeeping genes. All data were expressed as compared 
to non-stimulated control from corresponding time-points. Primers were 
designed with the Primer3 NCBI website with melting temperature ~60˚C. 
 
Statistical testing
Statistical testing was performed as follows. The repulsion assay experiments 
were tested by one-sample t-test. Embryonal DRG and F11 neurite outgrowth 
assays were tested by one-way ANOVA with Dunnets post-hoc testing compared 
to 0ng Wnt stimulated and un-transduced F11 cells. Ryk-/- DRG assay was tested 
by two-way ANOVA with Sidaks and Dunnets post-hoc testing. Adult DRG assay 
was tested by linear mixed model regression analysis with turkey’s post-hoc 
analysis. Schwann cell intra nuclear Sox2 intensity was tested with one-way 
ANOVA with Dunnetts post hoc analysis compared to mean Sox2 intensity of 0ng 
Wnt stimulated Schwann cells. A p value of <0.05 was considered significant. A p 
value of <0.05 was and indicated by *, p<0.01 by ** and p<0.001 by ***.
Results
Wnt5a is not a repulsive factor for E14 DRG neurons
In different cellular contexts, Wnt5a acts either as a neurotrophic 3,6,9 or a 
repulsive axon guidance factor 4,5,7,14-16. To investigate whether Wnt5a acts as 
a repulsive guidance cue for primary sensory neurons, a classical repulsion 
assay was employed (Fig. 1A-C). Aggregates of 293T cells (outlined by a 
dashed line in Fig. 1A) transfected with an expression plasmid encoding 
Wnt5a or a plasmid encoding the well-known chemorepulsive guidance 
cue Semaphorin3A (Sema3A) were embedded in a collagen matrix and 
placed adjacent to E14 DRGs. Cell aggregates transfected with the Sema3A 
construct exert a strong repulsive effect on outgrowing DRG axons (Fig. 
1A). In contrast, Wnt5a transfected aggregates, do not display any repulsive 
effects on DRG neurites (Fig. 1B). Quantification of the outgrowth ratio 
towards and away from the cell aggregate confirms that unlike Sema3A 
(p<0.05), Wnt5a is not repulsive for E14 DRGs in this assay (Fig. 1C).
Wnt5a, Wnt5b and Wnt4 stimulate neurite outgrowth of embryonal DRGs
To study whether Wnt5a, Wnt5b and Wnt4 display neurotrophic effects, 
a neurite outgrowth assay was performed (Fig. 1D). E14 DRG explants 
were exposed to increasing concentrations of recombinant Wnt proteins 
(0-30 ng / mL) and outgrowth was measured 48 hours later. Neurite 
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outgrowth was stimulated by Wnt5a and Wnt5b in a dose-dependent 
manner to a maximum of ~150% of the control by addition of 10 ng / mL 
Wnt5a and Wnt5b (p<0.001). This effect reaches a plateau at 10 ng / mL. 
Wnt4 enhanced axon growth to ~140% with 30 ng / mL stimulation (p<0.001). 
Two-way ANOVA analysis did not reveal significant differences between 
Wnt ligands. Combinations of Wnt4, -5a and -5b were also tested but this 
did not show a synergistic effect on axon growth (data not shown).  
Figure 1. Wnt ligands stimulate neurite outgrowth of embryonal DRG neurons
A-C, E14 embryonal rat DRG were cultured in matrigel alongside a 293T cell aggregate 
(indicated by dotted line) that was transfected for either Sema3A (A) or Wnt5a (B). A 
Sema3A producing cell aggregate has a strong repulsive effect on the DRG neurites that 
grow towards the cell aggregate while neurites growing away from the aggregate are not 
affected. Wnt5a secreting 293T cells do not disturb the radial outgrowth of DRG neurites. C, 
Quantification of neurite outgrowth show that the ratio of neurite length extending to/from 
the cell aggregate is decreased for Sema3A secreting 293T cells (p<0.05) but is not changed 
for Wnt5a secreting cells. D, increasing concentrations of recombinant Wnt5a, -5b and -4 
(0-30 ng / mL) cause an increased neurite outgrowth response of E14 DRG neurons. Neurite 
outgrowth increases dose responsively to ~150% with 10 ng / mL Wnt5a (open bars) or 
Wnt5b (grey bars; both p<0.001) respectively, this effect saturates at 30 ng / mL. Wnt4 (black 
bars) increased axon growth to ~140% with 30 ng / mL stimulation (p<0.001). Significance is 
indicated by stars (* p<0.05, ** p<0.01, *** p<0.001, error bars represent SEM).
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Figure 2. Wnt5a inhibits neurite outgrowth of a 
subset of cultured conditioned adult DRG neurons 
Conditioned and unconditioned adult DRGs 
were dissociated and cultured in the presence 
or absence of recombinant Wnt5a (A) and 
subsequently neurite outgrowth was analysed 
by neuromath software (B). C-E, unconditioned 
(open bars) and conditioned (black bars) adult 
DRG neurons were cultured in the presence of 
increasing concentrations of Wnt5a (0-30 ng / 
mL) and analysed for total neurite outgrowth 
(C), longest branch length (D) and branching 
complexity (E) all values are normalised to 
corresponding 0 ng / mL Wnt5a condition. DRG 
neurons were divided in small (<30 µm; left) and 
large diameter (>30 µm; right) neurons. C, Small 
diameter neurons do not show an altered total 
neurite outgrowth in response to conditioning 
and Wnt5a stimulation. Unconditioned large 
diameter neurons demonstrate a trend towards 
increased total neurite growth with both 3 and 30 
ng / mL Wnt5a (n.s.). Conditioned large diameter 
neurons show a significantly decreased total 
neurite outgrowth when stimulated with 3 (p<0.05) 
and 30 ng / mL Wnt5a (p<0.01) compared to 
unconditioned DRG neurons. D, The length of the 
longest branch of small diameter DRG neurons 
does not change in response to conditioning and 
Wnt5a stimulation. Unconditioned large diameter 
neurons demonstrate a trend towards longest 
neurite with both 3 and 30 ng / mL Wnt5a (n.s.). 
Conditioned large diameter neurons have a 
significantly shorter longest neurite in response 
to 30 ng / mL Wnt5a (p<0.001) compared to 
unconditioned DRG neurons. E, Conditioning 
of small diameter DRG neurons does not alter 
the branching complexity in response to Wnt5a. 
Conditioned large diameter neurons have a 
significantly decreased branch complexity in the 
presence of 3 ng / mL Wnt5a (p<0.05). Significance 
is indicated by stars (* p<0.05, ** p<0.01, *** 
p<0.001, error bars represent SEM). 
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Wnt5a inhibits neurite outgrowth of cultured large diameter adult DRG 
neurons only after a conditioning lesion
To examine whether Wnt5a affects neurite outgrowth of adult DRGs 
neurons, dissociated adult DRG neurons were cultured in the presence of 0, 
3 and 30 ng / mL Wnt5a and their total neurite outgrowth, longest neurite 
and branching complexity was measured in small (<30 μm) and large (>30 
μm) diameter neurons by neurite tracing. In Figure 2 an example neuron 
is shown together with its neurite tracing. Wnt5a does not significantly 
stimulate neurite outgrowth of unconditioned cultured adult DRGs (Fig. 2C-
E). However, Wnt5a appeared to have a small but consistent stimulatory 
effect on total neurite outgrowth, especially on the length of the longest 
neurite of large diameter neurons (Fig. 2C,D). However, this effect did not 
reach statistical significance (p = 0.1).
 
The up-regulation of a number of Wnt receptors by DRG neurons upon 
PNS injury as reported in Chapter 3 could have a significant impact on 
the responsiveness of DRG neurons to Wnt5a. Therefore we cultured DRG 
neurons from rats that underwent a sciatic nerve crush and investigate the 
Figure 3. Embryonal Ryk-/- DRGs show an increased neurite outgrowth response to Wnt5a
DRGs from RYK homozygous (Ryk-/-) and heterozygous (Ryk0/-) and wildtype mouse embryos 
were cultured with or without recombinant Wnt5a addition to the medium. Wildtype DRGs 
(open bars) display a two fold increased neurite outgrowth in response to Wnt5a stimulation. 
RYK-/- DRGs (black bars) stimulated with Wnt5a show a strongly increased neurite outgrowth 
response compared to DRGs from Ryk-/- not stimulated with Wnt5a (p<0.001). Heterozygote 
DRGs (Ryk0/-) display an intermediate response (p<0.05). The Wnt5a stimulated neurite 
outgrowth is significantly better in RYK-/- DRGs compared to wildtype DRGs (P<0.01). Without 
Wnt5a stimulation there are no significant difference between mutant and wildtype DRGs. (* 
p<0.05, ** p<0.01, *** p<0.001, error bars represent SEM).
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effect of Wnt5a on these “conditioned” DRG neurons. DRGs were harvested 
14d post injury. First, conditioned large diameter DRG neurons show a 
reduced total neurite outgrowth after exposure to 3 (p<0.05) or 30 ng / 
mL Wnt5a (p<0.01) compared to unconditioned DRGs (Fig. 2C). Secondly, 
conditioned large diameter neurons have a shorter longest neurite after 
exposure to 30 ng / mL Wnt5a (p<0.001; Fig. 2D). Wnt5a did not affect 
total neurite outgrowth or outgrowth of the longest neurite of conditioned 
small diameter neurons (Fig. 2C,D). Finally, the branching complexity is 
significantly decreased after 3 but not 30 ng / mL Wnt5a exposure in large 
diameter neurons compared to unconditioned DRGs (p<0.01; Fig. 2E). 
This demonstrates that upon a conditioning lesion, Wnt5a inhibits neurite 
outgrowth of cultured adult large diameter DRG neurons.
Embryonal DRGs derived from Ryk-/- mice display an enhanced neurite 
outgrowth response to Wnt5a
To investigate whether the Wnt receptor Ryk mediates the effects of Wnt5a 
on neurite outgrowth, the neurite outgrowth experiment was repeated 
with embryonic DRGs obtained from Ryk mutant mice (Fig. 3). E14 DRGs 
from wildtype mice display 197% increase in axonal outgrowth following the 
addition of 30 ng / mL Wnt5a to the culture medium. Remarkably, E14 Ryk-
/- DRGs exhibit a significant 260% increase in outgrowth response following 
Wnt5a stimulation compared to outgrowth from DRG derived from Ryk-/- 
mutants not stimulated with Wnt5a (p<0.001). Wnt5a stimulated E14 Ryk-
/- DRGs show a 220% outgrowth response compared to Wnt5a stimulated 
wildtype DRGs (p<0.001). DRGs derived from heterozygote mice display 
an intermediate phenotype of 230% increase in outgrowth compared to 
outgrowth from DRG derived from heterozygote mice not stimulated with 
Wnt5a (p<0.05). These data indicate that Ryk interferes with the neurotropic 
effects of Wnt5a and that the neurite outgrowth promoting effects of Wnt5a 
Table 1.  Endogenously expressed Wnt genes in F11 cells
Genes of the Wnt pathway that are endogenously expressed by the DRG-like F11 cell line as 
determined by microarray analysis. 
Wnt ligands influence axon growth
116
117
4
are mediated by another receptor. The Ryk-/- mice do not survive into 
adulthood. It was therefore not possible to study the consequences of Ryk 
knock-out on neurite outgrowth of adult DRG neurons.  
Different receptor compositions determine the neurite outgrowth 
response upon Wnt stimulation
The differential expression of Wnt receptors determines the outcome of Wnt 
ligand stimulation 23-25 and different combinatorial Wnt receptor expression 
at the growth cone determines the outcome of the effects of Wnt ligands 
on axonal outgrowth 13. In order to investigate which receptors mediate the 
neurotropic or repulsive effects of Wnt5a, a medium throughput neurite 
outgrowth screen was performed using F11 cells. F11 cells are a mouse 
neuroblastoma/rat embryonic DRG hybrid cell which have been used to 
study neurite outgrowth 21,22. Microarray analysis of F11 cells 22 was used to 
determine the endogenous expression of Wnt ligands, receptors and down-
stream pathway members in this cell line, where expression was defined 
as signal 2 times higher than background (Table 1). F11 cells endogenously 
express three Wnt ligands (Wnt5b, -7a and -11), five Wnt receptors (Ryk, Fzd1, 
-3, PTK7 and Mcam) and some constituents of downstream Wnt signalling 
pathways (Rac1, RhoA, Gsk3β and Axin1). F11 cells were co-transfected with 
Figure 4. Wnt receptor compositions determine the neurite outgrowth response
A medium throughput neurite outgrowth screen was performed using a DRG like cell line 
(F11). Cells were transfected with single or combinations of Wnt receptors and grown with 
or without Wnt5a, to assess the effect of Wnt receptors on neurite outgrowth. A-C, neurite 
outgrowth was measured at 24 (A), 48 (B) and 72h (C) and normalised to the control condition 
of the corresponding timepoint. A, the transfection of single receptors showed that several 
Wnt receptors increase neurite outgrowth independent of Wnt5a stimulation; Ror2, Fzd1, -5, 
-6 and -7 (all p<0.001). B, at 48h of culture Ror2, Fzd1 and Fzd1 + Wnt5a (all p<0.05), Fzd5 
and Fzd5 +Wnt5a, Fzd6 and Fzd6 + Wnt5a and Fzd7 and Fzd7 +Wnt5a (all p<0.001) exhibit 
a significant increase in neurite outgrowth. C, At 72h of culture Ror2, Fzd2 and Fzd5 + Wnt5a 
(all p<0.05) show a significant stimulating effect on neurite outgrowth. D, co-transfections 
were performed with all possible combinations of the above used Wnt receptors and results 
are represented in a clustered heatmap, blue indicates decreased and red increased 
neurite outgrowth. No significantly larger effects on neurite outgrowth were observed after 
transfection of combinations of Wnt receptors than found by transfection of single Wnt 
receptors at 24h. The Wnt receptor combinations in the clusters indicated by asterisks, do 
increase neurite outgrowth over the entire time course (5 out of 7 of these combinations 
include Fzd5). At 24 and 48h, Fzd2 with Ryk + Wnt5a significantly inhibited neurite outgrowth 
(p<0.05). At 48 and 72h Ror1 with Fzd1 significantly inhibited neurite outgrowth (p<0.01 and 
p<0.05). Fold increases and SEM of all combinations are provided in supplemental Table 1. 
(Stars indicate significance as follows: * p<0.05, ** p<0.01, 
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expression plasmids for GFP and the Wnt receptors that were up-regulated 
in the DRG after PNS injury, showed a trend towards up-regulation (Chapter 
3), or were deemed interesting based on their role described in the literature, 
namely: Fzd1, -2, -3, -5, -6, -7, Ror1, Ror2, and Ryk. Transfected F11 cells were 
cultured with or without 30 ng / mL recombinant Wnt5a for 24, 48 and 72h (Fig. 
4). After 24h and 48h in culture overexpression of Fzd1, Fzd5, Fzd6 and Fzd7 
significantly increased neurite outgrowth of F11 cells (p<0.001; Fig. 4A,B) both 
in the absence and in the presence of Wnt5a. Thus, addition of Wnt5a does 
not further increase the neurite outgrowth response following overexpression 
of these receptors. At 24h, Ror2 with and without Wnt5a show a significant 
effect (p<0.001; Fig. 4A), and at 48h and 72h, Ror2 (without added Wnt5a) 
exhibits a significant increase in neurite outgrowth (p<0.05; Fig. 4B,C). At 72h 
Fzd2 (p<0.001) without added Wnt5a and Fzd5 with added Wnt5a (p<0.001) 
show a significant stimulating effect on neurite outgrowth (Fig. 4C). 
In order to investigate whether combinations of the Wnt receptors exhibit a 
synergistic effect on neurite outgrowth, co-transfections were performed 
with all possible pairs of the selected Wnt receptors (Fig. 3D). No significantly 
larger effects were observed for any of the receptor combinations than 
found by transfection of the single Wnt receptors. At 24h a majority of 
the Wnt receptor combinations (22 of the 36) stimulate neurite outgrowth 
independently of the addition of Wnt5a. Most receptor combinations do 
not significantly increase neurite outgrowth at 48 and 72h, but two clusters 
of Wnt receptor combinations (these clusters are indicated by asterisks in 
Fig. 4D) do maintain their outgrowth stimulating effects over multiple days 
(Fig. 4D). Interestingly, of the seven Wnt receptor combinations in these two 
clusters, five include Fzd5. 
Overexpression of two combinations of receptors results in a decrease in 
neurite outgrowth in response to Wnt5a, namely Ryk + Fzd2 (p<0.05) and 
Fzd3 + Fzd6 (p<0.01; Fig. 4D) at the 24h time point. At 48h overexpression 
of Ryk + Fzd2 (p<0.05) and Ror1 + Fzd1 (p<0.01; Fig. 4D) inhibited neurite 
outgrowth in response to Wnt5a. For the 72h time point Ror1 + Fzd6 (p<0.01) 
and for the 72h with added Wnt5a, Ror1 + Fzd1 (p<0.01) exhibit significantly 
decreased outgrowth (Fig. 4D). At the 24 and 48h time points none of the 
Wnt receptor combinations significantly inhibited neurite outgrowth in the 
absence of Wnt5a. These results shows that different receptor combinations 
can either mediate neurotrophic effects independent of Wnt5a or inhibit 
neurite outgrowth in response to Wnt5a. 
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Schwann cells respond to Wnt ligands by up-regulating Sox2
Wnt ligands, such as Wnt1, Wnt3a, Wnt11 and the β-catenin signalling 
pathway are involved in the developmental differentiation of Schwann cells 
26-28 and in myelination 29. Therefore we investigated whether Schwann cells 
also respond to direct Wnt5a, Wnt5b and Wnt4 stimulation (Fig. 5). Cultured 
primary Schwann cells were treated with two concentrations (3 and 30 ng / 
mL) of Wnt5a, Wnt5b and Wnt4, for 48 or 96 hours. Subsequently Schwann 
cells were analysed for changes in the expression of Sox2, c-Jun, Gap43, 
GDNF, Atf3, GFAP, p75 and MBP mRNA since these are known markers for 
different stages of Schwann cell differentiation 30. 
Sox2 was significantly up-regulated in Schwann cells by stimulation of 
Wnt5a (p<0.001), Wnt5b (p<0.001) and Wnt4 (p<0.05; Fig. 5A). Markers 
for immature and de-differentiated Schwann cells such as GFAP (p<0.05-
0.001), Gap43 (p<0.01) and GDNF (p<0.01) were significantly down-
regulated after stimulation with Wnt5a, Wnt5b and Wnt4 (Fig. 5A). MBP was 
significantly down-regulated after 48h stimulation with Wnt5b and Wnt4 
(p<0.001), but up-regulated after 96h stimulation with Wnt4 (p<0.05; Fig. 
5A). 
Sox2 is a transcription factor that inhibits myelination and promotes de-
differentiation in Schwann cells 31. To investigate if known Sox2 target genes 
were also significantly regulated, an expression analysis was performed for 
three known Sox2 target genes, Nrp2, Nrp1 and Egr1. Of these three Sox2 
target genes, Nrp2 was significantly up-regulated by Wnt5a stimulation 
(p<0.05, data for NRP1 and Egr1 not shown). 
The above results show that Schwann cells up-regulate Sox2 mRNA after Wnt 
treatment. To investigate whether Wnt5a, -5b and Wnt3a (which is known 
to signal through the β-catenin pathway in Schwann cells 28) influence Sox2 
protein expression, the up-regulation of Sox2 protein after 48h of Wnt5a, 
-5b and -3a stimulation was investigated by IHC (Fig. 5B-N). Schwann cells 
cultured under control conditions exhibit low staining intensity for Sox2 in 
their nucleus (Fig. 5B-D). Following the addition of Wnt5a to the culture 
medium Schwann cells exhibit a ~80% increased nuclear Sox2 staining 
intensity, compared to control Schwann cells (Fig. 5F-H, O; p<0.001). Wnt5b 
and Wnt3a do not increase the staining intensity of Sox2 in the nuclei of 
Schwann cells at this time point (Fig. 5I-N). These findings are in line with 
our qPCR data for the 48h timepoint of Wnt5a and Wnt5b. 
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Discussion
In this study we explored the responses of neurites from DRG neurons to 
three Wnt ligands (Wnt5a, Wnt5b and Wnt4) that are induced following 
injury to a human (Wnt5a) and/or rat peripheral nerve (Wnt5a, Wnt5b and 
Wnt4). Additionally, we studied the effects of these Wnt ligands on cultured 
primary Schwann cells by assessing changes in the expression of a set of 
genes indicative for the differentiation state of Schwann cells. We show that 
Wnt5a does not act as a repulsive factor for embryonic DRG neurites in a 
classical repulsion assay. Wnt5a, -5b and -4 promote neurite outgrowth 
of embryonic DRGs. Cultured unconditioned adult DRGs neurons did not 
significantly respond to Wnt5a, but exhibited a trend towards enhanced 
neurite growth. In contrast, upon a conditioning lesion adult DRG neurons 
become sensitized to Wnt5a and show decreased neurite outgrowth in 
response to this ligand. Embryonic DRGs without Ryk (derived from Ryk-/- 
mice), exhibit better outgrowth in response to Wnt5a than wildtype DRGs. 
This demonstrates that Ryk can negatively affect neurite outgrowth of 
embryonic sensory neurites. The overexpression of specific Wnt receptors 
(or combinations) stimulates or impedes neurite growth in a DRG-like cell. 
The Wnt receptors Fzd1, -5, -6, -7 and Ror2 stimulate neurite outgrowth 
independent of Wnt5a. The receptor combination of Fzd2 with Ryk and Ror1 
Figure 5. Schwann cells respond to Wnt ligands by regulating expression of differentiation 
markers
A, cultured Schwann cells were stimulated with two concentrations (3 and 30 ng / mL) of 
Wnt5a, -5b or -4, for 48 or 96 hours (from left to right) and analysed for differentiation marker 
expression by qPCR. Data is represented in a clustered heatmap, blue indicates down-
regulation and red up-regulation. Sox2 was significantly up-regulated in Schwann cells by 
stimulation of Wnt5a (p<0.001), Wnt5b (p<0.001) and Wnt4 (p<0.05). Markers for immature 
and de-differentiated Schwann cells such as GFAP (p<0.05-0.001), Gap43 (p<0.01) and GDNF 
(p<0.01) were significantly down-regulated after stimulation with Wnt5a, Wnt5b and Wnt4. 
MBP was significantly down-regulated after 48h stimulation with Wnt5b and Wnt4 (p<0.001), 
but up-regulated after 96h stimulation with Wnt4 (p<0.05). B-N, Immunohistochemical 
analysis of Sox2 expression in cultured control Schwann cells (B-D) and Schwann cells that 
are stimulated for 48h with 30 ng / mL Wnt5a (F-H), -5b (I-K) or -3a (L-N). Co-staining for 
the nuclear marker DAPI (blue) and Sox2 (red) show that Sox2 is exclusively expressed in the 
nucleus of all Schwann cells (overlay). O, Quantification of Sox2 staining intensity (in AU) in 
the Schwann cell nuclei shows that Wnt5a stimulated Schwann cells (light grey bars) have 
significantly increased Sox2 expression (p<0.001) compared to control cells (open bars). 
Wnt5b (dark grey bars) and Wnt3a (black bars) stimulated Schwann cells are not different 
from control. Stars indicate significance (* p<0.05, ** p<0.01, *** p<0.001, error bars represent 
SEM).
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with Fzd1 mediate a Wnt5a dependent decrease in neurite outgrowth. In 
addition to a role in axon outgrowth, we demonstrate that cultured primary 
Schwann cells respond to Wnt5a, -5b and -4 stimulation by significantly 
up-regulating Sox2 and down-regulating GFAP, Gap43 and GDNF (all 
markers of immature Schwann cells) and down-regulating MBP (a marker 
of mature myelinating Schwann cells). 
Context dependent effects of Wnt ligands on neurite outgrowth.
We find that Wnt ligands stimulate or decrease neurite outgrowth 
dependent on the experimental context. Cultured embryonal DRG neurons 
respond to Wnt5a, -5b and Wnt4 with increased neurite outgrowth. Adult 
cultured unconditioned DRG neurons display a slight increase in outgrowth 
(although not significant), but adult 14-day conditioned DRG neurons 
switch their response to Wnt5a towards a decrease in neurite outgrowth. 
Changes in the Wnt receptor expression profile between unconditioned and 
conditioned DRG neurons may explain this difference in neurite outgrowth 
response to Wnt5a. Two experimental findings support the notion that the 
Wnt receptor expression profile determines the neurite outgrowth response 
of DRG neurons to Wnt5a. First, genetic removal of Wnt receptor Ryk in 
E14 embryonic DRG explants increased Wnt5a stimulated neurite growth, 
indicating that Ryk attenuates the Wnt5a-mediated neurite outgrowth 
response. Second, the altered neurite outgrowth response of unconditioned 
versus 14-day conditioned DRG neurons coincides with the up-regulation of 
Ryk expression (which peaks at 14 days after axotomy, Chapter 3). Wnt5a/
Figure 6. DRGs co-express neurite outgrowth inhibiting and stimulating Wnt receptors 
after peripheral nerve injury
A-C, The expression of multiple Wnt receptors in the rat DRG is regulated after peripheral 
nerve injury. The relative expression of Fzd1 and Ror1 (A) and Ryk and Fzd2 (B) is up-regulated 
after nerve injury, the overexpression of both of these receptor combinations causes a Wnt5a 
dependent decrease in neurite outgrowth in our cellular screen. The expression of a Wnt 
receptor that stimulate neurite outgrowth in our cellular screen, as Fzd5, is also up-regulated 
after nerve injury (C). The regulation of all receptors peaks in expression at 14 days after 
injury. 
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Ryk signalling has also been shown to inhibit regenerative axon growth 
following CNS injury 14-16. Hollis et al. found that in the ascending central 
branch of conditioned DRG neurons Ryk expression was increased and 
these DRG neurites are repelled by Wnt ligands expressed in the injured 
spinal cord 15. Function blocking Ryk antibodies prevented Wnt5a/Ryk 
mediated axon repulsion during development 7, whereas genetic deletion 
of Ryk results in increased CST plasticity and increased functional recovery 
after CNS injury 32. 
Changes in Wnt receptor profiles determine the neurite outgrowth 
response
Neurite outgrowth was significantly increased in F11 cells, a DRG-like cell line 
following over-expression of Fzd1, -2, -5, -6, -7 and Ror2. The role of Fzd5 in 
the stimulation of neurite outgrowth is further illustrated by the finding that 
Fzd5 was a constituent of five of the seven Wnt receptor combinations that 
stimulate neurite growth over the entire tested timeline. Wnt5a stimulation 
was not required to induce the increased neurite outgrowth response. 
F11 cells express several Wnt ligands (Wnt5b, -7a and -11). The expression 
of these endogenous Wnt-ligands may be sufficient to promote neurite 
outgrowth responses and may mask the effects of exogenously added 
Wnt5a. For instance, Wnt5b signals through Ror2 33 and Wnt7a signals 
through Fzd5 and -7 34-36.
Fzd1 and Fzd5 are potential receptors for Wnt5a, -5b and -4 that would 
mediate the stimulation of neurite growth in the injured peripheral nerve. 
The expression of Fzd1, -2 and -5 is up-regulated in axotomized DRGs 
(Chapter 3). Fzd5 is a known Wnt5a 37,38 and Wnt4 38 receptor and Fzd5 is 
expressed in growth cones of hippocampal neurons where it mediates 
neuronal polarity and dendrite growth 39. Fzd1 is predicted to be a binding 
partner of Wnt5a and Wnt5b 40 and a multilevel cellular screen identified 
Fzd1 as a gene that modulates neurite outgrowth 41. 
However, combined over-expression of Ryk - Fzd2 and Ror1 - Fzd1 caused 
Wnt5a dependent inhibition of neurite outgrowth in the F11 cell screen. 
Ryk, Fzd1 and Fzd2 are all significantly up-regulated in axotomized (or 
conditioned) DRGs and Ror1 displays a trend towards up-regulation 
(Chapter 3) 17. The expression of all these receptors gradually increased in 
the first 5 days after a lesion and peaks at 14d after injury (Fig. 6). Taken 
together with our cellular screen, this indicates that a number of Wnt 
receptors that are gradually up-regulated in DRG neurons after a nerve 
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lesion, confer responsiveness to Wnt ligands in F11 cells, but whether this 
is stimulatory or inhibitory for neurite outgrowth depends on the specific 
combination of receptors. 
The implication of these observations for the axon regeneration process in-
vivo, in the injured peripheral nerve, remains to be investigated. Temporal 
regulation of receptor expression is a mechanism that underlies alterations 
in the responsiveness of axons to specific axon guidance cues during 
development. For instance, during Xenopus, Drosophila and mammalian 
development, axons successfully cross the midline in the spinal cord by 
an axon pathfinding process that is tightly controlled by alterations in the 
expression of receptors for axon guidance cues. Axons are first attracted 
to the midline by Netrin/DCC signalling. When axons arrive at the midline, 
neurons up-regulate the Robo receptor. This causes axons to be repelled 
by a local source of Slit. Simultaneously, Robo inactivates the attractive 
signalling of Netrin/DCC. The inactivation of attractive signalling and 
activation of repulsive signalling through up-regulation of Robo causes 
Figure 7. Changes in Wnt receptor profiles determine the neurite outgrowth and Schwann 
cell differentiation response
A,B, We propose that the Wnt receptor expression of DRG neurons dictates their response 
to Wnt ligands in the injured nerve. A, in the early stages of nerve regeneration (0-14 days) 
DRGs express only very low levels of the axon outgrowth inhibitory Wnt receptors. This 
suggests that Wnt ligands expressed in the injured nerve at this stage will bind more to the 
Wnt receptors that can promote axon growth. B, in later stages of nerve regeneration (14-
28 days) DRGs up-regulate the expression of Wnt receptors that repel neurites from Wnt 
ligands (as Ryk and Fzd2, shown in red). This switch in receptor profile causes the axons 
that have passed the source of Wnt ligands to be “pushed” further distally down the nerve. 
C,D, We propose that in Schwann cells the Wnt receptor expression profile also dictates the 
interpretation of Wnt ligands. C, In the early stages of nerve regeneration (0-14 days) Wnt 
ligands Wnt5a, -5b and -4 stimulate the expression of, a key driver of demyelination, Sox2 
in Schwann cells. D, in later stages of nerve regeneration (14-28 days) Schwann cells alter 
their Wnt receptor expression and thereby activate the β-catenin Wnt pathway to drive the 
process of myelination. 
125
4
axons to be pushed across the midline 42-46. Kalil et al. demonstrated in 
cultured pyramidal cortical neurons that expression of Ryk alone results 
in increased Wnt5a-mediated neurite outgrowth, but co-expression of 
Fzd2 and Ryk mediates repulsive turning of pyramidal cortical axons and 
enhanced outgrowth away form a source of Wnt5a 13. 
The effect of Wnt5a in conditioned DRG neurons manifests itself as an 
overall decreased neurite outgrowth response. In our outgrowth assays 
Wnt5a was applied in the medium and not as a point source. These assays 
are therefore not suitable to determine whether local repulsive effects may 
results in enhanced outgrowth of sensory fibers by pushing the neurites 
away from the source. In an injured nerve, however, the interplay between 
the gradual changes in the receptor profile in DRG neurons, the up-
regulation of Wnt5a/b expression in the nerve and the progression of the 
regenerating axons through the distal nerve may result in attractive effects 
of Wnt5a/b on injured axons during the early stages of the regeneration 
process and repulsive effects that push the axons forward towards their 
target cells during the more advanced stages of regeneration.  
This scenario is supported by the observation that during the early post-lesion 
period, neurons express low levels of Wnt receptor combinations that repel 
neurite growth in the cellular screen (e.g. Ryk - Fzd2), whereas the expression of 
these repulsive receptors increased during the more advanced stages of axon 
regeneration. This suggests that during the early post-lesion stage, the Wnt5a/b 
receptor profile that mediates attractive axon outgrowth predominates, (Fig. 
7A), whereas during the later stages of the axon regeneration process, when 
most axons have advanced for several centimetres into the nerve and are 
approaching their target cells, repulsive signalling pushes axons towards their 
target cells (Fig. 7B). The end result would be that Wnt ligands promote neurite 
regeneration by first stimulating axon extension and subsequently pushing 
growth cones further down the nerve. 
Wnt ligands influence the expression of differentiation marker genes of 
Schwann cells
Cultured Schwann cells derived from adult sciatic nerves are responsive to 
Wnt stimulation. The transcription factor Sox2 (sex determining region Y- 
box 2) is up-regulated in cultured Schwann cells after exposure to Wnt5a, 
-5b or -4. Consistent with its function as a transcription factor, Sox2 protein 
is located in the nucleus of Schwann cells following stimulation with Wnt5a. 
Sox2 has been identified as a master regulator of pluripotency and self-
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Condition
Avg SEM Avg SEM Avg SEM Avg SEM Avg SEM Avg SEM
Ryk+Ror1 1.05 0.10 1.19 0.03 1.02 0.04 1.04 0.02 0.99 0.05 1.11 0.02
Ryk+Ror2 1.02 0.03 1.00 0.03 1.12 0.03 1.02 0.03 1.02 0.04 1.03 0.02
Ryk+Fzd1 1.35 0.06 1.37 0.07 1.07 0.04 1.16 0.04 0.89 0.02 0.96 0.04
Ryk+Fzd2 0.98 0.03 0.87 0.03 1.00 0.03 0.85 0.03 1.07 0.05 0.89 0.05
Ryk+Fzd3 0.88 0.03 0.88 0.03 0.91 0.03 0.91 0.02 1.04 0.04 0.99 0.03
Ryk+Fzd5 1.22 0.04 1.14 0.04 1.13 0.04 1.10 0.04 1.22 0.04 1.20 0.04
Ryk+Fzd6 0.99 0.03 1.00 0.02 0.97 0.04 1.00 0.04 1.01 0.04 1.08 0.03
Ryk+Fzd7 1.37 0.04 1.31 0.03 1.07 0.04 0.98 0.04 1.07 0.04 1.04 0.02
Ror1+Ror2 1.14 0.10 1.16 0.03 1.01 0.08 1.02 0.04 0.88 0.07 1.21 0.03
Ror1+Fzd1 1.39 0.04 1.24 0.07 1.04 0.04 0.84 0.08 0.96 0.07 0.85 0.06
Ror1+Fzd2 1.29 0.04 1.09 0.03 1.11 0.03 0.95 0.05 1.08 0.04 1.07 0.04
Ror1+Fzd3 1.17 0.02 1.11 0.03 1.05 0.05 0.96 0.04 0.99 0.05 1.11 0.07
Ror1+Fzd5 1.29 0.08 1.12 0.03 1.02 0.05 1.01 0.04 0.92 0.12 1.09 0.03
Ror1+Fzd6 0.91 0.08 1.00 0.03 0.90 0.04 0.93 0.05 0.83 0.06 1.07 0.06
Ror1+Fzd7 1.14 0.08 1.28 0.04 0.95 0.03 1.02 0.03 0.90 0.05 1.05 0.05
Ror2+Fzd1 1.48 0.07 1.42 0.03 1.16 0.05 1.08 0.04 1.02 0.03 1.01 0.03
Ror2+Fzd2 1.00 0.05 1.04 0.03 1.05 0.05 1.02 0.05 1.08 0.04 1.12 0.05
Ror2+Fzd3 0.98 0.07 0.94 0.04 0.94 0.03 0.87 0.06 1.04 0.02 1.02 0.02
Ror2+Fzd5 1.23 0.06 1.23 0.03 1.15 0.05 1.13 0.02 1.22 0.06 1.24 0.05
Ror2+Fzd6 1.12 0.03 1.20 0.06 1.04 0.04 1.06 0.04 1.10 0.07 1.20 0.09
Ror2+Fzd7 1.50 0.06 1.51 0.11 1.11 0.05 1.08 0.03 1.19 0.07 1.19 0.10
Fzd1+Fzd2 1.29 0.06 1.39 0.05 1.05 0.03 1.06 0.06 0.97 0.06 1.04 0.05
Fzd1+Fzd3 1.40 0.05 1.51 0.06 1.04 0.04 0.99 0.04 1.11 0.05 0.99 0.06
Fzd1+Fzd5 1.50 0.06 1.48 0.09 1.18 0.04 1.06 0.02 1.21 0.05 1.07 0.04
Fzd1+Fzd6 1.32 0.04 1.38 0.04 1.03 0.05 0.99 0.04 0.94 0.03 0.91 0.05
Fzd1+Fzd7 1.67 0.04 1.89 0.08 1.12 0.04 1.22 0.03 1.02 0.03 1.14 0.03
Fzd2+Fzd3 1.17 0.07 1.13 0.09 1.14 0.09 1.05 0.08 1.14 0.05 1.16 0.07
Fzd2+Fzd5 1.32 0.07 1.30 0.04 1.22 0.04 1.18 0.05 1.23 0.05 1.20 0.05
Fzd2+Fzd6 1.13 0.03 1.17 0.06 1.19 0.07 1.13 0.06 1.11 0.04 1.04 0.05
Fzd2+Fzd7 1.45 0.05 1.42 0.12 1.20 0.08 1.15 0.05 1.01 0.05 0.97 0.04
Fzd3+Fzd5 1.31 0.07 1.33 0.04 1.26 0.03 1.14 0.03 1.28 0.07 1.22 0.07
Fzd3+Fzd6 0.95 0.04 0.83 0.02 0.92 0.02 0.86 0.04 0.96 0.04 0.91 0.02
Fzd3+Fzd7 1.18 0.04 1.37 0.04 1.12 0.05 1.10 0.03 0.97 0.05 1.02 0.04
Fzd5+Fzd6 1.14 0.03 1.22 0.04 1.03 0.04 1.03 0.04 1.03 0.04 0.99 0.05
Fzd5+Fzd7 1.21 0.05 1.23 0.04 1.11 0.04 1.04 0.02 1.09 0.04 1.13 0.04
Fzd6+Fzd7 1.27 0.03 1.16 0.04 1.00 0.03 0.98 0.03 1.04 0.04 1.00 0.04
24h 24h	+Wnt 48h	 48h	+	Wnt 72h 72h	+Wnt
Supplemental figure 1
Fold change and SEM of neurite outgrowth in the DRG-like cellular screen shown in the heatmap 
of Fig. 4.
renewal in embryonal stem cells 47,48. Sox2 is up-regulated in Schwann 
cells after PNS injury 31 and has been identified as a negative regulator 
of myelination 49,50. In addition to suppressing myelination, Sox2 plays an 
important role in cell sorting during the formation of bands of Bungner 51, 
possibly through up-regulation of Neuropillin2 (Nrp2) 52, a Sox2 target gene 
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53 that was also up-regulated in Wnt5a treated Schwann cells. Wnt3a is 
also able to induce Sox2 expression in cultured embryonal (E13.5) Schwann 
cells 28, but since Wnt3a is not significantly up-regulated after nerve injury 
(Chapter 3), Wnt5a, -5b and -4 are the most likely candidates of Sox2 up-
regulation after nerve injury. The notion that Wnt signalling is involved 
in the de- and re-differentiation of Schwann cells of the injured nerve is 
further strengthened by the role of Wnt signalling in the developmental 
differentiation of neural crest cells into Schwann cells 26-28. Therefore, the 
current observations suggest that Wnt5a, -5b and -4 can influence a key 
molecular event that governs Schwann cell de-differentiation, namely up-
regulation of the transcription factor Sox2.
One of the best characterized regulators of Schwann cell de-differentiation 
following PNS injury is the transcription factor c-Jun 54. The up-regulation of 
Sox2 after PNS injury is independent of c-Jun because it occurs normally in 
Schwann cell specific c-Jun knock-out mice 54. This suggests that induction of 
c-Jun and Sox2 are two parallel events that are both involved in governing 
specific aspects of Schwann cell de-differentiation in the injured nerve. 
In addition to up-regulation of Sox2, Schwann cells down-regulate GFAP, 
GAP43 and p75 when exposed to Wnt5a, -5b and 4. All of these genes are 
markers of de-differentiated and non-myelinating Schwann cells 30 and 
are all markedly up-regulated by Schwann cells following nerve injury 
31,55,56. Indeed, GFAP is a known transcriptional target of c-Jun in astrocytes 
and Gap43 is down regulated in transected c-Jun mutant nerves 54,57. This 
suggests that Wnt5a, -5b and -4 are involved in distinct aspects of the de-
differentiation response observed in Schwann cells after PNS injury.
Changes in the Wnt receptor expression profile during the course of 
peripheral nerve regeneration may determine the differentiation state of 
Schwann cells. 
In cultured Schwann cells, Wnt5a, -5b and -4 stimulation causes up-regulation 
of Sox2 expression, a negative regulator of myelination 49,50. This shows that Wnt 
ligands are potentially involved in the demyelination of Schwann cells in the 
early stages of nerve injury. But in the injured nerve, Wnt5a, -5b and -4 are also 
enhanced at later post-lesion time points (till 90d p.i.) when remyelination is well 
underway. Possibly, Schwann cells alter their response to these Wnt ligands over 
time as the expression of Wnt receptors changes. The up-regulation of several 
Wnt receptors (including Fzd2, -4 and Lrp5 ,-6) and the Wnt-β-catenin pathway 
marker Axin2 in the injured nerve coincides with the re-myelination process in 
the injured nerve (Chapter 3). Combined expression of Fzd4 and Lrp5 leads to 
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activation of the Wnt-β-catenin pathway in HEK293 cells when stimulated with 
Wnt5a, where HEK293 cells normally inhibit the Wnt-β-catenin pathway when 
stimulated with Wnt5a 23. Therefore it is possible that the combined expression 
of Fzd4 and Lrp5 also leads to the activation of the Wnt-β-catenin pathway 
in Schwann cells in the later stages of nerve injury. The activation of the Wnt-
β-catenin pathway is essential for proper myelination during Schwann cell 
development 29. This suggests that activation of the Wnt-β-catenin pathway is 
also necessary for effective re-myelination of axons in the injured nerve. 
It is possible therefore that during the early post-injury period (0-14d after 
injury) Wnt5a, -5b and -4 stimulate the expression of Sox2 to drive Schwann cell 
de-differentiation and de-myelination (Fig. 7C). During the later stages of the 
regeneration process the Wnt receptor expression profile in the injured nerve 
changes and Schwann cells potentially change their response to Wnt5a, -5b 
and -4 towards activation of the Wnt-β-catenin pathway to drive re-myelination 
(Chapter 3; Fig. 7D). 
Conclusion
In this chapter we have demonstrated by various bioassays that the Wnt 
ligands Wnt5a, -5b and -4, can influence both neurite outgrowth and the 
expression of markers of Schwann cell differentiation, two main processes 
of PNS regeneration. In order to confirm if in the early stages of nerve injury 
Wnt ligands stimulate both neurite outgrowth and Schwann cell expression 
of Sox2, in-vivo manipulation of the Wnt pathway in the injured nerve is 
necessary. In chapter 5, it will be investigated if genetic deletion of Wnt5a 
and Lentiviral mediated overexpression of Wnt5a and Wnt sequestering 
protein Wif1 influences neurite outgrowth and Schwan cell Sox2 expression 
in early stages of PNS regeneration and the recovery of compound muscle 
action potentials in later stages of PNS regeneration. 
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Abstract
Wnt signalling plays a role in the response after injury and during 
regeneration of diverse tissues, including bone, muscle, skin and liver. 
In the injured spinal cord, Wnt ligands impede axon regeneration and 
this is mediated by the Wnt receptor Ryk. In this chapter we tested the 
hypothesis that Wnt ligands have a beneficial role in the peripheral nerve 
regeneration process. Surgical peripheral nerve repair was combined 
with lentiviral vector-mediated overexpression of Wnt-inhibiting factor 1 
(Wif1) of Wnt5a to examine the effects of Wnt ligand sequestering or Wnt5a 
overexpression. Moreover, mice with Schwann cell specific deletion of 
Wnt5a were created to study the impact of Schwann cell-derived Wnt5a on 
nerve repair. Overexpression of Wif1 delayed functional recovery and axon 
outgrowth after nerve surgery. Genetic deletion of Wnt5a in Schwann cells 
did impair axon outgrowth, but showed no effect on functional recovery. 
Overexpression of Wnt5a does induce the expression of Sox2 but had no 
significant effects on nerve regeneration. These observations demonstrate 
that interfering with Wnt-signalling in experimentally induced peripheral 
nerve injury hampers the axon regeneration process and suggest a role for 
Wnt ligands in nerve repair.
Introduction
Wnt ligand genes encode highly conserved, secreted glycoproteins that play 
numerous roles during development and in disease 1,2. In the developing 
nervous system, a number of Wnt ligands, including Wnt5a, are required 
for axon guidance 3-10. Wnt signalling also plays a role in the response 
after injury and during regeneration 11,12 of diverse tissues, including bone 
13, muscle 14, skin 15 and liver 16,17. In the injured spinal cord, the Wnt ligands 
Wnt5a and Wnt4 and the Wnt receptors Ryk and Frizzled (Fzd) are re-
expressed 18-21. Cells that form the scar at the injury site express Wnt5a and 
Wnt4, while the expression of Ryk and Fzd2 is up-regulated by injured axons 
20. Wif1 is a Wnt sequestering agent, binding Wnt ligands in the extracellular 
matrix and impeding them from binding to Wnt receptors 22. Wif1 has been 
shown to bind to Wnt ligands with its WIF and EGF-like domains 23 and is 
demonstrated to bind to Wnt1 24, -3a, -4, -5a, -7a, -9a and -11 and to a 
lesser degree Wnt5b, but does not bind Wnt7b and -9b 25. Interference of 
Wnt5a/Ryk signalling using Wif1 expressing bone marrow stromal cells 
or Ryk blocking antibodies resulted in a significant improvement in axon 
regeneration after central nervous system (CNS) injury 20,21. Finally, genetic 
deletion of Ryk results in increased functional recovery through increased 
plasticity after CNS injury 26. This shows that Wnt ligands and their receptors 
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can negatively influence central nervous system regeneration after injury. 
In chapter 3 and 4 of this thesis we provide evidence that Wnt signalling 
may also play a role in the regeneration process that occurs in an injured 
peripheral nerve. The expression of several members of the Wnt pathway 
is enhanced in human scar tissue formed in an injured peripheral nerve 
(often referred to as Neuroma in Continuity - NIC) as well as in an injured 
rat peripheral nerve. In the NIC Wnt5a is expressed by Schwann cells and 
at least one of its receptors, Ryk is expressed by axons that traverse the NIC. 
In the injured rat nerve, multiple Wnt-genes are co-regulated and display 
distinct temporal expression patterns. The expression of the Wnt ligand 
Wnt5a is increased in the proximal nerve stump and around the injury site, 
while Wnt5b and Wnt4 are up-regulated around the injury site and in the 
distal nerve stump. In addition to the changes in Wnt gene expression in 
the injured nerve, dorsal root ganglia (DRGs) up-regulate the expression 
of multiple Wnt receptors, including Fzd1, -2, -5 and Ryk, following a 
peripheral nerve lesion. The temporal expression pattern of Wnt genes in 
the nerve and Wnt receptors in the DRG indicates that Wnt signalling could 
be involved in diverse key aspects of PNS regeneration, including axonal 
regeneration, the activation and de-differentiation of Schwann cells and 
the re-myelination of regenerated axons. 
In chapter 4 we provide evidence that certain Wnt ligands can indeed regulate 
axon outgrowth and Schwann cell differentiation in-vitro. Embryonal 
DRG explants respond to Wnt5a, -5b and -4 stimulation by increased 
neurite outgrowth. Cultured adult DRG neurons exhibited a trend towards 
increased neurite outgrowth following stimulation with Wnt5a, whereas 
neurite outgrowth of cultured DRG neurons obtained from rats following 
a conditioning lesion is significantly decreased by Wnt5a stimulation. The 
altered response of un-conditioned versus conditioned cultured adult DRG 
neurons to Wnt5a coincides with their changed expression of Wnt receptors 
that either mediate an increase (such as Fzd5) or a decrease (Ryk-Fzd2) in 
neurite outgrowth when overexpressed in a DRG-like cellular screen. 
Taken together, these data suggest that during the early post-lesion stage 
of nerve regeneration, neurons express a Wnt5a/b receptor profile that 
mediates attractive axon outgrowth, whereas during the later stages of 
the axon regeneration process, a receptor profile that favours “repulsive” 
Wnt-signalling might accelerate axon growth towards the target cells. This 
model predicts that Wnt ligands promote neurite regeneration during the 
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early post-lesion period and at more advanced stages of regeneration will 
stimulate axon regeneration by pushing growth cones further down the 
nerve.  
In chapter 4 we also show that Wnt5a, -5b and -4 were able to influence 
the expression of a marker of differentiation in Schwann cells, namely Sox2. 
Since we show in chapter 3 that Schwann cells regulate many Wnt receptors 
after an injury and appear to activate the β-catenin pathway upon re-
myelination we hypothesize that Wnt5a, -5b and -4 drive de-differentiation 
of Schwann cells in the early-injured nerve, and differentiation and 
myelination in the late stages of regeneration. 
In this chapter we tested the hypothesis that Wnt ligands have a beneficial 
role in the peripheral nerve regeneration process.  First, we combined 
surgical peripheral nerve repair in rats with lentiviral vector-mediated 
expression of WIF1 or Wnt5a to test the effects of Wnt ligand sequestering 
or Wnt5a overexpression on the nerve regeneration process. Second, mice 
with Schwann cell specific genetic deletion of Wnt5a were generated to 
study the impact of Schwann cell-derived Wnt5a on nerve regeneration. We 
systematically compared the effects of these interventions by histological 
analysis at 2 and 20 weeks post-lesion and longitudinal electrophysiological 
analysis, to distinguish between early and late effects. 
Methods
Viral vector production
Second-generation lentiviral (LV) plasmids 27 were produced by replacing 
the green fluorescent protein (GFP) sequence in pRRLCMV-GFP-WPRE 
with coding sequences of either stealth GFP (sGFP) 28, mouse(Ms)-Wnt5a 
or Ms-Wif1. Plasmids were verified by sequencing and viral batches were 
produced and titered simultaneously as described previously 29. Titers were 
3.3x109 gc / mLl for LV-Wnt5a, 6.2x109 gc / mL for LV-Wif1 and 1.8*1010 gc / 
mL for LV-sGFP. Biological activity of LV-Wnt5a and LV-Wif1 was assessed by 
Topflash luciferase assay (Fig 1B). 
LV testing
A Topflash assay was performed on cultures of HEK293T cells in 10% FCS, 
DMEM medium.  HEK293T cells were transfected with a TopFlash TCF/LEF 
inducible luciferase construct or a TopFop control construct 30. Subsequently, 
cultures were transduced with LV-sGFP, LV-Wnt5a, LV-Wif1 or a combination 
of both LV-Wnt5a and LV-Wif1. One day after infection 0, 3 or 30 ng / mL 
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rWnt3a was added to the culture medium to instigate TCF/LEF signalling. 
After 24h the cell culture was analysed using a dual luciferase reporter assay 
kit according to the manufacturers protocol (Promega, Fitchburg, WI).  
Experimental animals
All animal experiments were approved by the KNAW animal ethical 
committee and in accordance with European directive 2010/63/EU. Female 
Wistar rats (n = 48, 180-220 g) were obtained from Harlan (Venray, the 
Netherlands) and housed under standard conditions.
Autograft experiment
The autograft and lentiviral vector injections were performed as described 
in detail previously 29. For each viral vector 16 rats were injected, of these 
8 were used for histology at two weeks after surgery and 8 were followed 
by electromyography for 20 weeks. Briefly, animals were sedated by 
isofluorane and the sciatic nerve was exposed at mid-thigh level. A 1 cm 
portion of the sciatic nerve was excised and injected with 2μl LV (mixed 
with fast green to aid visualization during injection; Fig 1C). Subsequently, 
the transduced nerve segment was re-implanted with 10-0 ethilon stiches 
(Johnson and Johnson, New Brunswik, NJ; Fig. 1C). Subsequently, muscle and 
skin were closed by sutures. Immediately after surgery and the following 
day all animals received Temgesic (0.03 mL / 100 g s.c.) as analgesic. 
Animals were sacrificed 2 or 20 weeks after surgery and their nerves were 
harvested and treated for immunohistochemistry.
Electromyography
The compound muscle action potential (CMAP) was measured in a total of 24 
animals (8 per group), which were followed for 20 weeks after surgery. CMAP 
measurements were obtained bi-weekly under isofluorane anaesthesia 
(Abbot, Hoofddorp, NL). Measurements were made by placement of the 
microelectrodes in either the tibial innervated gastronomic muscle or the 
peroneal innervated flexor muscles of the paw as described previously 
29,31. The nerve was proximally stimulated through the skin with a bipolar 
stimulator with 10.2 mV, 100 mA for 0.2 ms. Measurements were obtained 
by a Nicolet Viking electromyograph (Nicolet biomedical, Madison, WI). The 
peak latency and amplitude of CMAP response were measured. 
Wnt5a cKO animals
Wnt5afl/fl mice were generated at Hiroshima University, Research institute 
for radiation biology and medicine, Japan by dr. Hiroaki Honda. Mice 
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were transferred to the Netherlands Institute for Neuroscience and crossed 
with Schwann cell specific P0Cre mice 32, to generate Schwann cell Wnt5a 
conditional KO mice. Wildtype (WT) and heterozygote (het) littermates were 
used as control animals. A total of 18 animals received unilateral sciatic 
nerve crush at mid-thigh level under isoflurane anaesthesia as described 
previously 33. The crush site was indicated by the placement of a ligature 
through the epineurium. Regeneration was assessed by IHC and CMAP 
measurements as described by Wang et al. in rats 31.  
Westernblot
HEK293T cells were either transfected or transduced with LV-Wnt5a, after 
24h medium samples were taken up in Laemmli buffer and stored in 
-20˚C. Samples were sonicated boiled for 2 minutes and loaded on an 
8% acrylamide gel, after migration, wet transfer to Whatman Protran® 
nitrocellulose was performed. Before antibody incubation the blot was 
blocked with 5% milk in TBS tween-20. Blots were incubated ON with anti-
Wnt5a in blocking solution, washed with TBS tween-20 and subsequently 
incubated with HRP-conjugated secondary antibodies. Bands were 
visualized using enhanced chemiluminescence.
Immunohistochemistry
Animals were perfused transcardially with saline followed by 4% 
paraformaldehyde (PFA) in 0.1 M PBS, pH 7.4.  Sciatic nerves were dissected 
and post fixed in 4% PFA in 0.1 M PBS, pH 7.4, O/N at 4˚C and cryo-protected 
by 25% sucrose in 0.1 M PBS O/N at 4˚C. Finally, nerve segments were 
embedded in O.C.T. (Sakura, Alphen aan den Rijn NL), snap-frozen and 
stored at -20˚C before cryo-sectioning. 20 μm longitudinal sections were 
made on cryostat, afterwards sections were immersion post-fixed in 4% 
PFA in 0.1 M PBS, pH 7.4 for 15 minutes at R.T. Immunohistochemistry was 
executed in Tris-buffered saline (TBS), pH 7.4, including 0.2% Triton X100 and 
5% fetal calf serum.
Antibodies
The following antibodies were employed for immunohistochemistry: mouse 
anti-neurofilament (1:1000; 2H3; developmental studies hybridoma bank, 
University of Iowa, IA), rabbit anti-S100, (1:400; Dako, High Wycombe, UK), 
rat anti-myelin basic protein (MBP, 1:400; MAB386; Millipore, Temecula, 
CA), goat anti-Choline Acetyl Transferase (ChAT, 1:200; Millipore, Temecula, 
CA). Chicken anti-GFP (1:200; Sigma Aldrich, St. Louis, MO). Antibodies 
used for Western blot were: goat anti-Wnt5a (1:100; AF645; R&D systems, 
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Minneapolis MN), mouse anti β-actin (mab8226; Abcam, Cambridge, UK), 
secondary antibodies were anti-goat-HRP (Dako, High Wycombe, UK) and 
anti-mouse-HRP (Dako, High Wycombe, UK).
Neurite quantifications
Axons in rat autografts and in nerves of Wnt5a cKO mice were quantified 
as follows. Rat autografts and corresponding proximal and distal stumps 
were cut longitudinally on a cryostat and immunohistochemically stained 
for neurofilament to visualize neurites. Tiled images of proximal stumps, 
autografts and distal stumps were made on a Zeiss Axioplan 2 microscope 
(Overkochen, Germany) fitted with an Evolution QEi digital camera 
(MediaCybernetics, Silver Spring, MD), and using a 20x objective to span 
the entire width of the nerve. Rat nerves were subjected to two methods 
of neurite quantification: manual neurite counts, and neuromath based 
neurite tracing. Manual neurite counts were performed with a custom 
made script in Image pro. This software produced a line perpendicular to 
the nerve, neurites crossing the line were manually counted. Neuromath 
tracing software 34 was also employed to quantify the same images. 
The ‘total neurite length’ neurite quantification option in the Neuromath 
software was selected and from the following analysis the ‘confirmed total 
length’ output variable was employed for further calculations. No significant 
differences between the two methods of quantifying (manual axon counting 
and neuromath fibre tracing) were observed. Wnt5a cKO mice nerves were 
solely quantified by neuromath tracing software, because reliable manual 
quantification of axons crossing a perpendicular line was not possible due 
to low number of axons encountered in longitudinal sections of normally 
regenerating nerves. Not all longitudinal nerve sections were made on the 
exact same cutting plane, therefore all neurite counts and tracings were 
normalised to their proximal stump to mitigate longitudinal cutting plane 
quantification artefacts. 
Results
Lentiviral constructs encode for biologically active transgene products
The expression and biological activity of the proteins (Wnt5a, WIF1) encoded 
by the plasmids and lentiviral vectors generated for the current experiments 
were first assessed in-vitro (Fig. 1). To demonstrate transgene protein 
expression, HEK293T cells were transfected with pLV-Wnt5a or pLV-sGFP 
or transduced with LV-Wnt5a (MOI of 8.2 or 82). Wnt5a protein expression 
in transfected or transduced HEK293T cells was assessed in medium by 
Western blot analysis. Wnt5a runs at ~42 kD (indicated by an arrow in 
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Figure 1. Lentiviral testing and autograft nerve injury model
A, Western blot for Wnt5a expression in medium samples of cultured HEK293T cells that were either 
transduced with two dilutions of LV-Wnt5a (MOI 8.2 or 82; left lanes) or transfected with LV-Wnt5a 
or LV-sGFP plasmid (right lanes). Wnt5a runs at ~42kD, indicated by arrow. Transduction with 
higher MOI LV-Wnt5a corresponds with higher Wnt5a expression. pLV-Wnt5a transfected cells also 
show Wnt5a expression, but pLV-sGFP transfected cells demonstrate no detectable endogenous 
Wnt5a expression. B, Topflash assay to evaluate the biological activity of LV-Wnt5a and LV-Wif1 by 
measuring their ability to suppress Wnt3a mediated activation of the β-catenin pathway. Without 
stimulation, HEK293T cells demonstrate a low baseline Topflash activity (open bars). After cells are 
stimulated with 10 ng / mL Wnt3a (grey bars) or 30 ng / mL Wnt3a (black bars) Topflash activity 
is markedly stimulated, indicating activation of the β-catenin pathway. Transduction with LV-sGFP 
has no effect on baseline or Wnt3a induced Topflash activity but LV-Wnt5a transduction does 
significantly decrease Topflash activity induced by 30 ng / mL Wnt3a (p<0.05). LV-Wif1 transduced 
cells demonstrate a decrease baseline Topflash activity (p<0.01) but not in Wnt3a stimulated Topflash 
activity. Combined transduction with LV-Wif1 and LV-Wnt5a, significantly decreased baseline 
(p<0.001), 10 ng / mL Wnt3a stimulated (p<0.01) and 30 ng / mL Wnt3a stimulated (p<0.001) Topflash 
activity. C, Schematic representation of the autograft nerve injury model. A 1 cm portion of the intact 
sciatic nerve is excised, ex-vivo transduced with lentivirus and re-implanted to reconstruct the nerve. 
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Fig. 1A). After pLV-sGFP transfection no Wnt5a expression was detected. A 
clear increase in Wnt5a protein is detected in the medium of HEK293T after 
transfection with pLV-Wnt5a plasmid or when transduced with either an 
MOI of 8.2 or 82 of LV-Wnt5a virus (Fig. 1A). No Western blot was performed 
for Wif1 expression because there is no antibody for WIF1 that works on 
Western blots. In order to investigate the biological activity of Wnt5a and 
Wif1 encoded by the lentiviral vectors a Topflash assay was employed 30 (Fig. 
1B). Control cells (not transduced by LV) and cells transduced with LV-GFP 
increase their TCF/LEF signalling by approximately 5 fold when stimulated 
by 30 ng / mL Wnt3a (p<0.001). Cells transduced with LV-Wnt5a (MOI = 
3), however, display a significantly reduced luciferase activity following 
application of 30 ng / mL Wnt3a (p<0.05) compared to cells transduced with 
LV-sGFP indicating that Wnt5a antagonizes the effect of Wnt3a to activate 
the β-catenin pathway in HEK293T cells, as expected 35,36. This indicated that 
LV-derived Wnt5a is biologically active. Cells transduced with LV-Wif1 (MOI 
= 7) exhibit significantly attenuated baseline Topflash activity (p<0.05), 
but contrary to our expectations WIF1 expression did not interfere with the 
induction of luciferase expression observed following Wnt3a application. 
Finally, combined LV-Wnt5a and LV-Wif1 transduction resulted in a near 
total block of Wnt3a induced Topflash activity (0 ng / mL Wnt3a; p<0.001, 10 
ng / mL; p<0.01, 30 ng / mL; p<0.001). This was an unexpected result; Wif1 
was expected to independently inhibit Wnt3a mediated activation of the 
β-catenin, but was found to attenuate baseline Topflash activity and inhibit 
Wnt3a mediated activation of the β-catenin when combined with Wnt5a. 
Taken together we conclude that both LV-Wnt5a and LV-Wif1 produce 
biologically active proteins. 
Sequestering Wnt ligands decreases neurite outgrowth in the autograft 
The lentiviral vectors for WIF1 and Wnt5a were subsequently employed 
in an autologous nerve graft model (Fig. 1C). Three groups of eight 
animals received unilateral autograft nerve surgery, and autografts were 
transduced with LV-sGFP, LV-Wif1 or LV-Wnt5a. At the early post-surgery 
time point (2 weeks) LV-sGFP transduced autografts exhibit numerous sGFP 
positive intra-fascicular cells (Fig. 2A). In order to visualize the effect of 
Wnt5a overexpression and the effect of Wif1 mediated Wnt sequestering on 
axon regeneration, proximal stumps, grafts and distal stumps were stained 
tissue sections with a neurofilament antibody (Fig. 2B). Axonal growth was 
quantified by manual counting and neuromath neurite tracing software 
(Fig. 2C-E). LV-Wif1 transduced autografts display a significantly decreased 
number of axons (normalised to proximal stumps) and a decline in the 
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neuromath traced axon profiles compared to LV-sGFP (1.5 fold compared 
to 2.0 fold, p<0.05, Fig. 2D). LV-Wnt5a transduced autografts show a trend 
towards a reduction in axon outgrowth, but both manual axons counts as 
well as neuromath neurite tracing data are not statistically significant. In the 
distal stump there are no significant differences between the groups (Fig. 
2E). This demonstrates that sequestering of Wnt ligands by overexpression 
of Wif1 negatively influences neurite outgrowth in the peripheral nerve graft 
but overexpression of Wnt5a has no apparent effect. 
Wnt5a overexpression increases Sox2 expression in the autograft but has 
no effect on axon outgrowth
Wnt ligands are involved in the developmental differentiation of Schwann 
cells 37-39 and in myelination 40. In chapter 4 we show that Wnt5a increased 
both transcript and protein levels of the transcription factor Sox2 in 
cultured Schwann cells. Therefore, we investigated whether Wnt5a or 
Wif1 overexpression in autografts also influenced Sox2 expression (Fig. 
2F-O). Wnt5a overexpression induced Sox2 expression in the nuclei 
of intra-fascicular cells in the graft compared to LV-sGFP transduced 
autografts resulting in more Sox2 positive Schwann cells (Fig. 2M-O). LV-
Wif1 transduction did not increase average Sox2 intensity (Fig. 2J-L). Taken 
together, LV-Wnt5a transduction significantly increased nuclear Sox2 
expression in cells in the autograft (Fig. 2F; p<0.05). 
 
Figure 2. Sequestering Wnt ligands inhibits neurite outgrowth and overexpression of 
Wnt5a increases Sox2 expression 
A, Longitudinal sections of nerve autografts of control LV-sGFP injected animals two-week 
post surgery demonstrate numerous sGFP positive intra-fascicular cells. B-E, Autografts 
were analysed for axon regeneration. Autografts were stained for neurofilament for manual 
axon counting (B) and to trace neurites with Neuromath software (C). Both manual axon 
counts and Neuromath axon tracing show significantly decreased neurite outgrowth in LV-
Wif1 transduced grafts compared to LV-sGFP transduced grafts (p<0.05; D). Distal nerve 
stumps show no differential effect of lentiviral transduction on neurite regeneration (E). F-O, 
Sections of LV-sGFP (G-I), LV-Wif1 (J-L) and LV-Wnt5a (M-O) transduced autografts stained 
for nuclei with DAPI (blue) and Sox2 (red) show an increase in nuclear Sox2 expression 
in only the LV-Wnt5a injected nerve autografts. Quantification of nuclear Sox2 expression 
shows that LV-Wnt5a transduced autografts have significantly increased Sox2 expression 
(p<0.05) compared to LV-sGFP transduced grafts (F). G-I, LV-sGFP (G-I), LV-Wif1 (J-L) and 
LV-Wnt5a (M-O) transduced autografts stained for nuclei with DAPI (blue) and Sox2 (red). 
(Scale bar 100 µm for panel A, and 50 µm for panel G-O)
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Animals with LV-Wif1 transduced autografts have a delayed functional 
recovery of distal muscle groups.
Long-term (20 week) functional recovery was assessed by bi-weekly CMAP 
measurements in both the tibial innervated gastronomic muscle and 
peroneal innervated flexor muscles of the hind paw (Fig. 3). The gastronemic 
muscle (a proximal muscle) displays a total absence of CMAP amplitudes 
after nerve surgery. At 6 weeks after surgery, all animals exhibit a return 
Figure 3. Compound muscle action potential recovery is delayed after Wnt sequestering
Amplitude (A, B) and latency (D, E) of CMAP response was obtained in the gastronemic 
muscle and peroneal innervated flexor muscles of the paw until 20 weeks after autograft 
nerve injury. Animals transduced with LV-sGFP (black circles), LV-Wnt5a (blue squares) and 
LV-Wif1 (grey triangles) exhibit no effect on CMAP amplitude recovery in the gastronemic 
muscle (A). In the peroneal innervated flexor muscles LV-Wif1 transduced animals exhibit 
significantly slowed CMAP amplitude recovery (p<0.01; B) compared to LV-sGFP control. 
No effects of Lentiviral transduction were found on CMAP latency recovery were found in 
the gastronemic muscle (C). Animals with LV-Wif1 transduced autografts show significantly 
slowed CMAP latency recovery in the peroneal innervated muscles of the paw (p<0.05), 
especially in the 10-week timepoint (D).
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of a gastronemic CMAP response. After 20 weeks of recovery, average 
gastronemic muscle CMAP amplitudes have returned to pre-injured levels. 
CMAP recovery in the gastronomic muscle is not affected by LV-Wif1 of LV-
Wnt5a nerve transduction (Fig. 3A). The peroneal innervated flexor muscles 
of the hind paw (a distal muscle) also display total absence of CMAP response 
after surgery. At 10 weeks after surgery, all animals show a CMAP response 
and the amplitude of all groups recovers to 4- 5mV after 20 weeks, which is 
far from the average of 14mV measured pre-injury (Fig. 3B). The LV-Wif1 but 
not LV-Wnt5a injected animals display a delayed functional recovery of the 
CMAP response in the distal paw muscles compared to LV-sGFP injected 
animals. This delay is especially clear at earlier time points (week 8-14) 
and dissipates over time. Two-way repeated measures ANOVA analysis 
indicates that there is a significant effect of LV-Wif1 on CMAP amplitude 
recovery (p<0.01). The latency of the CMAP was also measured for both 
muscle groups. At initial CMAP return, the latency is greatly increased to 3.5 
milliseconds (ms) for both tested muscle groups and gradually returns to 2 
ms over the course of 20 weeks, whereas the latency before surgery was 1.2 
ms for the gastronemic muscle and 1.4 for the peroneal innervated muscles. 
In the gastronomic muscle, no differences in latency were found between LV-
Wif1, LV-Wnt5a and LV-sGFP treatment (Fig. 3C). In the peroneal innervated 
muscles an effect in the LV-Wif1 group was identified (p<0.05), the LV-Wif1 
group exhibits an increased latency at 10 weeks and returns the latency of 
the LV-Wnt5a and LV-sGFP groups at 16 weeks. The LV-Wnt5a group did not 
display any effects (Fig. 3D). Proximal stumps, autografts and distal stumps 
of 20 weeks post injury animals were also (immuno)-histochemically stained 
for DAPI (to visualise nuclei), MBP (myelin component), S100 (Schwann cell 
marker) and neurofilament but analysis showed no significant differences 
(data not shown). Taken together, overexpression of Wnt sequestering protein 
Wif1 is able to significantly delay CMAP recovery in PNS regeneration in distal 
muscle groups, both in the recovery of the amplitude as well as in the latency 
of the CMAP.
Schwann cell specific deletion of Wnt5a results in a decrease in axonal 
growth, but has no effect on recovery of function
In order to study the impact of SC derived Wnt5a on nerve regeneration, 
Wnt5a cKO mice were generated with Schwann cell specific Wnt5a knock-
out. Wnt5a cKO mice appear normal and healthy, are of normal weight and 
display no visible functional deficits. Uninjured sciatic nerves of Wnt5a cKOs 
appear healthy and have the same number of axons that appear to be 
normally myelinated as compared to wildtype littermates (Fig. 4A, B). The 
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Figure 4. Neurite outgrowth is decreased in Wnt5a cKO animals
Peripheral nerve regeneration was determined in mice with Schwann cell specific deletion 
of Wnt5a. A-B, The sciatic nerves of Wnt5a cKO animals were examined for developmental 
deficits. Osmium staining of myelinated axons in sciatic nerves of Wnt5a cKO animals 
demonstrates that these animals have normally developed nerves and myelinated axons 
(A). Myelinated axon counts of WT and heterozygote littermates are the same as Wnt5a cKO 
animals (B). The nerves of Wnt5a cKO animals and WT and het littermates were analysed 
for Wnt5a mRNA expression by qPCR with primers for Wnt5a (total Wnt5a mRNA; black bars) 
and Wnt5a exon2 (full length Wnt5a mRNA; light grey bars). Wnt5a cKO animals demonstrate 
a fourfold increase in Wnt5a, and roughly 50% decrease Wnt5a exon2, therefore the ratio 
of mutant to functional Wnt5a mRNA copies is 1 to 8 (C). D-F, Sciatic nerves of Wnt5a cKO 
mice, WT and heterozygote littermates were analysed for neurite outgrowth 14 days after 
nerve crush. Neurofilament staining of a WT (D) and Wnt5a cKO (E) animal at 14 days post 
Quantification of normalised neurite outgrowth 14 days post crush in the injury site and distal 
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normal development of the sciatic nerve in Wnt5a cKO makes these mice 
suitable for adult peripheral nerve injury studies. P0 driven Cre recombinase 
expression occurs in ~70% of Schwann cells of the adult peripheral nerve 
32. To analyse if the nerves of Wnt5a cKO mice express decreased levels 
of wildtype Wnt5a messenger qPCR analysis was performed on wildtype, 
heterozygote and homozygous Wnt5a cKO nerves with primers which detect 
either only full-length, wildtype Wnt5a mRNA (primers sequences inside the 
floxed Wnt5a exon 2) or total Wnt5a mRNA (primer sequences outside exon 
2 of Wnt5a; detecting mutated plus full-length, wildtype Wnt5a). Cells in the 
nerve of heterozygote animals exhibit a 0.4 fold decline in the expression 
of wildtype Wnt5a-mRNA and up-regulate total Wnt5a-mRNA expression 
by 1.5-fold (Fig 4C). Cells in the nerves of homozygous Wnt5a cKO exhibit 
a 0.5 fold decline of wildtype Wnt5a-mRNA and up-regulate total Wnt5a 
expression by 4 fold. These observations indicate 1) successful deletion of 
the Wnt5a gene resulting in a roughly 50% decline in wildtype Wnt5a mRNA, 
2) a compensatory increase in the expression of mutated Wnt5a-mRNA in 
cKO mice (Fig. 4C). This results in a situation where 1 out of 8 of the Wnt5a 
mRNA molecules in the nerve is encoding for wildtype functional Wnt5a in 
homozygous cKO animals, whereas 7 mRNA molecules represents mutant 
Wnt5a-mRNA. 
Heterozygote and homozygous Wnt5a cKO animals and wildtype 
littermates, were subjected to sciatic nerve crush injury. 14 days after crush 
axonal regeneration was visualised by IHC for neurofilament and was 
subsequently quantified by neuromath software (Fig. 4D-F). Wnt5a cKO 
mice demonstrate 40% decline in axon outgrowth in the injury site (p<0.05) 
and 50% decline in traced axons in the distal portion of the nerve (p<0.05) 
compared to wildtype animals. In heterozygote littermates only the distal 
nerve stump demonstrates a significant decrease of axonal outgrowth of 
40% (p<0.05). 
Longitudinal CMAP measurements were performed to investigate if Wnt5a 
cKO mice demonstrate changes in functional motor recovery after sciatic 
nerve of WT (black bars), heterozygotes (grey bars) and Wnt5a cKO animals (open bars) (F). 
cKO animals exhibit significantly decreased neurite regeneration in the injury site and distal 
nerve (both p<0.05), heterozygote litter mates demonstrate significantly decreased neurite 
outgrowth in the distal nerve (p<0.05) compared to WT littermates. G-H, Amplitude (G) and 
latency (H) of CMAP responses obtained in the gastronemic muscle of WT (black circles), 
heterozygotes (grey squares) and Wnt5a cKO (blue triangels) animals show no differences 
between the genotypes.
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nerve crush (Fig. 4G,H). Similar to the rat autograft experiment, the CMAP 
response disappears after sciatic nerve crush, but now the initial return of 
CMAP response is already seen at 11-14 days after injury. No differential 
effects were found in the recovery of CMAP amplitudes between the 
mutant and wildtype groups (Fig. 4G). Also the peak latency recovery 
demonstrates no differences between Wnt5a cKO and WT animals (Fig. 
4H). Taken together, Wnt5a cKO mice exhibit decreased neurite outgrowth 
2 weeks after injury, but these mice do not exhibit a detectable difference 
in functional motor recovery following sciatic nerve crush compared to 
wildtype mice. 
Discussion 
In this chapter we studied the role of Wnt ligands in the regeneration 
process after injury of the sciatic nerve. Lentiviral vectors were used to 
overexpress the Wnt sequestering protein Wif1 or the Wnt ligand Wnt5a in 
a nerve autograft employed to repair the transected rat peripheral nerve. 
Mice with Schwann cell specific Wnt5a gene deletion were used to examine 
the consequences of removal of Wnt5a on the nerve regeneration process. 
The findings of this study can be summarized as follows: 1) overexpression 
of Wif1 results in a significant decline in the number of axons into a nerve 
autograft at 2 weeks after the lesion, 2) targeted expression of Wif1 in 
autografts slowed down the recovery of the CMAP response for the distal 
but not for the proximal muscles, 3) axon regeneration is impaired in nerves 
with Schwann cell specific knock-out of Wnt5a, and 4) overexpression of 
Wnt5a does induce the expression of Sox2, a transcription factor with a role 
in Schwann cell dedifferentiation, but does not promote axon regeneration. 
These observations demonstrate that interfering with Wnt-signalling 
in experimentally induced peripheral nerve injury hampers the axon 
regeneration process and suggest a role for Wnt ligands in nerve repair. 
The main finding of this study is that lentiviral vector-mediated expression 
of Wif1 in an injured nerve slows down the axon regeneration process. The 
anatomical analysis indicates that sequestering of Wnt ligands interferes 
with the growth of axons into an autograft during the first two weeks after 
the injury. The electrophysiological analysis suggests that this delay in axon 
outgrowth has a negative impact on the reinnervation and function of the 
distal hind paw muscles, but not on reinnervation of proximal muscles. Wif1 is 
an unselective Wnt sequestering protein that has successfully been applied 
to sequester the Wnt ligands Wnt5a and Wnt4 in the injured spinal cord 
and in bone marrow development 20,41. In chapter 3 we show that multiple 
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Wnt ligands are expressed and some are induced in the injured nerve, 
including Wnt5a, Wnt5b, and Wnt4. Wif1 binds all three of these Wnt ligands 
25. The anti-regenerative effect of Wif1 could therefore result from functional 
interference with multiple Wnt ligands. Interestingly, overexpression of 
Wif1 in the autograft has no effect on the development of CMAPs of 
proximal muscles. Thus, in contrast to the delayed reinnervation of distal 
muscles, Wnt scavenging in the autograft does not affect the innervation 
of proximal muscles. In chapter 3 and 4 we provide data that suggest that 
injured sensory neurons change their responsiveness to Wnt ligands as 
regeneration progresses in time: during early stages of the regeneration 
process the receptor composition may favour “attractive” Wnt-signalling 
whereas during later stages the receptor expression profile may favour 
“repulsive” Wnt-signalling. We do not know whether a shift from “attractive” 
to “repulsive” Wnt-signalling also occurs in regenerating motor neurons. 
However, when this would be the case, the “repulsive” signalling mediated 
by Wnt receptors during the later stages of axon regeneration may have a 
greater impact on motor regeneration of distal muscles than the “attractive” 
signalling in earlier stages, since distal muscle innervation appears more 
impacted by Wnt sequestering than proximal muscle innervation.
A second important observation of this study is that Schwann cell specific 
mutation of Wnt5a alone results in significantly less regenerating axons in the 
distal portion of a transected sciatic nerve 2 weeks after injury. This suggests 
that Wnt5a is a protein with a beneficial role in the axon regeneration 
process. Wnt5a mRNA expression was not completely ablated but has 
been diminished by about 50% in the nerve. The P0 promoter driving Cre is 
active in only a subset of Schwann cells 32 resulting a significant remaining 
level of wildtype Wnt5a mRNA in the injured nerve. Our data also suggest 
that Schwann cell-specific Wnt5a gene deletion results in a certain degree 
of compensatory up-regulation of the expression of the wildtype Wnt5a 
mRNA (in non Cre expressing cells) and a striking four fold up-regulation of 
the expression of the mutant Wnt5a gene. A much more complete deletion 
of the Wnt5a gene in all Schwann cells would therefore be necessary to 
fully appreciate the effect of Wnt5a knock-out on the nerve regeneration 
process. 
In contrast to the functional impairments in distal muscle reinnervation 
observed in rats expressing the Wnt sequestering protein WIF1, mice 
with a Schwann cell specific Wnt5a mutation do not display a delay in 
functional recovery as measured by electophysiology. There may be 
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multiple explanations for this. First, scavenging of multiple Wnt ligands 
may result in a more robust effect than selective knock-out of a single Wnt 
ligand. In the Schwann cell specific knock-out animals Wnt5b, Wnt4 and 
several other Wnt ligands continue to be expressed in the injured nerve 
and these may compensate for the loss of Wnt5a. Secondly, Wnt5a may 
selectively affect sensory neurite regeneration and may have no effect on 
motor axon regeneration. Thirdly, our genetic approach may have induced 
the development of compensatory mechanisms during development 
(we do see differences in Wnt5a mRNA levels so maybe also other genes 
have changed), whereas this probably does not happen during acute 
WIF1 treatment. Fourthly, Wnt5a is a secreted protein, remaining (non Cre 
expressing) WT Schwann cells may release sufficient amounts of Wnt5a 
to compensate for the Wnt5a KO Schwann cells. Finally, other factors that 
may have contributed to the differences between the effect of Wif1 and 
Schwann cell specific Wnt5a knock-out may relate to the different lesion 
models (autograft versus crush) and different species (rats versus mice) 
used.    
Overexpression of Wnt5a in nerve autografts did not significantly alter the 
regenerative response at the anatomical or functional level. Our model 
predicts that Wnt ligands would promote neurite regeneration during the 
early post-lesion period and during more advanced stages of regeneration 
will stimulate axon regeneration by pushing growth cones further down 
the nerve toward the target cells. In chapter 3 we show that Wnt5a is up-
regulated in the proximal stump and in the injury site. Wnt5a peaks around 
28 days after injury, which is when most growth cones of regenerating 
axons have already reached the distal portion of the nerve. In view of this, 
high-level sustained lentiviral vector mediated expression of Wnt5a in the 
autograft throughout the post-lesion period (starting immediately after the 
injury and continuing for weeks) may create a situation that is unfavourable 
for axon outgrowth. Indeed we observe a trend toward less axon outgrowth 
in autografts treated with LV-Wnt5a immediately after injury and repair. This 
suggests that gain-of-function studies for Wnt5a are very complex because 
these should take into account both the time and the anatomical location of 
the lentiviral vector-mediated Wnt5a overexpression.     
Lentiviral vector-mediated overexpression of Wnt5a in the nerve autograft 
does results in a significant increase in Sox2 protein expression in Schwann 
cells. This is in line with earlier findings showing that Wnt5a caused 
increased Sox2 transcript and protein expression in cultured rat Schwann 
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cells (chapter 4). Sox2 is a negative transcriptional regulator of myelination 
in Schwann cells 42 and the induction of Sox2 in the nerve following Wnt5a 
overexpression suggest that Wnt5a may affect the myelinisation process in a 
regenerating peripheral nerve. The role of Wnt5a-mediated Sox2 induction 
in Schwann cells needs to be further investigated in future experiments.    
Conclusion
This study provides evidence that Wnt signalling has a role in the regeneration 
process of an injured peripheral nerve. Functional perturbation of multiple 
ligands with a Wnt sequestering protein or genetic deletion of a single Wnt 
gene (Wnt5a) in Schwann cells slows down axon regeneration. Sustained 
overexpression of Wnt5a in an autograft, however, has no benefit. Further 
studies are clearly required to determine how Wnt ligands influence 
regeneration. The complex and dynamic patterns of Wnt receptor expression 
in injured peripheral neurons (chapter 3) and the differential response 
of cultured embryonic and adult neurons to Wnt stimulation (chapter 4) 
suggest that the sensitivity to Wnt signals in the injured nerve may change 
as axons follow their path from the injury site to the target cells. Increasing 
our understanding of these and other signalling pathways in the injured 
nerve is of importance to the development of nerve repair strategies.
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Summary of this thesis
Approximately 67,000 individuals sustain a peripheral nerve injury in the 
United States annually 1,2. Severe lesions of a peripheral nerve can result 
in the formation of a neuroma-in-continuity (NIC) that interferes with 
functional recovery. The mechanisms by which a NIC forms interferes with 
axon regeneration remain elusive. This work described in this thesis has 
two related aims. The first aim was to identify key processes in the human 
NIC that interfere with functional recovery. The second aim of this thesis 
was to unravel the role of Wnt signalling in the regeneration process 
that occurs in a peripheral nerve. We focussed on Wnt signalling for two 
reasons. First, preliminary data generated in our laboratory showed that 
Wnt5a is significantly up-regulated in NIC tissue derived from patients that 
had undergone reconstructive surgery 3. Second, Wnt5a is a known axon 
guidance cue that exerts context dependent repulsive or growth promoting 
effect in developing and injured CNS axons. 
Chapter 1 provides an introduction to the process of peripheral nerve 
regeneration and the formation of a human NIC. This chapter also provides 
an overview of the complex canonical and non-canonical Wnt signalling 
pathways. 
Functional recovery does not occur in 10% of patients with neonatal brachial 
plexus palsy. In these patients, resection of a neuroma-in-continuity (NIC) 
and surgical nerve reconstruction is required. In chapter 2 human NIC 
tissue, removed during reconstructive nerve surgery, was studied by means 
of various histopathological techniques. We show that NIC tissue often 
exhibits multiple focal myelin deficits (FMD). FMD contain Schwann cells, 
which enwrap axons, but these Schwann cells do not form myelin (Thesis in 
a page; Thiap. 2A). A bio-mathematical analysis indicates that every axon 
that traverses the NIC would encounter multiple FMD (Thiap. 2B). Axons in 
a FMD did have disturbed nodes of Ranvier. Taken together, these findings 
suggest that most axons in a NIC course through a FMD and that this may be 
the neuropathological basis for the conduction blocks and the consequent 
lack of functional recovery in a subset of patients with brachial plexus injury. 
The aim of chapter 3 was to provide a comprehensive analysis of the 
expression of Wnt pathway genes in both human NIC and in the injured 
rodent peripheral nerve. Wnt5a is up-regulated in Schwann cells in NIC and 
is secreted in the extra-cellular space, in close vicinity to regenerating axons 
that express the Wnt receptor Ryk (Thiap. 3A). This suggests that Schwann 
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cells of the NIC potentially employ Wnt5a to signal to regenerating axons. 
These observations formed the starting point for further studies on Wnt 
gene expression in the injured rat peripheral nerve.
The injured rat nerve exhibits a coordinated expression of Wnt family genes. 
Four gene clusters (designated the F-Spon1, Wnt2, Axin2 and MBP clusters) 
with distinct temporal and spatial expression patterns that correspond to 
overlapping phases of the regeneration process could be identified. The 
F-Spon1 cluster is strongly up-regulated in the injury site and distal stump 
from 3 to 5 days until 90 days after injury and contains several Wnt ligands 
including Wnt5b and Wnt4 (Thiap. 3B). This suggests roles in early (e.g. de-
differentiation of Schwann cells and initiation of axon growth) as well as late 
regenerative processes (e.g. myelination, target innervation and Schwann 
cell differentiation). The Axin2 cluster consist of genes that are up-regulated 
from 14 to 28 until 90 days after injury. This implies a role in Schwann cell re-
differentiation and myelination. The MBP cluster is composed of genes that 
are down-regulated at early time points and return to baseline expression 
at 14-28 days after injury. This corresponds with a role in maintenance and/
or formation of myelin and the post-lesion maturation of Schwann cells. 
Axotomized rat DRG were analysed for the expression of Wnt receptors. 
Multiple Wnt receptors were significantly up-regulated in DRG neurons 
after axotomy, including Ryk, Fzd1, -2 and -5. Furthermore, R-spondin1 and 
-3 were found to be up-regulated by injured DRGs, known agonists for 
Wnt signalling in Schwann cells 4 (Thiap. 3C). Taken together, certain Wnt 
genes respond to injury in both human NIC and the injured rat nerve. The 
coordinated expression of genes of the Wnt pathway following peripheral 
nerve injury in the rat suggests important roles for Wnt signalling in major 
aspects of the process of peripheral nerve regeneration. The functional 
implications of these observations are further investigated in chapter 4 and 
chapter 5. 
In chapter 4 we investigated the effects of three Wnt ligands (Wnt5a, Wnt5b 
and Wnt 4) and the role of Wnt receptors, including Ryk, on neurite outgrowth 
using cultured primary DRG neurons and a DRG-like cell line. These Wnt 
ligands were selected for further functional studies because, as shown 
in chapter 3, their expression is enhanced in human NIC (Wnt5a) and/or 
the injured rat peripheral nerve (Wnt5a, Wnt5b and Wnt4). The effects of 
these Wnt ligands on cultured primary Schwann cells was also assessed 
by measuring changes in the expression of a set of genes indicative for the 
differentiation state of these cells. 
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Thesis in a page (THIAP)
THIAP 2A. FMD are present in human NIC
Focal myelin deficits (FMD) are spherical clusters of Schwann cells and contain axons but are 
devoid of myelin. FMD are devoid of myelin basic protein (MBP), and have decreased clustered 
markers of nodes of Ranvier such as Na(v)1.6, Ankyrin G and Caspr. 
THIAP 2B. Axons that traverse the NIC encounter multiple FMD
Axons that traverse from the proximal stump (green) trough the NIC (yellow) towards the distal 
stump (purple), are calculated to encounter multiple FMD (grey).
THIAP 3A. Human NIC tissue regulates multiple Wnt pathway genes
Regenerating axons present in human NIC tissue express Wnt receptor Ryk. NIC tissue (yellow) up-
regulates Wnt5a, Ror1, Daam1, Sfrp4 and down-regulates Nlk, compared to the proximal stump (green). 
THIAP 3B.  The injured rat nerve up-regulates multiple Wnt ligands 
The injured rat nerve up-regulates (in red) Wnt5a in its proximal stump and injury site (top row). 
Wnt5b is up-regulated in the injury site and distal stump (middle row) and Wnt4 and Wnt1 are up-
regulated in the injury site and distal stump (bottom row). 
THIAP 3C. Axotomized WDRG regulate multiple Wnt receptors
Upon injury axotomized DRG up-regulate the following Wnt receptors; Fzd1 ,-2, -5 and Ryk. 
Furthermore, multiple Wnt modulators are up-regulated such as R-Spondin1. 
THIAP 4A. DRG their neurite outgrowth response is sensitive to Wnt stimulation
E14 DRGs (orange circles, top left panel) respond to Wnt5a stimulation (in red) by increased neurite 
outgrowth. E14 Ryk -/- DRGs (white circles, top right panel) their neurite outgrowth response to Wnt 
stimulation is larger than wildtype DRGs. Unconditioned adult DRG neurons (grey circles, bottom left 
panel) do not alter their neurite outgrowth in response to Wnt5a stimulation. Conditioned adult DRG 
(yellow circels, bottom right panel) decrease their neurite outgrowth when stimulated with Wnt5a. 
THIAP 4B. Wnt receptor expression influences neurite outgrowth
A DRG like cell line (F11 cells, blue circles, top left panel) does not alter their neurite outgrowth when stimulated 
with Wnt5a (red). When the cell line overexpresses Fzd1, -5, -6, -7 or Ror2 (top right panel), neurite outgrowth 
was increased, irrespective of additional Wnt5a stimulation. When the cell line overexpresses a combination 
of Ryk with Fzd2 or Ror1 with Fzd1, neurite outgrowth was decreased when stimulated with Wnt5a. 
THIAP 4C. Schwann cells respond to Wnt ligands by regulating known markers of differentiation
Cultured adult Schwann cells up-regulate Sox2 and down-regulate GFAP, p75 and MBP when 
stimulated with Wnt5a ,-5b or -4 (in red). 
THIAP 5A. LV-Wif1 transduced autografts exhibit decreased neurite outgrowth
Animals have been subjected to autograft nerve surgery. Grafts were transduced with LV-sGFP (as 
control, top panel), LV-Wnt5a (overexpress Wnt5a, middle panel) and LV-Wif1 (sequester Wnt ligands, 
bottom panel). LV-Wif1transduced grafts display decreased neurite outgrowth 2 weeks after surgery.
THIAP 5B. LV-Wnt5a transduced autografts exhibit increaWsed Sox2 expression
Autografts transduced with LV-GFP (top panel), LV-Wnt5a (middle panel) and LV-Wif1 (bottom 
panel) were analysed for Sox2 expression. LV-Wnt5a transduced grafts demonstrate significantly 
increased nuclear Sox2 expression (in red). 
THIAP 5C. Wnt5a cKO animals exhibit decreased neurite outgrowth after PNS injury
Wnt cKO animals were subjected sciatic nerve crush injury. Wnt5a cKO animals (bottom panel) 
and heterozygote (middle panel) display significantly decreased neurite outgrowth in their distal 
stump compared to wildtype animals (top panel).
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Wnt5a does not act as a repulsive factor for embryonic DRG neurites in 
a classical repulsion assay, whereas Wnt5a, -5b and -4 promote neurite 
outgrowth of embryonic DRGs (Thiap. 4A). Cultured adult DRGs neurons 
derived from naïve rats (“unconditioned” DRG neurons) did not significantly 
respond to Wnt5a, although these neurons exhibited a clear trend towards 
enhanced neurite growth upon exposure to Wnt5a. Adult DRG neurons 
derived from rats that received a conditioning lesion 14 days prior to 
culturing (“conditioned” DRG neurons) show a decreased neurite outgrowth 
in response to Wnt5a stimulation. Thus, in contrast to non-conditioned DRG 
neurons, conditioned DRG neurons appear to be repulsed to Wnt5a. 
The differential response of non-conditioned and conditioned DRG 
neurons to Wnt5a prompted us to study the role of Ryk and Fzds in the 
neurite outgrowth response. Embryonic DRGs without Ryk (derived from 
Ryk-/- mice), exhibit enhanced outgrowth in response to Wnt5a compared 
to wildtype DRGs (Thiap. 4A). This demonstrates that the presence of Ryk 
can negatively affect neurite outgrowth of embryonic sensory neurites. The 
overexpression of (combinations of) Wnt receptors stimulates or impedes 
neurite outgrowth in a DRG-like cellular screen. Fzd1, -5, -6, -7 and Ror2 
stimulate neurite outgrowth independent of exogenous Wnt5a (Thiap. 4B). 
The combination of Fzd2 with Ryk and Ror1 with Fzd1 appear to mediate 
a Wnt5a dependent decrease in neurite outgrowth. Based on these data 
we postulated that the changes in Wnt receptor combinations in the DRG 
during the axon regeneration process might reverse the Wnt5a-mediated 
neurite outgrowth response from attractive (during the early stages of 
regeneration) to repulsive (during the later stages of regeneration). We 
refer to this as the pull-push hypothesis. 
Cultured primary Schwann cells respond to Wnt5a, -5b and -4 stimulation 
by significantly up-regulating Sox2 and down-regulating GFAP, Gap43 and 
GDNF (all markers of immature Schwann cells) and down-regulating MBP 
(a marker of mature myelinating Schwann cells; Thiap. 4C). The transcription 
factor Sox2 has been identified as a master regulator of pluripotency and 
self-renewal in embryonal stem cells. Thus, these observations suggest 
that Wnt5a, -5b and -4 can influence a key molecular event that governs 
Schwann cell de-differentiation, namely up-regulation of the transcription 
factor Sox2.
In chapter 4 we provide in-vitro evidence that the Wnt ligands Wnt5a, -5b 
and -4 do indeed affect axon outgrowth and Schwann cell differentiation. 
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In chapter 5 we tested the hypothesis that Wnt ligands have a beneficial role 
in the peripheral nerve regeneration process in-vivo. Surgical peripheral 
nerve repair in rats was combined with lentiviral vector-mediated 
expression of Wnt inhibiting factor 1 (Wif1, a protein that scavenges several 
Wnt ligands) or Wnt5a to test the effects of Wnt ligand sequestering or Wnt5a 
overexpression. Also, mice with Schwann cell specific genetic deletion of 
Wnt5a were generated to study the impact of Schwann cell-derived Wnt5a 
on nerve regeneration. 
Overexpression of Wif1 results in a significant decline in the number of 
axons into a nerve autograft at 2 weeks after the lesion and slowed down 
the recovery of the CMAP response for the distal but not for the proximal 
muscles (Thiap. 5A). Axon regeneration is impaired in nerves with Schwann 
cell specific knock-out of Wnt5a (Thiap. 5C). Overexpression of Wnt5a does 
induce the expression of Sox2, a transcription factor with a role in Schwann 
cell dedifferentiation, but Wnt5a overexpression does not promote axon 
regeneration (Thiap. 5A,B). These observations demonstrate that interfering 
with Wnt-signalling in experimentally induced peripheral nerve injury 
hampers the axon regeneration process and suggest a role for Wnt ligands 
in nerve repair. 
In chapter 6 we first discuss the possible biological mechanisms on 
how FMDs are formed and suggest strategies how to investigate which 
processes cause FMD formation. Second, the clinical impact of FMDs on 
NIC pathology is discussed and several possible treatments are proposed 
aimed to promote myelination in NIC. Third, we will discuss the proposed 
pull-push hypothesis, a hypothesis that proposes a mechanism on how 
Wnt ligands would promote functional recovery in the injured peripheral 
nerve. Fourth, we discuss polarised Wnt receptor expression as a potential 
mechanism explaining how Wnt signalling promotes regeneration of the 
peripheral branch but inhibits regeneration of the central branch of DRG 
neurons. Finally, we discuss the potential role of Sox2, a transcription factor 
acting as an ‘inhibitor of myelination’ in Schwann cells and induced by 
Wnt5a in the injured peripheral nerve. 
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General discussion
1 Focal Myelin Deficits (FMDs) – mechanism and clinical impact
1.1 Biological Mechanism underlying the formation of FMDs
The biological mechanism underlying the formation of FMDs is not clear. 
We considered a number of possible mechanisms by which FMD may be 
formed, including immune-mediated attack on (newly formed) myelin 
sheaths, a deficit in the capacity of Schwann cells to form new myelin, and 
a relationship with the degree of nerve fibrosis of the NIC. The absence 
of morphological features indicative of demyelination and the absence of 
macrophages suggest that FMD are not formed as a result of an immune 
system mediated process. Schwann cell myelin formation is controlled by 
an elaborate network of transcription factors with characteristic temporal 
expression patterns 5. Schwann cells in the FMD did not differentially 
express Oct6 and Krox20, two transcription factors that are expressed in 
pro-myelinating and mature myelinating Schwann cells respectively. cJun, 
a transcription factor induced in Schwann cells activated after nerve injury 
6,7, was not up-regulated in Schwann cells of the FMD. The use of these 
transcriptional markers did therefore not provide information about a 
potential aberrant state of differentiation of Schwann cells in FMDs. 
A broader investigation into the transcriptional as well as epigenetic 
changes in Schwann cells in FMD could shed more light on the mechanism 
underlying their failure to form myelin. Recent evidence points to 1) a link 
between DNA methylation patterns and the regulation of Schwann cell gene 
expression 8,9, 2) the involvement of the transcription factor Zeb2 10,11 which 
recruits the histone deacetylase HDAC to inhibit expression of Sox2 and 
Notch 12, two proteins with a direct negative impact on myelination, 3) the 
importance of the “strength” of ERK1/2 MAPK activation in demyelination/
myelination 13, and 4) a role for axon-associated factors in the initiation 
or inhibition of myelination 14-16. Collectively, these recent reports highlight 
the multidimensional nature of the regulation of Schwann cell activation, 
differentiation and myelination. 
In the future, Laser Capture Microscopy (LCM) mediated excision of FMDs 
and of control tissue containing myelinated axons of the NIC, could be 
used to perform a full-scale analysis of the transcriptional and epigenetic 
changes in FMD. A major limitation of such an exploratory study on human 
patient derived specimens would be that NIC tissue is only available from 
“end stage” NIC. A good animal model that mimics the formation of NIC 
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with FMDs would be a great asset to investigate the temporal dynamics of 
the formation and persistence of FMDs following peripheral nerve injury. 
However, the generation of a reliable and reproducible NIC animal model 
has proven to be a challenge as earlier attempts in rats and rabbits have 
resulted in neuromas with characteristics that are quite distinct from those 
seen in human NIC 17,18.  
1.2 Clinical impact: resection of NIC versus myelin repair
We observed strongly diminished clustering of three essential components 
of the nodes of Ranvier [Na(v)1.6 channels, Caspr and Ankyrin-G]. Thus, 
the formation of the nodes of Ranvier on axons in FMD has been severely 
compromised. The diminished clustering of these proteins suggests that 
saltatory action potential propagation through the NIC may be impaired. 
Our data may therefore provide a novel biological explanation for multiple 
reports that document a transduction block in patients with neurotmetic 
peripheral nerve lesions 19-21. 
In patients that show no recovery of function, neurosurgical exploration of 
a brachial plexus injury frequently reveals the formation of a NIC 22. The 
current treatment of a NIC involves the resection of the NIC followed by 
nerve grafting to bridge the lesion. In most patients this results in recovery of 
function, which is however, never complete 23-25. If the functional deficit were 
due to the formation of FMDs it would be imperative to develop strategies 
that would promote the myelinisation of axons. Brief electrical stimulation 
of an injured peripheral nerve has been shown to stimulate both axonal 
regeneration 26-29 as well as axon remyelination 30. Electrical stimulation of 
injured nerves is relatively straightforward and has been applied in two 
successful clinical trials 29,31. The non-invasive nature of electrical stimulation 
and positive effects on both axon outgrowth and myelination allows for 
universal application of this treatment to nerve injuries, including severely 
injured nerves prone to the formation of a NIC. Electrical stimulation could 
potentially also be beneficial in patients that demonstrate no recovery of 
function after several months due to NIC formation. Experiments using 
electrical stimulation in a reliable and reproducible NIC animal model would 
be necessary to first elucidate if early versus delayed electrical stimulation 
is most favourable in improving functional recovery.
Other treatments that can potentially stimulate myelin formation are still 
in a preclinical phase of development, including the transplantation of 
Schwann cells, Schwann cell precursors, bone marrow mesenchymal stem 
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cells, olfactory ensheating cells, and induced pluripotent stem cells (iPSCs) 
derived Schwann cells 32-34. iPSC derived Schwann cells have been shown to 
myelinate cultured DRG axons 35. Since iPSC can be produced in a patient 
matched manner it would in principle be possible to prepare iPSC derived 
Schwann cells from a patient with a brachial plexus injury and use these as 
an autologous transplant without the risk of rejection by the immune system. 
It remains unclear if or how transplanted cells will intermingle with Schwann 
cells that populate FMDs, or if local signalling from transplanted cells might 
stimulate non-myelinating cells of the FMD to initiate myelination.
An alternative strategy to promote myelination in FMDs would be to use 
small molecule treatment to stimulate Schwann cell myelination. There are 
several small molecules in development to stimulate oligodendrocyte (CNS) 
myelination 36, but to our knowledge there are no Schwann cell specific 
small molecules in development with the aim to stimulate myelination.
2 The pull-push hypothesis
Wnt5a can act as a repulsive axon guidance cue 37-39, or as a stimulant 
for axon growth 40-43. The differential response of unconditioned and 
conditioned adult DRG neurons to Wnt5a (chapter 4) coincides with changes 
in the Wnt receptor expression profile (chapter 3). Thus, regeneration axons 
that extend through an injured peripheral nerve may be initially attracted 
by Schwann cell-derived Wnt5a (“pull”), but as these fibers enter the more 
distal portion of the nerve and approach their target cells, Wnt5a may act 
as a repulsive factor and may “push” these axons towards their target. 
In chapter 5 we show that functional perturbation of Wnt ligands with 
lentiviral vector-mediated WIF1 or by Schwann cell specific knock-out of 
Wnt5a (loss of function experiments) negatively impacts axon regeneration 
in a peripheral nerve. This provides evidence that Wnt ligands play a role in 
peripheral nerve regeneration. However, overexpression of Wnt5a (gain of 
function) did not stimulate nerve regeneration. The explanation for this may 
be that Wnt ligands are up-regulated several fold in a peripheral nerve 
after injury and increasing the levels of Wnt5a by viral vector-mediated 
expression has no additional effect. 
Further in-vivo studies are required to determine how Wnt ligands and their 
receptors influence peripheral nerve regeneration and to gather evidence 
in support of the pull-push hypothesis. Injury-induced complex and 
dynamic patterns of Wnt receptor expression suggest that the sensitivity 
of growing axons to Wnt signals may change during the regeneration 
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process. Future studies will have to focus on the localization and axonal 
transport of the receptor pairs Ryk/Fzd2, and Ror1/Fzd1 at early and later 
time points following a nerve lesion. In chapter 3 we made a start with 
these studies and show that Ryk is gradually up-regulated in DRG neurons 
reaching a peak at 14 post-injury. Information about Ryk, Fzd2, Ror1 and 
Fzd1 expression and their transport in regenerating axons would allow us to 
theoretically predict which of these 4 receptors, or combinations, has a role 
in the axon regeneration process. These predictions could subsequently 
be tested by adeno-associated viral vector-mediated overexpression or 
knock-down of individual receptors in regeneration DRG neurons to study 
the consequences on axon regeneration. These experiments are required 
to increase our understanding of the Wnt signaling pathway in peripheral 
nerve regeneration.       
3 Different roles of Wnt5a/b in CNS and PNS regeneration
A number of studies have shown that Wnt/Ryk signalling in CNS injury impairs 
regeneration 44-46. When Wnt signalling through Wnt receptor Ryk was 
impeded with either Wif1 or Ryk blocking antibodies, this resulted in significant 
improvements in axon regeneration 44. In contrast to these observations 
in the injured CNS, we demonstrate that peripheral nerve regeneration is 
impeded when Wnt signalling is hampered. This is remarkable since the 
studies in the CNS and PNS investigate axonal regeneration of the same 
cells, namely DRG neurons. In this context it is important to note that the 
CNS injury studies did investigate the central branch of DRG neurons and 
our PNS injury studies study the response of the peripheral branch of the 
DRG and of peripheral nerve motor axon. 
Fzd receptors are expressed in a polarized fashion in other cells, including 
in hair cells in the mammalian cochlea (inner-ear) 47,48. The differential 
response to Wnt stimulation of the central branch of DRG neurons to Wnt 
stimulation compared to the peripheral branch might also be based on a 
differential or polarised Wnt receptor expression/composition occurring in 
the first 14 days after injury. The peripheral branch may express combinations 
of Wnt receptors that are more prone to stimulate axon growth and the 
central branch expresses a receptor composition that is more prone to 
mediate chemo-repulsion. In chapter 4 of this thesis we demonstrate 
that some Wnt receptors stimulate neurite outgrowth (for example Fzd1 
and Fzd5) and others inhibit neurite outgrowth (Fzd2, Ryk combination). 
Ryk is transported to both branches of DRG neurons 44,49, but Fzd2 may be 
selectively transported to the central branch in injured unconditioned DRG 
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neurons. The lack of Fzd2 antibodies suitable for immunohistochemistry 
has hampered our initial attempts to investigate differential localization of 
Fzd2 between the central and peripheral branch of DRG neurons. Polarized 
expression of Fzd2 could be investigated by generating transgenic knock-
in mice expressing an Fzd2-GFP fusion protein in (DRG) neurons or with 
experiments employing AAV mediated transduction of DRG neurons driving 
expression of Fzd2-GFP fusion protein. By using these approaches it would 
also be possible to investigate broader differences in Fzd2 expression and 
axonal transport between CNS neurons and PNS neurons.     
4 Wnt ligand Wnt5a stimulates the expression of Sox2 an ‘inhibitor of 
myelination’ in Schwann cells
In chapter 3 we show Wnt5a is up-regulated by Schwann cells after 
peripheral nerve injury. In chapter 4 and 5 of this thesis we show that 
exogenous Wnt5a stimulates the expression of Sox2 in Schwann cells in-
vitro and in-vivo. Upon nerve injury Sox2 is up-regulated in Schwann cells 50, 
where it functions as a negative regulator of myelination in conjunction with 
other negative regulators of myelination such as c-Jun 7,50,51. The molecular 
pathway that normally controls Sox2 expression in Schwann cells is not 
known. Sox2 is not regulated by c-Jun, as c-Jun conditional mutant mice are 
still able to up-regulate Sox2 after nerve injury 6. Wnt5a appears to be an 
activator of Sox2 expression in Schwann cells and therefore Wnt5a plays a 
role in the de-myelination response of the injured peripheral nerve. 
There is evidence for a Wnt5a-Sox2 pathway in Schwann cell precursor 
cells and their lineage. Sox2 has a ‘cross regulatory’ interaction with Mitf 
during development to regulate the rise of melanocyte progenitor cells 
(melanogenesis) from Schwann cell progenitor cells 52. Interestingly, this 
process is found to be under the control of Wnt5a. This was corroborated 
in cultured melanoma cells where Sox2 knock-down results in Mitf up-
regulation, but also Wnt5a down-regulation 53. Furthermore, TGF-β 
stimulation of melanoma cells results in both Wnt5a and Sox2 up-regulation 
53. Recent studies have identified Zeb2 as an inhibitor of the myelin-inhibiting 
molecular pathway of Sox2 in Schwann cells 10,11. A Zeb2-Mitf-Zeb1 pathway 
is also involved in melanogenesis and melanoma progression, where Zeb2 
is proposed to regulate Mitf levels 54. Taken together, both Zeb2 and Wnt5a 
appear to converge on Sox2 during Schwann cell lineage development 
and myelination. It would interesting to investigate the effect of Wnt5a 
stimulation on Zeb2 expression in Schwann cells to further unravel the role 
of Wnt5a in the molecular pathways that govern de-myelination. 
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Next to the potential role of Wnt5a in de-myelination we show preliminary 
data that suggest that other Wnt pathway genes are involved in the re-
myelination response after injury. In chapter 3 we show that Wnt pathway 
genes grouped in the MBP cluster are down-regulated at the time de-
myelination and return to baseline coinciding with re-myelination. The Wnt 
pathway genes grouped in Axin2 cluster are up-regulated coincidentally 
with initiation of re-myelination and remain up-regulated till at least 90 days 
after PNS injury. Axin2 gene expression itself is stimulated by the β-catenin 
Wnt pathway 55,56, and has therefore been employed as an indicator for 
active β-catenin Wnt signalling 57 also in Schwann cells 4. The Axin2 cluster 
includes several genes that are involved in the β-catenin pathway, including 
Lrp5/6, Fzd1/2/3/4/6/7 and Wnt3a. This all suggests that the Axin2, and the 
Axin2 cluster reflects active β-catenin signalling, a pathway essential for 
lineage progression of neural crest cells 58, the process of axonal sorting 4 
and for myelination in Schwann cells 59.
In the human NIC, Wnt5a and TGF-β mRNA are both up-regulated as 
shown in our microarray analysis of the NIC. Therefore a potential causal 
relationship between Wnt5a up-regulation and FMD formation mediated 
through Sox2 would be a possible molecular mechanism underlying the 
formation of FMDs. However the microarray analysis demonstrates that 
Sox2 mRNA expression is reduced in NIC tissue 3. The reduction of Sox2 mRNA 
could be caused by a decreased Schwann cell/ fibroblast ratio compared to 
the proximal stump, as a result of the excessive fibrosis observed in the NIC. 
This is also reflected in a decrease of several other Schwann cells markers, 
including GFAP and S100b. Zeb2 is in the 10% most down-regulated genes, 
although it is not significantly down-regulated (p=0.21), whereas Mitf mRNA 
expression in NIC is not changed. A full-scale analysis of the transcriptional 
changes in myelination Schwann cells and Schwann cells of an FMD (as 
proposed in section 1.1) might also provide in changes in Wnt-Sox2 signalling 
in the NIC and its potential role in FMD formation. 
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Nederlandse samenvatting
Wereldwijd lopen naar schatting vele tienduizenden, zo niet 
honderdduizenden, mensen perifeer zenuwletsel op. Ernstig zenuwletsel 
kan resulteren in de vorming van een neuroma-in-continuity (NIC). Een 
NIC remt de regeneratie van zenuwvezels af en belemmert het functioneel 
herstel, maar het is onduidelijk waarom dat zo is. 
Dit proefschrift heeft twee verwante doelen. Het eerste doel was het 
identificeren van de processen die aan de basis liggen van hoe een NIC 
functioneel herstel belemmert. Het tweede doel was om de rol van Wnt 
(wingless-type MMTV interation site family)-signalering in de regenererende 
perifere zenuw te achterhalen. Er waren twee redenen waarom we ons op 
Wnt-signalering wilden richten: ten eerste omdat onze onderzoeksgroep 
ontdekt had dat Wnt5a is op-gereguleerd in NIC-weefsel van patiënten die 
chirurgische reconstructie van de zenuw ondergaan hadden, en ten tweede 
omdat Wnt5a een bekende axon groeifactor is, met context-afhankelijke 
repulsieve of groei-stimulerende effecten, zowel tijdens de ontwikkeling als 
na letsel van het centraal zenuwstelsel. Het kan dus zo zijn dat Wnt5a ook 
de regeneratieve axongroei in het NIC remt. 
Hoofdstuk 1 geeft een gedetailleerde introductie van het proces van 
perifere zenuwregeneratie en de vorming van humaan NIC. Verder 
geeft dit hoofdstuk een overzicht van de verschillende complexe Wnt-
signaaltransductieroutes.
Functioneel herstel blijft uit bij 10% van de patiënten met neonataal 
brachiaal plexus letsel. Bij deze patiënten is chirurgische verwijdering van 
de NIC en reconstructie van de zenuw met een zenuwtransplantaat nodig. 
In hoofdstuk 2 gebruiken we diverse histopathologische technieken om 
humaan NIC weefsel dat verwijderd werd tijdens een neurochirurgische 
hersteloperatie te bestuderen. We tonen aan dat NIC-weefsel vaak op 
meerdere plaatsen focale myeline defecten (FMD) heeft. Een FMD bevat 
Schwanncellen, die axonen omhullen, maar geen myeline vormen (Thesis 
in een pagina; Thiap. 2A). Door middel van een bio-wiskundige aanpak 
konden wij berekenen dat elk axon in een NIC meerdere FMD tegenkomt 
(Thiap. 2B). Axonen in een FMD hebben verstoorde knopen van Ranvier. 
Dit betekent dat FMD, deels,  de neuropathologische basis zouden kunnen 
vormen voor de geblokkeerde actiepotentiaalgeleiding en het daarmee 
gepaard gaande ontbreken van het functioneel herstel zoals we dat zagen 
in een subset van patiënten met brachiale plexus letsel.
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Wnt liganden zijn evolutionair zeer goed geconserveerde geglycosyleerde-
eiwitten die een belangrijke rol spelen bij weefselontwikkeling en 
-regeneratie. In hoofdstuk 3 wordt een uitgebreide analyse gemaakt 
van Wnt pathway genexpressie in humane NIC en beschadigd perifeer 
zenuwweefsel van de rat. Wnt5a is op-gereguleerd in Schwanncellen van 
het NIC en kan na uitscheiding in de extracellulaire ruimte binden aan de 
Wnt receptor Ryk, die aanwezig is op de celmembraan van nabij gelegen 
regenererende axonen (Thiap. 3A). Schwanncellen in het NIC zouden dus de 
bron kunnen zijn van Wnt5a en dit kan de groei van regenererende axonen 
beïnvloeden. Deze observaties gaven de aanzet tot verder onderzoek naar 
Wnt-genexpressie na zenuwletsel in de rat. Onderzoek bij ratten is nodig 
om de functie van Wnt’s tijdens het proces van zenuwregeneratie te kunnen 
bepalen.
Na beschadiging van de nervus ischiadicus van de rat namen we een 
gecoördineerde regulatie van Wnt genexpressie waar. We identificeerden 
vier genclusters (genaamd de F-Spon1, Wnt2, Axin2 en MBP clusters) met 
specifieke temporele en spatiële expressiepatronen die correspondeerden 
met overlappende fases van het regeneratieproces. Het F-Spon1 cluster is 
van 3 - 5 dagen tot 90 dagen na zenuwletsel sterk op-gereguleerd op de 
plaats van het letsel en in de distale zenuwstomp en bevat meerdere Wnt–
liganden, waaronder Wnt5a en Wnt4 (Thiap. 3B). Dit wijst er op dat deze 
genen een rol spelen in zowel vroege (de-differentiatie van Schwanncellen 
en initiatie van axongroei) en late regeneratieprocessen (myelinevorming, 
re-innervatie en Schwanncel differentiatie). Het Axin2 cluster bestaat 
uit genen die zijn op-gereguleerd vanaf 14-28 dagen tot 90 dagen na 
letsel, wat wijst op een rol in de omvorming van myeline en Schwanncel 
differentiatie. Het MBP cluster bestaat uit genen die in expressie naar 
beneden gaan op vroege tijdspunten en terugkeren naar het basale 
expressieniveau rond 14-28 dagen na letsel. Dit zou kunnen duiden op 
een rol in de her-differentiatie van Schwanncellen en de omvorming 
van myeline. De expressie van Wnt receptoren werd onderzocht in DRG 
neuronen van de rat na axonschade. Meerdere Wnt receptoren waren 
significant op-gereguleerd in DRG neuronen na axonschade, inclusief 
Ryk, en Fzd1, -2 en -5. Verder werd gevonden dat R-Spondin1 en -3 op-
gereguleerd zijn door beschadigde DRG neuronen. R-Spondin1 en -3 zijn 
bekende agonisten voor Wnt signalering in Schwanncellen (Thiap. 3C). 
Al met al is de expressie van een klein aantal Wnt genen na zenuwletsel 
gereguleerd in zowel humaan NIC als in dat van de rat. De gecoördineerde 
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expressie van genen van de Wnt pathway na perifeer zenuwletsel in de rat 
wijst op een belangrijke rol voor Wnt signalering in processen die essentieel 
zijn voor een voorspoedige perifere zenuwregeneratie. De functionele 
implicaties van de waarnemingen beschreven in hoofdstuk 3 zijn verder 
onderzocht in hoofdstuk 4 en hoofdstuk 5. 
In hoofdstuk 4 onderzochten wij het effect van drie Wnt liganden (Wnt5a, 
Wnt5b en Wnt4) en de rol van Wnt receptoren, inclusief Ryk, op neuriet–
uitgroei, met gebruikmaking van gekweekte primaire embryonale en 
volwassen DRG neuronen en een DRG-achtige cellijn. We kozen voor 
deze Wnt liganden voor onze verdere functionele studies omdat, zoals 
aangetoond in hoofdstuk 3, hun expressie verhoogd is in humaan NIC 
(Wnt5a) en/of de beschadigde rattenzenuw (Wnt5a, Wnt5b en Wnt4). 
Daarnaast bestudeerden we de effecten van deze Wnt liganden op 
gekweekte primaire Schwanncellen door de expressie van genen die 
indicatief zijn voor de staat van differentiatie van deze cellen te meten.
Wnt5a fungeert niet als een repulsieve factor voor embryonale DRG 
neurieten in een klassiek repulsie–assay, maar Wnt5a, -5b en -4 stimuleren 
de neuriet-uitgroei van embryonale DRGs (Thiap. 4A). Na blootstelling 
aan Wnt5a vertoonden gekweekte volwassen DRG neuronen verkregen 
uit naïeve ratten (“ongeconditioneerde” DRG neuronen) geen significante 
reactie op Wnt5a, maar wel een duidelijke trend richting verhoogde neuriet-
uitgroei. Volwassen DRG neuronen verkregen uit ratten die 14 dagen voor 
kweek een conditionerende laesie ondergingen (“geconditioneerde” 
DRG neuronen) vertonen een verminderde neuriet-uitgroei in reactie op 
behandeling met Wnt5a. In tegenstelling tot niet-geconditioneerde DRG 
neuronen lijken geconditioneerde DRG neuronen dus repulsief te reageren 
op Wnt5a.
De uiteenlopende reacties van niet-geconditioneerde en geconditioneerde 
DRG neuronen op Wnt5a gaf ons de aanzet tot bestudering van de rol van 
de Wnt receptoren Ryk en Fzds in de neurietuitgroei. Embryonale DRG’s 
zonder Ryk, verkregen uit Ryk-/-muizen, vertonen significant meer uitgroei 
na stimulatie met Wnt5a dan wildtype DRGs (Thiap. 4A). Dit toont aan dat de 
aanwezigheid van Ryk de uitgroei van embryonale sensorische neurieten 
negatief kan beïnvloeden. De overexpressie van (combinaties van) Wnt 
receptoren stimuleert of remt neurietuitgroei van een DRG-achtige cellijn in 
een cellulaire screening. Fzd1, -5, -6, -7 en Ror2 stimuleren neurietuitgroei, 
onafhankelijk van exogeen Wnt5a (Thiap. 4B). De combinatie van Fzd2 
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met Ryk en Ror1 met Fzd1 lijken een door Wnt5a gemedieerde afname van 
neurietuitgroei te veroorzaken. Gebaseerd op deze bevindingen stellen wij 
dat de veranderingen in expressie van Wnt-receptoren in DRG neuronen 
gedurende het axonregeneratieproces de Wnt5a gemedieerde uitgroei 
respons veranderen van aantrekkend (gedurende de vroege stadia van 
regeneratie) naar afstotend (in latere stadia van regeneratie). We noemen 
dit de pull-push hypothese.
Gekweekte primaire Schwanncellen reageren op Wnt5a, -5b en -4 stimulatie 
met een opregulatie van Sox2 en met verminderde expressie van GFAP, 
Gap43 en GDNF (allen markers voor gededifferentieerde Schwanncellen), 
en met verminderde expressie van MBP (een marker voor gedifferentieerde 
myeliniserende Schwanncellen; Thiap. 4C). Deze observaties wijzen er 
op dat Wnt5a, -5b en 4 een sleutelrol spelen in de moleculaire pathways 
die Schwanncel dedifferentiatie aansturen, namelijk de op-regulatie van 
transcriptiefactor Sox2. 
In hoofdstuk 4 laten we zien dat, in-vitro, de Wnt-liganden Wnt5a, -5b en 
-4 inderdaad de axonuitgroei en Schwanncel-differentiatie beïnvloeden. 
Hoofdstuk 5 doet verslag van de test van de hypothese dat, in-vivo, Wnt 
liganden een positieve rol spelen bij perifere zenuwregeneratie. We hebben 
gekeken naar de combinatie van chirurgische perifere zenuwreparatie in 
ratten  met lentivirale vector-gemedieerde expressie van ‘Wnt inhibiting 
factor 1’ (Wif1, een eiwit dat meerdere Wnt liganden afvangt) of Wnt5a, om 
te zien wat het effect van meer of minder Wnt zou zijn op axonregeneratie. 
Verder hebben we muizen met Schwanncel-specifieke genetische 
deletie van Wnt5a gegenereerd om de impact van door Schwanncellen 
geproduceerde Wnt5a op zenuwregeneratie te bestuderen. 
Overexpressie van Wif1 bleek te resulteren in een significante afname van het 
aantal axonen dat twee weken na laesie in een zenuw-autograft groeide. 
Het vertraagde tevens het herstel van de CMAP voor de distale, maar 
niet voor de proximale spieren (Thiap. 5A). Tevens werd axon-regeneratie 
afgeremd in zenuwen met Schwanncel-specifieke knock-out van Wnt5a 
(Thiap. 5C). Overexpressie van Wnt5a induceerde wel de expressie van 
Sox2, maar Wnt5a overexpressie stimuleerde geen axonregeneratie (Thiap. 
5A,B). Deze waarnemingen laten zien dat verstoring van Wnt signalering 
in experimenteel geïnduceerd perifeer zenuwletsel het axonregeneratie 
proces verhindert en wijst op een rol voor Wnt liganden bij zenuwherstel.
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In hoofdstuk 6 bediscussiëren we eerst de biologische mechanismen die ten 
grondslag zouden kunnen liggen aan de vorming van FMD en bespreken 
we strategieën om deze mechanismen verder te kunnen bestuderen. Ten 
tweede bespreken we de klinische impact van FMDs op NIC pathologie, 
alsmede  mogelijke strategieën die kunnen leiden tot de bevordering 
van myelinisering. Ten derde bespreken we de voorgestelde ‘pull-push’ 
hypothese: hierbij stimuleren Wnt liganden de axonen aanvankelijk om 
naar de plek van zenuwletsel toe te groeien, maar later doen ze het 
tegenovergestelde, zodat ze juist weggroeien van de plek van zenuwletsel 
- en dus verder de distale zenuw in. Als vierde bediscussiëren we 
gepolariseerde Wnt-receptorexpressie als een mechanisme dat mogelijk 
kan verklaren hoe Wnt signalering regeneratie van de perifere tak stimuleert, 
maar regeneratie van de centrale tak van DRG neuronen remt. Als laatste 
komt de mogelijke rol van Sox2 aan de orde, een transcriptiefactor die een 
sleutelrol speelt als remmer van myelinisering in Schwanncellen en die op-
gereguleerd wordt door Wnt5a bij perifeer zenuwletsel. 
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